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“Whenever a theory appears to you as the only 
possible one, take this as a sign that you have 
neither understood the theory nor the problem 
which it was intended to solve.” 
―    Karl R. Popper  
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ABSTRACT 
 
The main aim of this thesis was to study the functional properties of health-promoting 
compounds in vitro with an emphasis on milk proteins, vitamin E and micronutrients. 
The health-promoting effects of intact whey and casein proteins were evaluated 
after in vitro SGD. Permeate (absorbed fraction) and retentate (intestinal fraction) were 
obtained and used to study their health-effects in vitro. Soya protein was include as non-
animal protein in all the experiments performed. Following SGD, the milk proteins 
exhibited antioxidant activity, ACE-inhibitory activity and tropho-functional properties at 
the intestinal cell level. The whey protein permeate exhibited a higher ACE-inhibitory 
activity compared with the casein and soya protein permeate. SGD increased the ACE-
inhibitory activity of whey protein and the antioxidant activity of all the protein tested. At 
specific concentrations, casein, whey and soya proteins were able to modulate intestinal 
cell viability and the production of intestinal mucus. Moreover, the proliferation of 
Lactobacillus casei was increased by specific concentrations of whey and casein proteins. 
Modulations of mucus production and probiotic bacteria growth were observed, and 
casein was the primary protein that was able to stimulate MUC5AC gene expression and 
promote Lactobacillus casei growth. Altogether, the analyses of goblet cell proliferation 
and prebiotic bacterial growth may represent complementary approaches to study the 
bioactivities and the functions of food proteins in the gut. Additionally, the comparison of 
the effect of the two major intact milk proteins performed in this thesis could provide 
valuable information regarding which is more efficacious in improving health.  
α-tocopherol has been demonstrated to play an important role in reducing oxidative 
stress at cellular level, in different in vitro models. Food toxicants, as OTA, have been 
found to be able of disrupting the cell monolayer and damaging DNA, which leads to cell 
death. OTA reduced tight junctions protein localization in cell membranes and influenced 
cell-cell interactions. The immunofluorescence analyses revealed changes in the patterns 
of occludin and Zo1 proteins in the presence of OTA, compared with control cells. OTA 
cytotoxic effects were counteracted by the presence of α-tocopherol. The pre-treatment 
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with α-tocopherol blocked the loss of occludin protein in the tight junctions of kidney cells 
treated with OTA. α-tocopherol supplementation has demonstrated to counteract short-
term OTA toxicity at different cellular levels, supporting the defensive role of this 
compound in the cell membrane.  
Finally, the in vitro roles of different micronutrients, specifically 
choline/methionine and different Zn formulations, were determined. Due to their 
physiological health-promoting effects, both choline/methionine and Zn are commonly 
used in animal nutrition. The results of this thesis confirmed that under condition of stress, 
choline and methionine have important roles in enhancing cell viability and counteracting 
oxidative stress. Specific concentrations of different Zn sources maintained the viability 
of human and swine intestinal cells, which underlines the beneficial role of Zn in human 
and swine intestinal epithelia. 
Overall, these results contribute to the identification of the roles of different dietary 
health-promoting compounds in human and animal target tissues by making in vitro 
models an essential tool. However, further in vivo experiments are necessary to extend 
these in vitro results and to clarify the contributions of health-promoting components in 
animal feed and human formulations. The improved knowledge related to milk protein 
bioactives, antioxidants and micronutrients represents a crucial subject for future 
systematic efforts to improve food and feed quality.  
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LIST OF ABBREVIATIONS 
 
ACE   Angiotensin-Converting Enzyme 
BME-UV1  Bovine Mammary Epithelia – University of Vermont – clone 1 
CVD   Cardiovascular Disease 
EGF    Epidermal Growth Factors  
HT29-MTX  HT-29 cells selected by adaptation to methotrexate 
IGF-I   Insulin-like Growth Factor-I 
INT-407  Intestine 407 
MDCK  Madin Darby Canine Kidney 
NaACE  Sodium Acetate 
NaBt   Sodium Butyrate 
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OTA   Ochratoxin A 
SCFA   Short Chain Fatty Acid 
SGD   Simulated Gastrointestinal Digestion 
TGF-α   Transforming Growth Factor α 
TGF-β1  Transforming Growth Factor β1 
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Zo1   Zonulin 1  
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PREFACE 
 
Nutritional research commonly employs in vitro models to study the roles of health-
promoting food compounds. The application of biological in vitro assays represents a 
preliminary step for the development of powerful in vivo studies. Among the health-
promoting compounds that have received interest in recent years, milk-derived bioactives 
and antioxidant molecules (e.g., vitamin E) exhibit a wide range of health-promoting 
applications in humans and animals. 
The studies reported focused primarily on the evaluation of the physiological and health-
promoting effects of milk bioactives, vitamin E and other micronutrients that were 
investigated with an in vitro approach. 
This Ph.D. thesis is composed of three chapters.  
Chapter I. In the first chapter, the health-promoting role of in vitro-digested milk proteins 
was investigated with consideration for the antioxidant and ACE-inhibitory effects. 
Further, the influence of protein digesta was investigated at the gut level in terms of 
intestinal cell proliferation, the production of the intestinal mucus and the effect on the 
growth of prebiotic bacteria (Lactobacillus casei). The experiments reported in this 
chapter were conducted in collaboration with the University of Aarhus (DK) and the 
University of Reading (UK). 
Chapter II. In the second chapter, I present three studies related to the health-promoting 
role of vitamin E as an antioxidant in vitro. Specifically, I evaluated the relative 
bioefficacies of two different forms of α-tocopherol in counteracting the cytotoxicity 
induced by hydrogen peroxide. To this purpose, in vitro models of the mammary gland 
(BME-UV1) and the kidney (MDCK) were employed. Moreover, the role of α-tocopherol 
in the counteraction of OTA toxic activity in the kidney was determined. To this purpose, 
the mechanism of action of OTA at the cellular level (DNA integrity, 8-OHdG adduct 
formation, DNA methylation pattern) was determined in vitro. 
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Chapter III: In this chapter, I present two studies about cell-micronutrient interactions 
that I performed during my Ph.D. studies. Specifically, the first study aimed to investigate 
the roles of choline and methionine in counteracting cytotoxic damage using an in vitro 
mammary cell model. The second study aimed to identify the contribution of Zn in the 
swine intestine and the human epithelium. 
In the add-on project section, I report the training activities I performed during may 
experience abroad at Reading University (UK) as a research scholar. At Reading 
University, I was involved in the set-up and design of the in vivo human study that sought 
to investigate the acute and chronic effects of milk proteins on heart disease risk markers, 
such as blood pressure and vascular function. The obtained results will be submitted to a 
scientific journal after the completion of the data analysis and will be compared with the 
results of the in vitro investigation of the effects of digested proteins that are reported in 
chapter I of this thesis.  
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GENERAL INTRODUCTION 
 
Health-promoting compounds 
 
The food industry is one of the most important sectors of the EU economy. Despite the 
low intensities of research and development (Garcia Martinez, 2000), innovation and 
novel production development represent important strategies for company growth and the 
satisfaction of consumer demands (Menrad, 2003 & 2004). Specifically, over the past two 
decades, consumer ‘expectations have become more direct regarding healthier and higher 
quality foods, and the consumer demand for foods that support functional needs has 
rapidly expanded. Food components are not only demanded due to their traditional 
nutritional value but are also demanded for their health-promoting activities. This factor, 
combined with the increase in unhealthy diet-related disease (e.g., diabetes and 
cardiovascular disease) (Li Chain, 2015), led to strong development of the concept of 
health-promoting compounds. Health-promoting compounds may be defined as food 
ingredients with specific bioactive functions, such as antioxidant, ace-inhibiting, anti-
inflammatory, prebiotic and probiotic functions, despite their traditional nutritional roles. 
Health-promoting compounds represent a sustainable trend in the food market (Bigliardi 
and Galati, 2013) and an interesting area of research for the scientific community. 
Numerous bioactive compounds appear to have beneficial health effects in vivo and in 
vitro.  
In this context, food-derived peptides have high nutritional values and are healthy 
compounds that are suitable for the development of health-promoting functional foods. 
Milk proteins are considered one of the most important sources of bioactive peptides and 
are encrypted in inactive forms in parent protein sequences. Peptides can be released 
through gastrointestinal digestion. The activities of the gastric and pancreatic enzymes 
induce the production of bioactive peptides that have been identified as potential 
ingredients in health-promoting foods. Once released, milk bioactive peptides exert a wide 
range of physiological effects that differ from those of their parental proteins, including 
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antihypertensive, antithrombotic, prebiotic and antioxidant effects and the ability to 
modulate gastro-intestinal cell activity and function (Wada and Lonnerdal, 2014; Petrat-
Melin et al., 2015; Plaisancié et al., 2014). The greatest bioavailability and bioactivity 
occur when the size of a bioactive peptide is approximately 3–20 amino acids, such amino 
acids are encrypted within the parental proteins and become activated following their 
release, which is induced by the actions of gastric and pancreatic enzymes (Kekkonen 
2009; Korhonen 2009; Korhonen et al., 1998).  
Vitamin E, carotenoids and flavonoids have been studied for their potential health benefits 
particularly those related to antioxidant activity and potential roles in disease prevention 
(Virtamo et al., 2003 and 2014). Vitamin E is an oil-soluble antioxidant that is associated 
with several health benefits, such as reducing CVD, diabetes and cancer (Sylvester et al., 
2011; Traber et al., 2008). Moreover, vitamin E plays roles in hemoglobin biosynthesis, 
the modulation of immune responses, and the stabilization of the structures of membranes. 
Meydani et al. (2000) described the rationale for including food containing high levels of 
vitamin E in the daily diet in combination with generous amounts of supplemental vitamin 
E in designed functional foods. Vitamin E, in the context of dairy cow nutrition, has a role 
as antioxidant that is able to prevent free radical-mediated tissue damage and delay the 
development of degenerative and inflammatory diseases. Vitamin E seems to be involved 
in the immune system function of cows. Supra-nutritional levels of the vitamin may result 
in improved immune responses (Baldi, 2005). Smith and co-workers (1984) established 
that supplementation with vitamin E, in conditions in which dietary selenium is adequate, 
significantly reduces the incidences of intramammary infections (IMI) and clinical 
mastitis. In vitro, vitamin E is one of the most important components of cellular 
antioxidant systems. Vitamin E (tocopherols and tocotrienols) is present in all cell 
membranes and plasma lipoproteins. Vitamin E is one of the major lipid-soluble chain-
breaking antioxidants that protects DNA, low-density lipoproteins (LDLs), and 
polyunsaturated fatty acids from oxidative damage. Tocopherol has previously been 
demonstrated to protect the cell from oxidative damage in vitro (Baldi et al., 2004) and 
reduces DNA fragmentation and apoptotic body formation (Fusi et al., 2008). However, 
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only a few reports in the literature have compared the activities of different tocopherol 
isomers in terms of in vitro oxidative environments. 
Scientific food and feed research commonly uses in vitro models to study interactions 
between health-promoting compounds and the intestinal, mammary and renal epithelia. 
The application of in vitro assays represents a useful tool for the development of powerful 
in vivo studies. 
 
In vitro cell culture models 
 
In light of the strong international concern to reduce the use of experimental animals, cell 
culture technology is reaching growing interest among nutritional and food researchers. 
In vitro models are used to study proliferation, differentiation, toxicology potential of the 
food and feed compounds, limiting the use of experimental animals. Moreover, 
considering the high-defined in vitro parameters and conditions, cell culture models lead 
to the production of reproducible results essential for a well design of in vivo studies. 
Cell-based bioassays are representative of the in vivo situation and physiology and 
therefore they are considered a suitable alternative for in vivo experimentation. The need 
of reliable in vitro cellular models as alternatives to animal studies is considered by the 
European legislation (http://www.euractiv.com/en/science/ eu-wants-fewer-animals-
used-research-news-497607). As the science behind in vitro technology advances, and 
results from new alternatives are shown to be both transferable and reproducible, in vitro 
models continue to gain acceptance among research community and regulatory bodies 
(Cheli & Baldi, 2011). Cell-based bioassays have many advantages including 
accessibility, homogeneity of cell population, reproducibility, stable growth rate, and can 
be designed to reflect cell and tissue responses and address specific experimental 
conditions and challenges (Langerholc et al., 2011). Nowadays, there are centers 
throughout the world that focus on the development, validation, and use of alternatives in 
the biomedical sciences.  
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The interest of food and pharmaceutical industry to cell-based bioassays is mainly related 
to toxicological and bioavailability tests of newly developed food ingredients and drugs, 
inevitable for bringing products to the market. The research regarding the safety and 
efficacy of additives and new functional food ingredients is an open issue and may take 
advantage from the use of specific cell-based functional bioassays (Baldi & Cheli, 2011). 
The use of cell-based models in food research has many advantages; several 
concentrations of a compound could be assayed at the same time, under strictly control of 
chemical, physical and physiological conditions, also considering the hormesis concept 
(Calabrese et al., 1998; Calabrese, 2010). For each food constituent tested, several 
endpoints can be investigated, such as cell proliferation, viability, cell migration and the 
regulation of gene-expression, making the in vitro cell technology a promising sector of 
food research. Further, cell-based bioassays represent a low-price and speed response 
alternative to animal testing, in line with the European Union guidelines (Cheli et al., 
2015). 
However, the use of cell model is not free of problems. Depending on the model selected, 
cell cultures may not reflect the in vivo situation due to the loss of architecture and three-
dimensional tissue-specific interactions between cells. The lack of endocrine and nervous 
systemic components in the cultural environment represent a limitation with difficulties 
to maintain cell differentiation. Moreover, in vitro studies do not take into consideration 
the effects of bioavailability, pharmacokinetics, metabolism, distribution and interaction 
with binding and transport proteins, or other biological processes that occur in the intact 
organism, all of which may influence the biological effects of food and feed compounds. 
Cell metabolism is more constant in vitro but not fully representative of the in vivo tissue. 
Therefore the results obtained in vitro need to be translate in well-design animal and 
human studies in order to define the physiological effect of bioactive food components 
(Purup & Nielsen, 2012). In vivo experiments provide information on the net effect of a 
compound in the whole organism, whereas cell-specific answers may be attained with in 
vitro tests. In order to ameliorate the use of in vitro model in food research, scientists 
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should carefully considered the type of cells on the basis of the target organ of the 
compound to be tested and the most important endpoints to measure. 
 
Type of cell-based cultures 
 
A cell culture is a generic term used to indicate the process by which cells, arising from 
the breakdown of tissues or isolated from biological fluids such as blood, are grown and 
maintained strictly controlled conditions. 
In vitro systems have been designed to simulate the in vivo conditions preserving both the 
characteristics of the original tissue and the cell-cell interactions (Zucco et al., 2004). A 
wide range of cell-based models is currently available for food researcher including organ 
cultures, primary cultures, immortalized cells, and three-dimensional models (Zucco et 
al., 2004). 
 
Organ cultures 
 
Organ culture retains whole or partial (explant) original tissue characteristics and cell–cell 
interactions in vitro. Therefore, organ culture could preserve the differentiated properties 
of the derived tissue, making this in vitro model useful for morphological studies. 
However, organ cultures cannot be propagated and do not proliferate rapidly, hence 
remain in culture for a limited period of time. In addition, organ cultures are characterized 
by a high intersample variation, with high implication in the reproducibility of the 
experiments, making difficult to extend the employment of these model in nutritional 
studies. 
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Primary cultures 
 
A primary cell culture is the stage of the culture after the isolation of the cells and before 
the first subculture. The wild-type nature of primary cells make this model useful for 
mechanicist and morphological studies. However, the reduced lifespan together with the 
altered cell phenotypes of primary cell cultures, the slow proliferation rates and metabolic 
capacities limits the applicability of these models in food and nutritional research 
experiments. Moreover, the cell population of a primary culture is not homogeneous and 
can be propagated to a limited number of passages (Astashkina et al., 2012). 
 
Immortalized cell cultures 
 
After the first sub-culture, the primary culture become a cell line and may be propagated 
and subcultured several times. Three-dimensional (3D) models, characterized by a well-
defined geometry, maintains cellular interactions and the relationship between structure 
and function, preserving the cellular interactions. 3D models make use of different 
substrates and the culture can be homotypic or heterotypic. This system enables the main 
cellular functions to be maintained for a limited period of time and generally, do not reach 
a complete stage of differentiation (Mueller-Klieser, 1997). 
 
Barrier systems cultures 
 
Barrier systems are used to study the epithelia (eg. skin, intestine), which are focal points 
of interaction with xenobiotics and nutrients. The epithelial intestinal barrier is the first 
gate which actively interact with food compounds, after ingestion. In particular, HT-29 
and Caco-2 cell lines have been extensively characterized and widely used for studying 
the intestinal barrier function, due also to their ability to differentiate in mature enterocytes 
during long-term culture. HT29-MTX-E12 are also a model of the colonic environment, 
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with the main property of differentiating in culture into a mucus-producing cell line 
(Behrens et al., 2001). 
 
Three-dimensional cultures 
 
The immortalized human cells ‘‘jump’’ the senescence barrier, without losing the other 
physiological properties. These cells undergo cycles of indeterminate replication through 
the introduction of sequences of DNA tumor viruses, such as SV40, Papilloma virus and 
Epstain-Barr virus (Zucco et al., 2004). The fast growth rate, the high nucleus/ cytoplasm 
ratio compared with primary cells and the ability of growth up to high cell density are 
some of the characteristics of this in vitro system. Immortalized cells retain few 
characteristics of differentiated tissue, and a relative homogeneity; their use facilitates the 
comparison of results from different laboratories. 
 
Functional in vitro models and their application in food and nutritional science 
 
Food science research developed several in vitro models to study and reproduce in vitro 
the mammary, kidney and intestinal epithelia. These models represent interesting and 
efficacious systems to study the interaction between food components and target cells. 
Despite the primary role of the intestinal epithelium in the food compound uptake and 
metabolism, the kidney and mammary gland epithelia represent secondary targets of 
several intestinal metabolites. There is a strict interaction among the gut epithelium and 
the secondary target tissues, due to chemical and biological signals mediated by food 
compounds and/or their metabolites. Food compounds modulate primarily the intestinal 
epithelium after the ingestion, but after the intestinal absorption may influence the 
function and the physiology of other tissue and organs. Cell-nutrient interaction studies 
represent a promising system to study and well-describing the role of bioactive at cell 
level. 
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In vitro models of the intestinal epithelium 
 
The gastrointestinal tract is the primary target of dietary compounds, and represent the 
first and most important interface between food and the internal body. therefore, intestinal 
in vitro models are of great interest in food and feed research. 
The intestine is an important environment responsible for processing digestive foodstuff, 
absorbing nutrients and protecting the body against pathogens entering with food. The 
intestinal mucosa is defined by sheets of epithelial cells connected by tight junctions that 
form the epithelial barrier of the intestinal wall. The intestinal epithelial monolayer 
consists of several subsets of epithelial cells that cooperatively constitute a physical and 
biochemical network for the maintenance of the homeostasis between the body and the 
luminal environment (Goto & Kiyono, 2012; Cencic & Langerholc, 2010). the 
predominant cell type in the intestinal epithelium is the enterocytes n the small intestine 
and colonocyte in the large intestine. Enterocytes are specialized for digesting molecules 
and transporting small molecules coming from digestion, colonocytes are absorbing cells, 
mainly implicated in the transport of electrolytes and water.  
Among the cell line available, caco-2 cells have been widely used for proliferative and 
mechanistic studies. They express characteristic and functionality of enterocyte, upon 
reaching confluence (Langerholc, 2010). The human colon carcinoma HT-29 cells, 
besides being a model to study the different aspects of the biology of human cancer, they 
are receiving interest in food digestion and bioavailability studies (Didier et al., 1996; 
Takahashi et al., 1996).  
Along the intestinal tract, goblet cells are present in different number, representing one of 
the major cell types in the intestine. Goblet cells have a crucial role of secreting mucins, 
glycoproteins responsible for the viscoelastic properties of the intestinal mucus layer and 
in maintaining the homeostasis of the intestinal microenvironment and in controlling the 
localization of commensal bacteria (Goto and Kiyono, 2012). Goblet cells can be 
mimicked in vitro using mucus secreting cell lines, such as HT29-MTX-E12 (Figure 1). 
HT29-MTX-E12 cells were extensively used to study the role of bioactive peptides in gut 
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function (Martinez-Maqueda et al., 2013) even if they were not fully characterized respect 
to the major components of the gut. 
 
Figure 1: representative image of HT29-MTX-E12 cell line in culture (40X) 
 
Since the human intestine is the first target of bioactive molecules entering with food, the 
identification of the effects of specific bioactive factors at the intestinal cell level may give 
novel insight into promoting gastro-intestinal development and health, and may have 
applications for the treatment of a number of diseases. 
 
In vitro model of the mammary gland 
 
Mammary tissue cells or explants have been widely-used over the last years as models to 
understand the physiological function of mammary gland. The mammary gland is a target 
organ for several food derived bioactive and therefore a number of mammary cells, in 
particular of bovine specie, have been established.  
Therefore, emphasis has been placed on cell culture methodologies to study growth 
regulation, hormonal responsiveness or biochemical properties of mammary epithelial 
cells (MEC). Some of these previous work have led to the development of stable epithelial 
cell lines of bovine mammary gland (Hu et al., 2009).  
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MAC-T cell lines, BME-UV and BME-UV1 are some of the in vitro models widely used 
to study the biology of the mammary gland of ruminants. 
The MAC-T cell line was obtained by transfection of bovine primary epithelial cells with 
the antigen SV40. This cell line maintains in vitro many of the morphological 
characteristics of breast epithelial cells and can differentiate into a secretory phenotype. 
This cell model has been widely used to characterize the role of various growth factors in 
the bovine mammary epithelial cells or to study the interaction of pathogenic bacteria with 
bovine epithelium. MAC-T cells do not respond to the epidermal growth factor (EGF), a 
known modulator of mammary function (Zavizion et al., 1996). However, MAC-T is not 
a homogeneous cell line: the three sub-clones of this cell line differ in size, growth pattern 
and cytogenetic features (Cheli et al., 1999). 
Other in vitro models of the bovine mammary epithelium are represented by BME-UV1 
(Figure 2) and UV2, obtained by microinjection of the large-T antigen of SV40 in 
epithelial cells of bovine mammary gland in culture (Zavizion et al., 1996). Clones BME 
BME-UV1 and UV2 assume the "cobblestone" morphology, typical of the mammary 
epithelial cells. In particular, if they are grown on plastic alone, assume a polygonal 
morphology, while, on collagen assume a columnar morphology and a domed structure, 
typical of the organization epithelial cells in vivo. Additionally, they are able to form 
desmosomes and microvilli on the apical surface.  
BME-UV cells express functional and biochemical markers of mammary epithelial cells: 
they are, in fact, competent in the synthesis of α-lactalbumin and αs1casein (Zavizion et 
al.,1996). The BME-UV1 cells increase their rate of proliferation in the presence EGF and  
IGF-I (Zavizion et al., 1996) , representing the unique bovine epithelial cell line that 
responds to EGF. Moreover, BME-UV have been used for studying the effect of a number 
of bioactive food components, as milk peptides, growth factors, antioxidants as vitamin E 
and C, considering several endpoints to measure, such as cell metabolic activity, apoptotic 
body formation and gene expression (Pecorini et al., 2012; Fusi et al., 2008; Baldi et al., 
2004). Therefore, these cells represent a valuable in vitro system to examine the 
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interaction between food metabolites and the proliferation, differentiation and cell-to cell 
communication of the mammary epithelial cell. 
 
Figure 2: representative image of BME-UV1 cell line in culture (20X) 
 
In vitro model of the kidney 
 
Among the models of the kidney epithelium, LLCPK and MDCK cell lines are of the most 
used and studied in food and nutrition research (Cho et al., 1989) 
LLC-PK1 possess the main characteristics of the proximal tubule, such as Na+ dependent 
transport systems, enzymes located in the apical membrane and maintained in vitro the 
differentiated morphology and had a well developed endocytotic apparatus (Nielsen et al., 
1998) These characteristics motivated the wide use of this in vitro model for in vitro study 
on the kidney epithelium. 
Figure 3: representative image of MDCK cell line in culture (20X) 
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Madin-Darby canine kidney (MDCK) cells (Figure 3), derived from the kidney of a 
normal Cocker Spaniel dog, show monolayer growth in culture and have several 
functional and anatomical properties like the epithelioid morphology of normal distal 
tubular epithelial cells (Gaush et al., 1966). 
MDCK cells are characterized by apico-basolateral polarity and well defined cell 
junctions. Due to the clear apico-basolateral polarity, well defined cell junctions and the 
rapid growth rate, MDCK cell line provides a tractable model for studying cell polarity 
and junctions (tight, adherens, desmosome and gap) physiology and damage in epithelial 
cells.  
Different strains of MDCK cells are available, as MDCK I, MDCK II, MDCK.1, MDCK.2 
and the parental cell line (Figure 3). MDCK I cells were isolated from low passage 
parental MDCK cells while MDCK II cells were obtained from higher passage parental 
MDCK cells.  
MDCK I display high TER values are negative for the tight junction protein claudin-2, 
displaying an unstable epithelial phenotype. MDCK II display low TER values and are 
positive for claudin-2. MDCK II are larger and taller than MDCK I and they do not present 
gap junctions (Dukes et al., 2011).  
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Table 1: Portfolio of cell lines used in this thesis 
  
Cell line 
Cell 
morphology 
Cell origin Type Species References 
HT29-MTX-E12 
 
Colon 
adenocarcinoma 
Epithelial human Lesuffleur et al., 1990 
INT-407 
 
Small intestine Epithelial human 
Henle & Deinhardt, 
1957 
IPI-2I 
 
Small intestine Epithelial boar Kaeffer et al. 1993 
BME-UV1 
 
Mammary gland Epithelial bovine Zavizion et al., 1996 
MDCK 
 
Kidney Epithelial canine Gaush et al., 1966 
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AIMS OF THE THESIS 
 
The general aim of this thesis was to determine the functional properties of health-
promoting compounds in vitro with an emphasis on bioactive milk peptides, antioxidants 
(e.g., vitamin E) and micronutrients. 
The specific aims were: 
 To study the effect of in vitro-digested whey and casein proteins at both the 
systemic and intestinal levels. The systemic effects were assessed via analyses of 
the antioxidant and ACE-inhibitory properties of whey and casein digested. The 
intestinal effects of digested whey and casein were investigated via an in vitro 
intestinal cell model (HT29-MTX-E12) and a prebiotic bacterial strain 
(Lactobacillus casei) that is physiologically present in the gut.  
 To study the effect of two different α-tocopherol forms in counteracting the 
oxidative damage induced by oxidative stressors in vitro (e.g., hydrogen peroxide 
and OTA). To achieve this goal, in vitro models of the mammary gland (BME-
UV1 cells) and the kidney (MDCK cells) were employed.  
 To study the roles of different micronutrients in the proliferation of different cell 
culture models. To achieve this aim, the first study assessed the roles of choline 
and methionine in reducing oxidative stress in the mammary gland epithelia, and 
the second study examined the trophic effects of two different Zn forms in the 
intestinal epithelia of humans and pigs using INT-407 and IPI-2I cells, 
respectively.  
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CHAPTER I: THE HEALTH-PROMOTING ROLE OF IN VITRO-DIGESTED 
MILK PROTEINS  
 
Milk protein digestion 
 
Dairy products, particularly milk, have several and well-known health benefits. Milk 
represents a rich source of biologically active molecules and possesses a high nutritional 
value and a wide range of clinical benefits (Hill, 2015). Among the different milk 
components, the bioactivity of milk is partly derived from intact high-quality proteins and 
peptides (Fox et al., 2015). Thirty-four grams of protein/liter are present in bovine milk, 
including 20% whey protein and approximately 80% casein protein. Milk proteins are 
considered to be the most important sources of bioactive peptides. Beyond the well-known 
nutritional values of milk proteins, these proteins exhibit an extensive range of 
bioactivities that promote general health and the functions of specific organs and tissues. 
The most important health benefits of milk proteins are obtained following gastrointestinal 
digestion and milk peptides release. Subsequently, the health-promoting functions of 
peptides are related to their structures, which depend on the parent protein composition 
and the liberation of peptides following gastrointestinal digestion. 
In vivo protein digestion begins when food proteins reach the stomach, and protein 
digestion is assisted by the highly acidic gastric environment. This acidic environment in 
the stomach causes the unfolding of proteins, and the gastric enzymes are thus granted 
easier access to the protein structures to cleave them into smaller pieces. Pepsin is the 
gastric enzyme that is responsible for the breaking down of dietary proteins into smaller 
protein portions, i.e., polypeptides. Further, the gastric-protein digesta reaches the small 
intestine where two pancreatic enzymes, trypsin and chymotrypsin, cleave the polypeptide 
chain into specific amino acid sequences. Additional enzymes, such as carboxypeptidase 
and aminopeptidase, which are present in the small intestine, contribute to the intestinal 
digestion of proteins. Di- and tripeptides can be transported by specific transporters or 
hydrolyzed into amino acids in the epithelial cells and subsequently absorbed into the 
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bloodstream and distributed throughout the body where they elicit unique functions 
(Shimizu, 2004).  
In vitro methods for the stimulation of the gastrointestinal protein digestion process are 
widely used in food research to attempt to simulate in vivo physiological conditions in 
terms of pH, temperature, and digestive enzyme concentration (Minekus et al., 2014). 
These methods are rapid, less expensive and involve fewer ethical restrictions compared 
with human trials, which are considered to be the gold standard for studying and 
describing food protein digestion and function. In vitro SGD begins with the mouth phase 
and then reaches the stomach (gastric phase) where pepsin initiates the degradation of 
protein in the acidic pH conditions. Furthermore, the digesta are hydrolyzed by pancreatic 
enzymes (intestinal phase), which results in the production of peptides and amino acid 
sequences of different sizes. The lengths of the bioactive peptide sequences vary between 
3-20 amino acids, and the molecular masses of these peptides are 6000Da (Meisel and 
Fitzgerald, 2003; Sun et al., 2004). Regulatory peptides may be absorbed via carrier-
mediated transport or via paracellular transport to subsequently reach the target tissues 
where they can elicit their specific health-promoting effects. The absorption is regulated 
by the intestinal tight junctions and different food substances that may facilitate the 
paracellular transport of milk peptides (Meisel & Bockelmann, 1999). Milk protein-
derived bioactive peptides may act on different intestinal and peripheral target sites of the 
mammalian organism as exogenous regulatory compounds (Meisel & Bockelmann, 
1999). 
 
Milk bioactive peptides obtained by gastrointestinal digestion 
 
It has been widely demonstrated that bioactive peptides derived from milk protein 
digestion display a wide scope of functions (Hernandez-Ledesma et al., 2014). These 
properties range from pre-absorptive functions in the gastrointestinal tract (i.e., anti-
microbial, prebiotic, and citomodulatory) to post-absorptive functions in the target organs 
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(ACE-inhibitory, immunostimulating, antioxidant, and hypocholesterolemic functions), 
and the majority of the peptides display multifunctional properties (Wada and Lonnerdal, 
2014). 
 
Antioxidant peptides 
 
Free radicals are physiologically produced in the body and are involved in several positive 
functions such as the provision of defense against pathogens and infections and signaling 
roles. The excessive production of reactive oxygen species (ROS) may induce oxidative 
stress and cell damage at the membrane, protein and DNA levels. Milk protein peptides 
have been demonstrated to be potent antioxidant molecules with low side effect profiles 
and high levels of stability and nutritional properties compared with synthetic 
antioxidants. 
Milk-derived peptides exhibit antioxidant properties that counteract radical species or 
inhibit oxidative reactions (Power et al., 2013). 
These factors are of particular interest for the development of novel foods and food 
ingredients with health-promoting functions. 
Several assays have been developed to measure the in vitro antioxidant potentials of 
protein/peptide-enriched preparations. However, there is no a validated technique for 
measuring the total antioxidant activity of a feed or food because of the complex network 
of antioxidant systems. Additionally, the diversity of methodologies that have been 
employed makes it difficult to directly compare the data. 
Among the available analytical techniques, the trolox equivalent antioxidant capacity 
(TEAC) assay is among the most frequently used (Zulueta et al., 2009). The mechanism 
of this assay is based on the scavenging of the 2,2-azinobis- (3-ethylbenzothiazoline-6-
sulphonic acid; ABTS) radical cation (ABTS+) by the antioxidant molecules present in 
the sample. 
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The ferric-reducing antioxidant power (FRAP) assay measures the ability of a molecule 
to reduce the ferric ion ferric 2,4,6-tripyridyl-s-triazine complex [Fe(III)-(TPTZ)2]3 to the 
[Fe(II)-(TPTZ)2]2 ferrous complex at pH 3.6 (Benzie and Strain, 1996).  
The FRAP technique exhibits high reproducibility and is simple and rapid to perform 
(Thaipong et al., 2006). 
 
ACE-inhibitory peptides 
 
CVDs have become an important health issue worldwide. Elevated blood pressure is one 
of the major risk factors for CVD. In recent decades, there has been a strong interest in 
the development of functional foods that exhibit beneficial activities that affect the 
cardiovascular system (Livingstone et al., 2012). The consumptions of milk and dairy 
products have been demonstrated to be associated with positive effects at the 
cardiovascular system level, particularly in relation to the control of blood pressure 
(Fekete et al., 2013). Among the bioactive peptide from milk, ACE-inhibitory peptides 
have received growing interest in the last two decades due to the high prevalence of 
hypertensive subjects and CVD in western countries. 
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Figure 1: Effect of milk bioactive peptides on ACE activity. 
 
ACE is a multifunctional enzyme that is localized in various tissues and associated with 
the renin-angiotensin system that controls blood pressure. Specifically, the ACE enzyme 
converts angiotensin-I to the octapeptide angiotensin-II, which is a potent vasoconstrictor 
that hydrolyses bradykinin, which is a vasodilating agent (Phelan and Kerins, 2011). The 
inhibition of ACE can affect various regulatory systems of the body, such as the 
modulation of blood pressure, the immune system and central nervous system functions 
(Meisel, 1993). Milk contains many ACE-inhibitory peptides that are able to reduce blood 
pressure, particularly in hypertensive subjects. Schlimme & Meisel (1995) reported that 
caseochinine peptides derived from casein fragments exert an antihypertensive effect that 
reduces blood pressure and increases the local blood flow in the intestinal mucosa. These 
peptides may originate either from the action of digestive enzymes, such as pepsin, trypsin 
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and chymotrypsin, or from the actions of proteolytic enzymes at the level of the mammary 
gland to modulate local blood flow and the functionality of the mammary gland itself 
(Schanbacher et al., 1997; Madureira et al., 2010). A recent meta-analysis revealed the 
abilities of lacto-tripeptides (LTPs), obtained from casein digestion, to reduce systolic and 
diastolic blood pressure (Fekete et al., 2015). Additionally, whey protein enzymatic 
digestion determines the release of ACE-inhibitor peptides (Moller et al., 2008) as 
demonstrated by in vivo studies conducted in humans (Pal et al., 2010a; Pal et al., 2010b; 
Pal & Ellis, 2011). It has been shown that the casein proteins and some whey proteins are 
essential sources of bioactive peptides that elicit positive health effects. However, the 
EFSA scientific opinion regarding the functional anti-hypertensive activities of some tri-
peptides have led to the conclusion that there is still no definitive evidence of a cause-
effect relationship between the consumption of these peptides and the control of blood 
pressure and artery elasticity (EFSA Journal, 2009). 
 
Gut modulating peptides 
 
The GI tract is commonly in contact with food digesta, peptides and growth factors are 
regularly present in the gut where they are secreted by glands or ingested with foods, such 
as milk and colostrum (Playford et al, 2000). The gastrointestinal formation of bioactive 
peptides has been the subject togrowing interest among the food scientists. Several 
peptides have been demonstrated to modulate different functional properties of various 
intestinal cells and bacteria. The control of the intestinal epithelial cell growth may be 
regulated by interactions between growth factors, peptides and the various cell types of 
the small and large intestinal epithelia. Peptide growth factors and hormones have pivotal 
roles in the regulation of the functional properties of intestinal cells, including 
proliferation and differentiation (Dignass & Sturm, 2001). Milk peptides play a role as 
modulators of intestinal function and exert both prebiotic and citomodulatory roles at the 
gut level. 
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Gut modulating peptides: Citomodulatory peptides 
 
Peptides and growth factors are regularly present in the gut where they are secreted by 
glands or ingested with foods, such as milk and colostrum (Playford et al, 2000). Several 
regulatory peptides have been found to be present in the intestine and to modulate different 
functional properties of various intestinal cells. The control of intestinal epithelial cell 
growth is regulated by interactions between growth factors and the various cell types of 
the small and large intestinal epithelia. 
Peptide growth factors and hormones play pivotal roles in the regulation of the functional 
properties of epithelial cells, such as proliferation and differentiation (Dignass and Sturm, 
2001). In the intestinal mucosa, receptors for IGF, EGF, TGF-α, TGF-β and the lactogenic 
hormone estradiol-17β have been found, which suggests that these factors may exhibit 
biological activities in the intestinal environment (Purup et al, 2007; Caiazza et al, 2007; 
Galluzzo et al, 2007). However, the data regarding the precise roles of these bioactive 
factors in the regulation of the growth and proliferation of intestinal epithelial cells are 
limited and conflicting. Further knowledge about the activities of various growth factors 
and hormones may contribute to the clarification of their roles at the intestinal level.  
The human gastrointestinal tract harbors an extensive microbial community, and the colon 
contains microbe concentrations as high as 1011- 1012 microorganisms per gram. The 
microbial community of the human colon is responsible for the active breakdown of foods, 
particularly carbohydrates and proteins, which have escaped digestion in the small 
intestine (Windey et al, 2012). The daily intake of fermentable carbohydrates influences 
the composition of the colonic microbiota and the synthesis of SCFAs and thus influences 
colonic health. At the gut level, complex carbohydrates, such as dietary fibers, are 
metabolized by colonic bacteria and then fermented into SCFAs, including butyrate, 
propionate and acetate (Tremaroli and Backhed 2012; Brahe et al, 2013). SCFAs are 
pivotal metabolites of the luminal contents of the large intestine. They provide energy for 
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colonocytes, which require absorptive processes to take up these bacterial metabolites. It 
has been demonstrated that butyrate induces an enhancement in epithelial barrier function 
and the maintenance of colonic health (Peng et al, 2007), whereas, following intestinal 
absorption, propionate and acetate, are involved in cholesterol metabolism, lipid 
biosynthesis and lymphocyte proliferation (Hugenholtz et al, 2013; Curi et al, 1993). 
Because the human intestine is the first target of bioactive molecules that enter with food, 
the identification of the effects of specific bioactive factors at the intestinal cell level may 
provide novel insight into the promotion of gastro-intestinal development and health and 
may have applications for the treatment of a number of diseases. In this context, cell 
culture models have been widely used to evaluate the cellular mechanisms related to 
dietary compounds (Rebucci et al, 2007-2013; Baldi et al, 2004). 
Cell growth-modulating peptides derived from milk protein digestion may stimulate the 
development and maintenance of the health of the gastrointestinal tract. The evaluation of 
the effects of bioactive peptides on the gastrointestinal health is an arduous task as 
demonstrated by the lack of clinical studies. In vitro studies that use intestinal cells 
represent a valuable screening tool with moderate predictive power regarding in vivo 
functions. Cell cultures have been used to investigate the potential health effects of 
bioactive peptides. In vitro cell models allow for the evaluation of the citomodulatory 
effects of milk bioactive compounds in terms of their influences on cell growth, cell 
differentiation and mucus production by goblet cells. Specifically, goblet cells represent 
one of the major cell types in the human intestine and have crucial roles in the maintenance 
of the homeostasis of the intestinal microenvironment and the control of the localization 
of commensal bacteria (Goto and Kiyono, 2012). Goblet cells can be mimicked in vitro 
using mucus-secreting cell lines, such as HT29-MTX-E12 These cells are a subpopulation 
of HT29 human colonic adenocarcinoma cells that have been selected for resistance to 
methotrexate. These epithelial cells can differentiate into mature mucus-producing goblet-
like cells (Behrens et al 2001) but can also be used for proliferation and viability activity 
studies in an undifferentiated state. It is generally accepted that these cells can provide an 
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important alternative to in vivo studies of the gut microenvironment (Behrens et al, 2001). 
HT29-MTX-E12 cells have been extensively used to study the effects of milk peptide 
obtained from casein and whey proteins (Martínez-Maqueda et al., 2012; Martínez-
Maqueda et al., 2013a; Martinez Maqueda 2013b; Zoghbi et al., 2006).  
Given their impressive array of functions, peptides may be incorporated into functional 
foods and drug preparations. Even if the effects of peptides are less than those of synthetic 
drugs, they are characterized by less tissue accumulation and reduced side effects 
compared with synthetic drugs (Li-Chan, 2015).  
 
Gut modulating: Prebiotic peptides 
 
Multiples nutrients that are present in milk have well-recognized prebiotic functions that 
support the beneficial intestinal microflora. Specifically, milk and colostrum contain a 
group of bioactive peptides and oligosaccharides that is characterized by a powerful 
growth promoting activity toward the probiotic microorganisms that are responsible for 
the maintenance of balanced intestinal microflora (Newburg, 2005; Newburg, 1996). 
Numerous studies have demonstrated that lactoferrin can exhibit a prebiotic action that 
stimulates the growth of bacteria of the genera Lactobacillus and Bifidobacterium (Liepke 
et al., 2002; Kim et al., 2004). The stimulatory effects on growth are strain-dependent and 
may be related to the presence of specific receptors for lactoferrin on the surfaces and in 
the cytosolic fractions of sensitive bacteria (Kim et al. 2004). In vitro studies have 
demonstrated that bovine, human and porcine lactoferrins recombinantly expressed in 
Pichia pastoris are able to stimulate the growth of four Lactobacillus strains, including the 
Lactobacillus casei ssp casei (Pecorini et al.,2005). Oligosaccharides are also effective in 
modulating the enteric flora, influencing the activities of the digestive tract and 
modulating inflammatory processes (Kunz et al., 2006; Yu et al., 2012). 
For the abovementioned reasons, milk-derived bioactive peptides are considered to be 
notable candidates for the production of health-promoting functional foods that target the 
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health of different body levels including the heart, bone and digestive system and also 
improve immune defense, mood and stress control. The previously discovered positive 
effects of milk proteins at the systemic and intestinal levels have primarily focused on 
hydrolyzed peptides. Few studies that have started from intact milk proteins are available. 
Therefore, study of bioactivities of milk peptides obtained via the in vitro digestion of 
intact milk proteins is the topic of research of the first chapter of this thesis. 
The main points addressed in the chapter I are listed below.  
 The antioxidant capacities and ACE inhibiting activities of whey, casein and soya 
protein permeate and retentate, obtained by in vitro SGD, were determined. 
Further, the effects of digested milk proteins on the human gut epithelium were 
investigated using the in vitro cell model HT29-MTX-E12 and the probiotic bacterial 
strain Lactobacillus casei.  
 HT29-MTX-E12 cells were adequately characterized (e.g., medium culture 
conditions, growth maintenance and effects of growth factors and SCFAs). 
 Finally, the citomodulatory and prebiotic roles of whey, casein and soya protein 
retentate obtained by in vitro SGD were determined.  
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Study I: Antioxidant capacity and ACE- inhibitory activity of whey and casein proteins 
obtained by in vitro SGD 
 
Aim of study I 
 
The main aim of this study was the further development and the adaption of the in vitro 
SGD protocol described by Mills et al., (2008) for milk protein isolated to study the 
protein’s bioactivities upon digestion. In particular, the antioxidant capacity and the ACE- 
inhibitory activity of whey, casein protein obtained by in vitro SGD were determined.  
The soya protein was included as non-animal protein source. Maltodextrin was included 
as non-protein source. 
 
Materials and methods 
Chemicals 
 
Whey protein isolate 90% (Volac International Ltd, 50 Fishers Lane, Orwell, Royston, 
SG8 5QX, Hertfordshire, UK); calcium caseinate >88% (Cambridge commodities, LTD); 
soya protein isolate 90 and maltodextrin 100% (My protein, The Hut.com Ltd, UK). All 
other chemicals were purchased by Sigma-Aldrich (Sigma–Aldrich Company, Dorset, 
UK), unless otherwise indicated. 
 
In vitro SGD  
 
The SGD of the protein samples was performed according to Mills et al. (2008) with slight 
modifications. Briefly, 20 grams of each protein sample was mixed with 150mL of 
distilled H2O in a plastic bag and stomached for 5’. After 12 h of equilibration in the 
fridge, the samples were maintained at room T for 1 h and a small amount of the 
undigested proteins were sampled in Eppendorf tubes and snap frozen in liquid nitrogen 
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before storing at -80 °C for further experiments. The SGD experimental procedure 
(Figure 1) involved three following phases. For the mouth phase 6.66 mg α-amylase in 
2.083mL of 1 mM CaCl2, pH 7 were added to the samples and an incubation of 30 min at 
37°C on a shaker was performed. The pH was decrease to 2 with HCl 6M. For the gastric 
phase, 0.9g of pepsin in 8.33 mL of 0.1 M HCl, pH 2. The samples were incubated 120 
min at 37°C on a shaker. The pH was increase to 7 with NaOH 6M. For the small intestinal 
phase 0.18mg pancreatin and 1.16 g bile in 0.5M NaHCO3, pH 7 were added to the 
samples and a final incubation of 180 min at 37°C on a shaker was performed. Afterwards, 
the total digesta obtained for each sample was weighed and transferred to 3kDa 
VIVASPIN 20 Sartorius centrifuge tubes in order to simulate the intestinal absorption. 
The samples were centrifuged for 16’ at 4500 rpm. Permeate (absorbed fraction) and 
retentate (intestinal fraction) were obtained. Finally, total digesta, permeate and retentate 
were sampled in Eppendorf tubes and snap frozen in liquid nitrogen before storing at -80 
°C for further experiments. 
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Figure 1: In vitro SGD procedure performed for whey, casein and soya intact proteins. 
 
Determination of protein concentration 
 
The quantification of nitrogen content in total digesta, permeate and retentate was 
performed with Kjeldahl method. The total amount of protein was calculated in each 
samples and used for the determination of antioxidant and ACE-inhibitory activities. 
 
Antioxidant capacity (AOC): ABTS assay 
 
Measurement of antioxidant activity was performed using the method of Re et al., 1999 
with some modifications. 7 mM ABTS stock solution was mixed with 140 mM potassium 
persulfate and allowed to react in the dark at RT for 12–16 h for the formation of the 
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ABTS•+ radical . The radical was stable up to 6 days if store in darkness at room T. The 
ABTS•+ stock solution was diluted in 5 mM phosphate-buffered saline (PBS, pH 7.4) to 
give an absorbance of 0.70 ± 0.02 at 734 nm in a 1 cm cuvette. Protein samples were 
diluted 1:10 with 5mM PBS. A volume of 20uL of protein samples or Trolox standard in 
PBS was mixed with 2mL of ABTS•+ working solution and incubated in dark for 6 min t 
RT before measuring absorbance at 734 nm on the spectrophotometer (Jasco). Appropriate 
solvent blanks were run in each assay. Maltodextrin was included as non-protein control. 
Results are the mean values of three triplicates. The percentage inhibition of absorbance 
at 734 nm was calculated and plotted as a function of the concentration of antioxidants 
and of Trolox for the standard reference data. The ABTS decolorization properties 
permitted the calculation of the Trolox equivalent antioxidant capacity (TEAC) of the 
protein samples. Results are expressed as µmol Trolox equivalent/mg protein. 
 
Antioxidant capacity (AOC): FRAP assay 
 
The method is based on the reduction of a ferric 2,4,6-tripyridyl-s-triazine complex (Fe3+-
TPTZ) to the ferrous form (Fe2+-TPTZ) (Benzie and strain, 1996). The reaction was 
carried out in a microtiter plate. Protein samples were diluted 1:10 in distilled water. FRAP 
(300 μl) reagent stock solution (acetate buffer, 2,4,6-tripyridyl-s-triazine and ferric 
chloride solution) was mixed with 10μL of diluted protein samples  and standard in 
distilled water. The reaction mixture was then incubated at 37°C for 1 min and absorbance 
was recorded at 595 nm, using a spectrophotometer (UV-VIS Jasco). The concentration 
of FeSO4was in turn plotted against concentrations of the standard antioxidants (Ascorbic 
acid). Maltodextrin was included as non-protein control. Results are expressed as µmol 
ascorbic acid equivalent/mg protein. 
 
ACE inhibitory (ACEi) activity 
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The measurement of the ACE inhibitory activity of digested proteins was performed with 
the ACE inhibitory assay using FAPGG as the synthetic substrate for ACE enzyme (Sigma 
Aldrich). The substrate FAPGG solution (150µL of 0.5mM FAPGG substrate) and 
samples (10μL of 0.2%w/v protein concentration) were incubated at 37°C for 5’ in the 
Microplate Reader, according to XFluor4 software indications. After the incubation, the 
ACE enzyme (50 μL of 15mU enzyme) was added to the sample/substrate mixture and 
the kinetic reaction started. The kinetic reaction was monitored for the following 30’ in 
the Microplate Reader at 340nm. Captopril was used as a positive control. Hydrolysis of 
FAPGG by ACE enzyme will result in a decrease in absorbance at 340 nm. ACE inhibitory 
activity was measured by the ability of whey, casein and soya digested proteins to decrease 
the hydrolysis of FAPGG as previously reported (Theodore & Kristinsson, 2007; 
Raghavan & Kristinsson, 2009). Maltodextrin was included as non-protein control. A 
100% ACE inhibitory activity would indicate complete inhibition of the enzyme and no 
decrease in absorbance. All experiments were done in duplicates: 
%ACE inhibition= [(Absno sample – Abssample) / Absno sample ]×100. 
Absno sample is the absorbance of the enzyme-substrate mixture in the absence of digested 
protein, and Abssample is the absorbance of the enzyme-substrate mixture in the presence 
of digested protein. 
 
Statistical analysis 
 
All assays were carried out in three independent experiments and each protein was tested 
in duplicate. The statistical software SAS (version 9.3) was used to analyze differences 
between different proteins and stage of digestion by ANOVA Differences were deemed 
statistically significant if P<0.0 
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Results & Discussion 
Antioxidant capacity (AOC): ABTS assay 
 
Figure 2: Antioxidant activity of protein fractions obtained by SGD of whey, casein and 
soya proteins. Different superscript letters (a, b, c) indicate statistical difference (P<0.05) 
(Abbreviations: UND= undigested proteins; P= protein permeate; R=protein retentate). 
The antioxidant activity of undigested proteins, permeate and retentate were first 
quantified by ABTS°+ decolorization assay and expressed as µmol/mg protein. This 
method is one of the widely used method for assessing antioxidant properties of extract 
and food/feed components (Thaipong, et al., 2006). 
All undigested proteins had TEAC values below 0.5µmol trolox equivalents/mg proteins. 
Following SGD, it has been observed a significant increase (P<0.05) in TEAC for whey, 
casein and soya protein permeate to 2.32, 2.49 and 2.26 µmol trolox equivalents/mg 
proteins, respectively (Figure 2). Whereas, the TEAC values obtained for whey, casein 
and soya protein retentate were 0.81, 0.69 and 0.71 µmol, respectively. All proteins tested, 
after the SGD, exhibited higher antioxidant properties. A similar extent was reported for 
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whey, casein and soya fractions. No antioxidant activity was reported for maltodextrin, as 
no-protein control (data not shown).  
The SGD significantly (P<0.05) enhanced antioxidant activity of the proteins. Moreover, 
it has been observed an overall effect of permeate/retentate separation (P<0.05) obtained 
by ultracentrifugation at the end of the in vitro SGD (data not shown). The strongest 
antioxidant properties have been detected in the permeate fraction of all protein analyzed. 
 
Antioxidant capacity (AOC): FRAP assay 
 
Results obtained with the FRAP assay confirmed the highest antioxidant properties of the 
permeate fractions compared with undigested proteins. In particular, whey and casein 
permeates had a similar antioxidant value (4.06 and 4.45 µmol ascorbic acid/mg protein 
for whey and casein, respectively).  
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ACE-inhibitory assay 
 
Figure 3: %ACEi inhibition of whey, casein and soya protein fractions obtained by 
SGD.*P<0.05 compared with undigested whey, casein permeate and soya permeate. 
 
ACE-I inhibitory activity of whey, casein and soya protein fractions was measured for 
permeate, retentate and undigested proteins. As shown in Figure 3, the highest ACE value 
is reported for the whey protein, compared with casein and soya proteins. The whey 
protein permeate exhibited a significant ACE-inhibitory activity, compared with soya and 
casein permeate and compared with undigested whey protein. Casein and Soya protein 
fractions do not showed significant ACE-inhibitory properties. 
TEAC and FRAP results demonstrated the antioxidant activity of whey, casein and soya 
proteins. ACE inhibition has been detected in the whey protein tested, with the highest 
value detected in whey protein permeate. The SGD enhanced their antioxidant activity of 
milk and soya proteins tested and ACE-I inhibitory activity of whey protein. Among the 
protein considered, the milk permeates, which reflect the systemic/absorbed peptides, 
possessed the highest antioxidant and ACE-inhibitory properties. The in vitro antioxidant 
and ACE-inhibitory properties of milk proteins were previous demonstrated. Petrat-Melin 
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et al., 2015 reported values of 0.8µmol of trolox equivalent /mg protein for undigested 
proteins and an increase in antioxidant potential following digestion. This effect is 
probably related to the whey protein amino acid composition and it is consistent with the 
previously described health-benefit of whey proteins on CVD in vivo. The ACE-
inhibitory-antioxidant protein fractions may contribute to lower blood pressure and 
increase the antioxidant defense in humans. Pal et al. (2010a; 2010b) investigated the 
effects of whey protein isolate and casein protein isolate on cardiovascular health, 
demonstrating a significant reduction in blood pressure of both whey and casein protein-
consumers, compared with the control group. Considering the emerging results related to 
their properties in vivo, we can speculate that milk proteins, after oral administration, 
gastrointestinal digestion and absorption, may resist to plasma peptidase degradation and 
can reach their target tissues where they contribute to antioxidant and ACE inhibitory 
defenses. Beside the traditional nutritional value, the health- promoting properties of milk 
proteins together with the lack of side effects elect them as potential ingredients of 
functional foods. 
The nutritional strategies that provide a rich source of antioxidant and ACE-inhibitory 
proteins could help in meeting the nutritional requirements of humans, providing a novel 
approach to promote healthy aging.  
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Study II: HT29-MTX-E12 cells characterization: set up of the in vitro cell model 
 
Aim of study II 
 
The aim of the present study was the characterization of HT29-MTX-E12 cell line in order 
to set up the culture condition for this cell line and use this cell culture as a model of the 
human intestinal goblet cells. The impact of different growth factors, hormones as well as 
different combinations of the three major SCFAs on the metabolic activity and 
proliferation of human undifferentiated HT29-MTX-E12 cells. First, the metabolic and 
proliferative activity of HT29-MTX-E12 in the presence and absence of IGF-I, EGF, 
TGF-α, TGF-β1 and the hormone estradiol 17-β were investigated, since an adequate 
characterization of the response of these cells to several bioactive factors is still lacking. 
Next, the response to different concentrations of the SCFAs butyrate, propionate and 
acetate, alone and in combination, was assessed on the metabolic activity of HT29-MTX-
E12 cells in culture. The obtained results contribute in the justification for use of a specific 
cell culture media, rarely provided in published reports. 
 
Materials & methods 
Chemicals 
 
AlamarBlueTM and PicoGreen® reagents were purchased from Invitrogen (Taastrup, 
Denmark). Fetal bovine serum (FBS) was purchased from Bio Whittaker (Lonza 
Copenhagen Aps, Copenhagen, Denmark). IGF-I and EGF were purchased from Austral 
Biologicals (AH diagnostics, Aarhus, Denmark). TGF-α and TGF-β1 were purchased 
from R&D Systems (Abingdon, United Kingdom). Estradiol 17-β, NaBt, NaAce, and 
NaProp were purchased from Sigma-Aldrich (St. Louis MO, USA). IGF-I was dissolved 
in culture medium (0.05% FBS) to obtain a stock solution of 50 ng/mL. EGF was 
dissolved in culture medium (0.05% FBS) to obtain a stock solution of 50 ng/µL. Estradiol 
17-β was dissolved in culture medium (0.05% FBS) to obtain a stock solution of 10 mM. 
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TGF- α was dissolved in culture medium (0.05% FBS) to obtain a stock solution of 10 
µg/mL. TGF-β1 was dissolved in culture medium (0.05% FBS) to obtain a stock solution 
of 1 ng/µL. NaBt, NaProp and NaAce were dissolved in culture medium (0.05% FBS) to 
obtain stock solutions of 1 M. Stock solutions were stored in the dark at 4°C. All the 
remaining reagents were purchased from Sigma Aldrich. 
 
Cell line & cell culture 
 
HT29-MTX-E12 cells were kindly donated by Dr. David Brayden and Dr. Sam Maher 
(UCD Conway Institute, Dublin, Ireland). This human colorectal adenocarcinoma cell 
line, a clone of HT29 cells, could differentiate into a mucus-producing goblet-like cell 
line. Cell maintenance was performed in 25 cm2 flasks using 15 mL of Dulbecco’s 
modified Eagle’s medium (DMEM) with glucose (4.5 g/L) which was supplemented with 
10% of FBS, 1% 1 M HEPES, 1% (v/v) penicillin/streptomycin, 2% Glutamax and 1% 
MEM NEAA. The cells were cultivated at 37°C in a humidified incubator with 5% CO2. 
Cells were subcultured using 0.05% trypsin-EDTA at 60 to 80% confluence. All 
experiments were carried out using undifferentiated HT29-MTX-E12 cells, within six cell 
passages (from passage 43 to 49) to ensure reproducibility. 
HT29-MTX-E12 cells were plated at low density (1000 cells/well) in 96-well plates and 
cultured for 48 hours. Preliminary experiments were carried out and growth curves were 
obtained with different concentrations of FBS for 6 to 8 days of culture to ensure that cells 
were in the sigmoid phase of the growth curve when components to be tested were added 
to the culture medium. 
Several concentrations of FBS (from 0 up to 10%) were tested on the cells and the optimal 
concentration to support cell attachment was found to be 0.05%. Therefore, this FBS 
concentration was added to the treatment medium in all experiments. 
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Treatment medium was composed of basal medium DMEM and 0.05% FBS containing 
IGF-I, TGF-α of EGF at different concentrations (0.1, 1, 2.5, 5, 10, 50 and 100 ng/mL); 
TGF-β1 at different concentrations (10, 50, 100, 500, 1000, 5000, 10000 pg/mL); estradiol 
17-β (0.1 pM, 1 pM, 0.01 nM, 0.1 nM, 1 nM, 0.01 µM, 1 µM, 0.1 mM); or NaBt, NaProp 
or NaAce at different concentrations (0.5, 1, 5, 10, 25, 50 and 100 mM). In this study, 
NaBt, NaProp or NaAce were also added to the treatment medium in combination.  
Two combinations of SCFAs defined the low SCFA combination (LowSCFAs) and the 
high SCFA combination (HighSCFAs) were chosen in accordance with Le Gall et al, 
(2009) in order to reproduce the physiological ratio of SCFAs in the human digestive tract. 
These combinations are shown in Table 1. 
Table 1: Estimation of physiological and sub-physiological concentrations of SCFAs 
produced by intestinal fermentation in vivo (Le Gall et al., 2009). 
 Physiological [ ] 
 mM 
Sub-physiological [ ] 
mM 
ACETATE 70 35 
PROPIONATE 18 9 
BUTYRATE 8 4 
 
Treatment medium (200 μL per well in 96-well plates) was added to individual wells. 
Preliminary time-course experiments showed that all treatments affected cell metabolic 
activity and proliferation at 72 hours but not at 24 and 48 hours. Therefore, incubation for 
72 hours was used in all experiments of this study.  
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Cell viability: metabolic activity and proliferation 
 
The first part of the study investigated the effect of IGF-I, EGF, TGF-α, TGF-β and 17-β 
estradiol on the metabolic activity and proliferation rate of HT29-MTX-E12 cells whereas 
the second part of this study examined the activity of butyrate, propionate and acetate on 
cell metabolic activity. Two methodologies were used in these studies. The first method 
considered was the AlamarBlueTM (AB) assay, used to assess cell metabolic activity. AB 
is a tetrazolium-based dye, incorporating resazurin and resorufin as oxidation–reduction 
indicators that yield colorimetric changes and a fluorescent signal in response to metabolic 
activity of the cell; the blue non-fluorescent oxidized form (resazurin) becomes pink and 
fluorescent (resorufin) upon mitochondrial reduction in metabolically active cells. Briefly, 
after the removal of treatment medium, 110 µL aliquots of AB solution (dilution 1:10 in 
PBS) were added to each well and incubated with the cells for 2 hours. The color change 
was monitored, and a fluorimetric evaluation of cell vitality was performed using an 
EnVision fluorometer (Perkin Elmer). The fluorescence values were detected at 544 nm 
(excitation) and 596 nm (emission). As the negative control, AB was added to medium 
without cells.  
The second methodology used was the PicoGreen® (PG) assay in order to assess cell 
proliferation. The Quant-iT™ PicoGreen® dsDNA reagent is fluorescent nucleic acid 
stain for highly selective quantitating double-stranded DNA (dsDNA) over single-
stranded DNA and RNA in solution. Upon binding to dsDNA the dye exhibits 
fluorescence enhancement.  
72 hours after the addition of treatment medium to the cells, the PicoGreen® assay was 
performed according to the manufacturer’s instruction. Medium was removed and 100 μL 
of TE buffer was added to each well. To lyse cells, plates were stored in -80°C freezer for 
45 minutes and then thawed. After three times of freezing and thawing, 100 µL of PG 
working solution (Quant-iT™ in TE) were added to each well and the cells were incubated 
in the dark at room temperature for 5 minutes. The fluorescence signal was detected using 
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a fluorescent plate reader (EnVision fluorometer) at 485 nm (excitation) and 535 nm 
(emission). 
 
Statistical analysis 
 
Results were depicted as the mean value ± standard error of three independent 
experiments. A one-way ANOVA, using the GLM procedure (PROC GLM) of SAS 9.3 
(SAS Institute, Cary, NC, USA), was used to evaluate the effects of various treatments. 
Differences between means were considered statistically significant at P<0.05 (*) and 
P<0.0001(**). 
 
Results & discussion 
 
First of all, the effect of increasing concentrations (from 0 up to 10%) of FBS in the culture 
medium was examined to test how cell growth was affected by the presence of serum in 
the culture medium. Cell proliferation increased in undifferentiated HT29-MTX-E12 cells 
in a dose dependent manner (data not shown). In light of these observations, a 
concentration of 0.05% FBS was chosen as the concentration of FBS in treatment medium 
when growth factors, hormones and SCFAs were examined in order to support and 
simulate physiological cell growth.  
 
Effects of IGF-I, EGF, TGF-α, TGF-β, and estradiol 17-β on metabolic activity and 
proliferation of HT29-MTX-E12 cells 
 
At 72 hours of incubation, IGF-I stimulated the metabolic activity of HT29-MTX-E12 
cells in a significant manner (P<0.0001; P<0.05) compared with control cells (0 ng/mL 
IGF-I) (Figure 1a). The maximal stimulation was detected in the range from 10 up to 100 
ng/mL of IGF-I. IGF-I dose dependently increased the proliferation rate of HT29-MTX-
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E12 cells (Figure 1b). Concentrations of 5 and 10 ng/mL of IGF-I significantly (P<0.05) 
increased cell proliferation by 20%, whereas the highest concentrations tested (50 and 100 
ng/mL) significantly (P<0.0001) increased proliferation by 30%. 
EGF in concentrations ranging from 0 to 100ng/mL did not affect the metabolic activity 
or the proliferation rate of HT29-MTX-E12 cells (Figure 1c and 1d). 
 
Figure 1: Effect of increasing concentrations of IGF-I and EGF added to the culture 
medium for 72 hours on metabolic activity (a, c) and proliferation (expressed as dsDNA 
content) (b, d) in HT29-MTX-E12 cells. Results are from three independent experiments 
with quadruplicate wells and presented as least square means ± SEM relative to metabolic 
activity/proliferation obtained in basal medium (0 ng/mL). Values significantly different 
from the metabolic activity/dsDNA content obtained in basal medium are indicated by * 
(P<0.05) or ** (P<0.0001). 
Both TGF-α and TGF-β1 affected the metabolic activity of the intestinal cells. In 
particular, this inhibition was about 24% in the presence of 1 ng/mL of TGF-α (P<0.05) 
(Figure 2a). TGF-α treatment at 10 ng/mL showed a significant (P<0.05) impact on cell 
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proliferation (Figure 2b). However, no significant effects were obtained with TGF-β1 on 
cell proliferation (Figure 2d).  
 
Figure 2: Effect of increasing concentrations of TGF-α and TGF-β1 added to the culture 
medium for 72 hours on metabolic activity (a, c) and proliferation (expressed as dsDNA 
content) (b, d) in HT29-MTX-E12 cells. Results are from three independent experiments 
with quadruplicate wells and presented as least square means ± SEM relative to metabolic 
activity/proliferation obtained in basal medium (0 ng/mL) (0 pg/mL). Values significantly 
different from metabolic activity/dsDNA content obtained in basal medium are indicated 
by * (P<0.05). 
The metabolic activity of HT29-MTX-E12 cells was significantly (P<0.05) stimulated by 
specific concentrations  of estradiol 17-β (from 0.1nM up to 1µM), while the highest 
estradiol 17-β concentration tested (0.1 mM) strongly inhibited the metabolic activity 
(P<0.0001; Figure 3a). However, the lowest concentration of estradiol 17-β increased the 
proliferation of HT29-MTX-E12 cells to 129%, while the highest concentration of 
estradiol 17-β significantly (P<0.0001) reduced the proliferation rate to 66% (Figure 3b). 
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Figure 3: Effect of increasing concentrations of estradiol 17-β added to the culture 
medium for 72 hours on metabolic activity (a) and proliferation (expressed as dsDNA 
content) (b) in HT29-MTX-E12 cells. Results are from three independent experiments 
with quadruplicate wells and presented as least square means ± SEM relative to metabolic 
activity/proliferation obtained in basal medium (0). Values significantly different from 
metabolic activity/dsDNA content obtained in basal medium are indicated by * (P<0.05) 
or ** (P<0.0001). 
 
Effect of butyrate, propionate and acetate and combinations on the metabolic activity of 
HT29-MTX-E12 cells 
 
In preliminary experiments the metabolic activity assay (AlamarBlueTM) showed to fit for 
the purpose of describing the effect of SCFAs on intestinal HT29-MTX-E12 cells. 
Therefore, undifferentiated HT29-MTX-E12 cells were grown alone or in the presence of 
several concentrations of either NaBt, NaProp or NaAce and cell metabolic activity was 
evaluated. 
The addition of NaBt alone in the culture medium caused a dose dependent decrease in 
the metabolic activity of the cells. Figure 4 clearly shows that NaBt exerted the strongest 
effect in terms of inhibition, after 72 hours of incubation, compared to both NaProp and 
NaAce. 
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Concentrations of NaBt above 1 mM significantly (P<0.0001) inhibited the metabolic 
activity of HT29-MTX-E12 compared with control (0 mM). Indeed, the addition of 
NaProp at concentrations ≥1 mM led to weaker inhibition compared with the same 
concentrations of NaBt. Also, increasing the NaAce concentration caused a reduction in 
the metabolic activity of HT29-MTX-E12 cells in a dose dependent manner. However, 
NaAce, among the SCFAs considered in this study, was devoid of any significant effect 
at the lower concentrations. Only concentrations higher than 25 mM significantly 
(P<0.0001) inhibited metabolic activity; in particular, the presence of 50mM of NaAce 
reduced the metabolic activity by 39% compared with control cells (0mM). 
 
Figure 4: Effect of increasing concentrations of NaBt, NaProp and NaAce added to the 
culture medium for 72 hours on metabolic activity in HT29-MTX-E12 cells. Results are 
from three independent experiments with quadruplicate wells and presented as least 
square means ± SEMs, relative to metabolic activity obtained in basal medium (0 mM). 
Values significantly different from metabolic activity obtained in basal medium are 
indicated by * (P<0.05) or ** (P<0.0001). 
The effect of the addition of the combinations of the SCFAs on HT29-MTX-E12 cell 
metabolic activity is shown in Figure 5a and 5b. These results indicate an additive 
interaction effect of the three SCFAs at both high (HighSCFAs) and low (LowSCFAs) 
b b 
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concentrations. In particular, the dose dependent inhibitory effect of increasing 
concentrations of NaBt was significantly (P<0.0001) enhanced by the addition of specific 
concentrations of NaAce and NaProp. 
 
 
Figure 5: Effect of the HighSCFAs combination (a) and the LowSCFAs combination (b) 
added to the culture medium for 72 hours on metabolic activity of HT29-MTX-E12 cells. 
Results are from three independent experiments with quadruplicate wells and presented 
as least square means ± SEMs, relative to metabolic activity obtained in NaBt alone. 
Values obtained with NaBt combined with other SCFAs significantly different from values 
of obtained with NaBt alone are indicated by ** (P<0.0001). 
In this study, it is reported the impact of growth factors, estradiol 17-β and SCFAs on the 
metabolic activity and proliferation (dsDNA content) of the undifferentiated HT29-MTX-
E12 intestinal cell line.  
HT29-MTX-E12 can be a useful model for food and nutritional in vitro studies, even 
though this cell line has not yet been adequately characterized with respect to bioactive 
components. The first finding of this study is that HT29-MTX-E12 cells respond to IGF-
I. IGF-I stimulates the growth and proliferation of several cell types, as demonstrated in 
previous studies (Theodorou et al, 2011; Meng et al, 2007; Purup et al, 2007). This growth 
factor is responsible for several cellular physiological processes through binding with 
IGF-R1 located on the cell surface that stimulates a signal transduction cascade, which is 
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involved in cell viability and proliferation (Rodon et al, 2008). Furthermore, at the 
intestinal level, IGF-I is involved in several functions such as the regulation of 
carbohydrate and protein metabolism, and it has a key role in gastrointestinal growth and 
development by its effects on the proliferation of intestinal cells (Luo et al, 2011). 
However, it has previously been demonstrated that IGF-I does not affect intestinal cell 
differentiation (Sanderson and Walker, 1999). The results obtained in this study confirm 
that IGF-I stimulates both the metabolic activity and proliferation of intestinal HT29-
MTX-E12 in a dose dependent manner. In addition, estradiol 17-β had a significant effect 
on HT29-MTX-E12 intestinal cells, increasing both metabolic activity and proliferation 
in a concentration dependent manner, whereas the highest amount of estradiol 17-β 
significantly reduced cell viability and proliferation. However, this inhibitory effect was 
detected at a concentration above the physiological range that could reach the colon. Other 
studies have previously demonstrated the gut to be an estrogen-responsive tissue (Caiazza 
et al, 2007; Galluzzo et al, 2007). Thomas et al. (1993) demonstrated the presence of 
estrogen receptors (ERα and ERβ) in the intestine, even though the abundance of estrogen 
receptors in the intestinal epithelium is relatively low compared to the reproductive tissue. 
Estradiol levels may affect intestinal tissues at times other than during reproduction 
(Caiazza et al, 2007), such as during the consumption of dietary compounds such as milk 
and colostrum.  
These findings suggest that both IGF-I and estradiol 17-β may have a crucial role in up-
regulating the proliferation and metabolic activity of intestinal epithelial cells. 
TGF-α inhibited cell metabolic activity at specific concentrations. This inhibition could 
not be attributed to direct toxicity since the proliferation rate of the cells treated with TGF-
α was maintained throughout the 72 hours of culture at all concentrations tested. TGF-α 
expression in the small and colonic intestinal epithelium occurs mainly in non-
proliferative zones. This finding suggests that its role may be to regulate different 
processes rather than cell proliferation. TGF-β1 is structurally different from TGF-α, and 
its major site of expression is the superficial proliferative zone of the intestine. Therefore, 
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it may be involved in cell proliferation processes and in maintaining epithelial homeostasis 
(Playford et al, 2000). Koyoama et al. (1989) revealed the complementary role of TGF-α 
and β1 in balancing proliferation and differentiation processes in the intestinal epithelium. 
Other studies have shown that TGF-β1 inhibits the proliferation of intestinal epithelial 
cells, whereas TGF-α promotes the growth and development of the gastrointestinal tract 
(Booth et al, 1995; Kurokowa et al, 1987). 
In the present study, EGF did not produce any significant effect, suggesting that EGF is 
not a mitogen in this cell line. These data are consistent with the results of Kurokowa et 
al. (1987), which demonstrated that the role of EGF in the enhancement of intestinal cell 
proliferation is minor compared to other growth factors, such as IGF-I.  
Such variations in the effects of growth factors support the hypothesis of a narrow range 
at which each growth factor and hormone present in milk, colostrum and in other nutrients 
may stimulate gut epithelial cells. 
The major types of complex carbohydrates in the human colon are cellulose, pectin and 
hemicellulose, commonly referred to as dietary fibers (Cummings, 1981). SCFAs are 
produced by bacterial fermentation of carbohydrates, which occurs in the colon. Colonic-
derived SCFAs provide from 5% up to 15% of the total energy requirement by humans, 
depending on nutrient intake and the composition of the microbiota (Bergman, 1990). The 
major products of the saccharolytic fermentation are butyrate, propionate and acetate. 
They are involved in several physiological processes such as blood pressure regulation 
(Pluznick et al, 2013), inflammation (Tedelin et al, 2007), lipid metabolism, mineral and 
ammonia absorption (Fava et al, 2008; Hamer et al, 2008). They can prevent the 
overgrowth of pathogenic bacteria, lower the pH in the colon (Roy et al, 2006) and they 
have a protective role against tumors by modulating cell proliferation and apoptosis 
(Scharlau et al, 2009). Butyrate is the main energy source for colonocytes, as demonstrated 
by Donohoe et al. (2011) who discovered that the lack of butyrate in germ-free mice 
induces autophagy in colonocytes in order to extract amino acids for energy metabolism. 
Besides being an essential energy source for large intestine epithelial cells, butyrate is 
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involved in a wide array of cellular functions such as the promotion of apoptosis and gene 
expression modulation (Meijer et al, 2010; Purup and Larsen, 2007; Brahe et al, 2013).  
The metabolic activity assay AlamarBlueTM (AB) measures the mitochondrial activity at 
a given time point which is related to the number of viable cells. The PicoGreen® assay 
gives the amount of DNA at the end of the experiment, which, if the amount of DNA in a 
cell is constant, measures the total number of cells (viable or not). In preliminary 
experiments conducted with SCFAs, a detrimental effect of either NaBt, NaProp or NaAce 
on metabolic activity of HT29-MTX-E12 cells was demonstrated. AB showed to fit for 
the purpose of describing the effect of SCFAs on intestinal HT29-MTX-E12 cells, and, 
therefore, it has been used in the second part of this study. 
The present study showed the anti-proliferative role of butyrate, which was the most 
effective SCFA able to inhibit HT29-MTX-E12 metabolic activity, exerting a strong dose 
dependent effect on these cells. Our findings show that propionate could also modulate 
cell growth and proliferation. Previous studies reported the role of propionate at the 
cellular level. Vecchia et al. (1992) demonstrated the inhibitory role of propionate in 
cancer cells, whereas Curi et al. (1993) reported that specific concentrations of propionate 
cause the inhibition of lymphocyte proliferation. Acetate is the most abundant SCFA in 
the human intestine. It is a precursor for the biosynthesis of lipids and increases 
phospholipid and cholesterol synthesis. Vecchia et al. (1997) reported that acetate exerts 
an antineoplastic effect, while Hague et al. (1995) found an apoptotic effect induced by 
80 mM acetate on a colorectal cell line, similar to 4 mM butyrate. This observation is in 
line with our findings in which only high concentrations of acetate strongly compromised 
HT29-MTX-E12 metabolic activity. 
The concentrations of SCFAs employed in the present study are in accordance with 
amounts encountered in the gastro-intestinal tract of humans (Le Gall et al., 2009). 
Specifically, Cummings et al (1987) reported butyrate levels around 24 mmol/kg digesta 
and acetate levels around 60 mmol/kg digesta in the proximal colon of humans. From a 
recent study conducted in swine, levels of 9-16 mmol/kg wet digesta of butyrate in the 
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colon have been reported (Nielsen et al, 2014). In this study, when SCFAs were tested in 
combination, the concentrations chosen were comparable (HighSCFAs) and below 
(LowSCFAs) those amounts found in the intestinal lumen. The effect of butyrate, 
propionate and acetate in combination at concentrations comparable to those found in the 
human bowel was also observed in another cell line (Vecchia et al, 1997). With regard to 
SCFA combinations, propionate and acetate enhanced the inhibitory activity of butyrate 
on HT29-MTX-E12 cells, suggesting an additive effect of the three major SCFAs on 
intestinal epithelial cells. 
Taken together, the inhibitory effect of SCFAs on the HT29-MTX-E12 cell line observed 
in this study is also interesting from the point of view that HT-29 cells are of cancer origin. 
The data presented herein suggest a protective effect of SCFAs against the proliferation 
of colon cancer cells, underlining the beneficial role of a fiber-rich diet. Of the SCFAs 
tested, butyrate was the most effective and its effect was enhanced by the addition of 
propionate and acetate. These data support the proposition that nutritional manipulation 
with a fiber-rich diet could have a crucial role in controlling the occurrence of colorectal 
cancer and other gastrointestinal disorders. 
Another interpretation of the results reported here is the fact that the HT29-MTX-E12 
cells were kept in a medium containing glucose as the main energy source. Treatment with 
alternative energy sources, such as butyrate, propionate or acetate, might be affected by 
the presence of glucose in the culture medium. Singh et al. (1997) reported that butyrate, 
in the presence of glucose, inhibits the growth of HT29 cells, whereas it stimulates cell 
proliferation in glucose-depleted medium. Whether the effects of the three major SCFAs 
occurred due to the presence of glucose in the culture medium remains to be examined in 
glucose-depleted HT29-MTX-E12 cells.  
Overall, this study showed that several bioactive compounds and fermentation metabolites 
have an essential role in the growth and development of the human intestinal epithelium. 
In addition, these results contribute to the characterization of the response of HT29-MTX-
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E12 cells with respect to dietary compounds, which can pass to the intestine in intact form, 
and to fermentation metabolites produced by colonic bacteria. 
Undifferentiated HT29-MTX-E12 cells provide an opportunity to examine the potential 
role of growth factors, hormones and SCFAs in the regulation of metabolic activity and 
proliferation of the intestinal cells. HT29-MTX-E12 cells have been shown to be a suitable 
in vitro model for cell-nutrient interaction studies.  
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Study III: Citomodulatory and prebiotic roles of whey, casein and soya protein retentate 
obtained by in vitro simulated gastro-intestinal digestion 
 
Aim of study III 
 
The aim of the study was to investigate the in vitro effects of milk protein retentate on 
human gut health, after in vitro SGD.  
Specifically, citomodulatory roles of whey and casein protein retentate were determined 
via the use of human intestinal HT29-MTX-E12 cells, and the prebiotic activities of the 
protein retentate were determined according to their abilities to modulate Lactobacillus 
casei proliferation. Soya protein was included in all experiments as a non-animal protein 
source. 
 
Material & methods 
 
All chemicals were purchased from Sigma Aldrich (St. Louis MO, USA) unless otherwise 
indicated. 
Cells & culture conditions 
 
The HT29-MTX-E12 cells were kindly donated by Dr. David Brayden and Dr. Sam Maher 
(UCD Conway Institute, Dublin, Ireland). This human colorectal adenocarcinoma cell 
line, which is a clone of HT29 cells, is able to differentiate into a mucus-producing goblet-
like cell line. Cell maintenance was performed in 25-cm2 flasks using 15 mL Dulbecco’s 
modified Eagle’s medium (DMEM) with glucose (4.5 g/L) and supplemented with 10% 
of FBS, 1% 1 M HEPES, 1% (v/v) penicillin/streptomycin, 2% Glutamax and 1% MEM 
NEAA. The cells were cultivated at 37°C in a humidified incubator with 5% CO2. The 
cells were subcultured using 0.05% trypsin-EDTA to at 60 to 80% confluence. All 
experiments were performed using HT29-MTX-E12 cells within six cell passages 
(passages 40 to 45) to ensure reproducibility. 
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Undifferentiated HT29-MTX-E12 cells were plated at a density of 1.5x104 cells/well in 
96-well plates and cultured for 24 hours. For the viability assay, the cells were in the 
sigmoid phase of growth when the protein retentate were added to the culture medium. 
The treatment medium was composed of basal DMEM and 0.05% FBS containing whey, 
casein and soya protein retentate at different concentrations (0.39 up to 50 µg/µl) that were 
chosen based on preliminary tests on this cell line to reproduce the physiological ratios of 
protein retentate that may be reached the human colon. Retentate stocks were obtained by 
SGD as indicated in the study I of this chapter. 
 
MTT assay: Cell viability 
 
The viability of the HT29-MTX-E12 cells after 3 and 24 h of treatment was calculated 
with the MTT test. MTT assay measures the production of the chromophore formazan 
from 3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazoliumbromide (MTT). Formazan is 
produced in viable cells by the mitochondrial enzyme succinate dehydrogenase. Three 
replicates per treatment were employed, and the experiments were repeated at least twice. 
Specifically, the cell viability percentages induced by the protein retentate treatments were 
calculated as follows: 
% cell viability = (mean optical density of treated cells/ mean optical density of 
control cells) x 100. 
 
Effect of whey, casein and soya protein retentate on HT29-MTX-E12 mucin production: 
PCR of the MUC5AC gene and cyclophilin reference gene 
 
HT29-MTX-E12 cells were maintained for 21 days in culture. It has been reported that, 
after 21 days of culture, HT29-MTX cells express a stable amount of mucus (Lesuffluer 
1993; Martized-Maqueda et al., 2012).  
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To control the mucus production, HT29-MTX-E12 cells were seeded into 2-well chamber 
slides at 2 × 104 cells/cm2 and maintained in complete medium without passaging for up 
to 21 days. At selected time points, mucin production was detected using Alcian blue stain. 
The cell monolayers were first fixed with chilled 99% methanol for 10 minutes and 
washed 3 times with PBS. Next, incubation with 1% Alcian blue/3% acetic acid for 3 h at 
room temperature was performed. The cells were subsequently washed three times with 
PBS to remove any residual stain, and mucin production (assessed based on the level of 
blue staining) was examined by light microscopy. Paint Shop Pro 7.04 software was used 
to capture the images. 
The HT29-MTX-E12 cells were also plated at a density of 5x105 cells/well in 12-well 
plates and maintained for up to 21 days in complete medium. At day 21, the cells were 
washed with PBS, and the medium was replaced with 0.05% FCS medium for 24 h (cell 
starvation). The treatment medium (0.05%FCS) with or without whey, casein or soya 
protein retentate at different concentrations (0.78 up to 3.12 µg/µl) was added to the cells, 
which were then incubated in a controlled atmosphere (37°C / 5% CO2). The concentration 
range was chosen based on the MTT test results. 
At the end of the incubation, total RNA was extracted from the treated and untreated 
HT29-MTX-E12 cells using a nucleospin RNA II kit (Macherey-Nagel, Duren, Germany) 
according to the manufacturer’s protocols. The RNA was reverse transcribed using the 
iScript cDNA synthesis kit (BioRad), and the resulting cDNA was used as a template for 
the qualitative and quantitative PCRs. MUC5AC was amplified by PCR with primer 
sequences that have previously been published by Martínez-Maqueda et al., 2012 (Table 
1), and cyclophilin was included as a reference gene. Qualitative PCRs were performed 
on all samples under the following thermocycling conditions: 10’ initial denaturation at 
95°C; followed by 40 cycles of amplification at 95°C for 15-s, 1’ of annealing at 60°C 
and 1’ extension at 72°C; and a final 3’ elongation step at 72°C. The PCR products were 
analyzed by gel electrophoresis in 2% agarose to detect the cyclophilin, β-actin and 
MUC5AC rRNA bands (Image Lab™, BioRad, software analysis). 
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Table 1: Primers for qualitative and real time PCRs 
Gene (&bp) primers References 
MUC5AC (240bp) 5’- CGACCTGTGCTGTGTACCAT-3′  
5′-CCACCTCGGTGTAGCTGAA-3 
Martínez-Maqueda et al., 2012 
β-actin (197bp) 5′-CTTCCTGGGCATGGAGTC-3′ 
5′GCAATGATCTTGATCTTCATTGTG-3′ 
Martínez-Maqueda et al., 2012 
Cyclophillin (160bp) 5′-CTTCCTGGGCATGGAGTC-3′  
5′-GCAATGATCTTGATCTTCATTGTG-3′ 
Martínez-Maqueda et al., 2012 
 
Effect of whey, casein and soya protein retentate on HT29-MTX-E12 mucin production: 
Real-time PCR 
 
Real-time PCR quantification analyses were performed with SYBR green methodology 
using a real-time PCR system (Strategene Mx3000p). 
Each reaction tube contained 2X SYBR Green real-time PCR Master Mix, gene-specific 
forward and reverse primers and the cDNA. The master mix included Maxima® Hot Start 
Taq DNA polymerase, dNTPs in an optimized PCR buffer, and SYBR® Green I dye 
supplemented with ROX passive reference dye. The primers and lengths of the amplified 
fragments are listed in table 1. One microliter of cDNA was used for each sample. The 
samples were tested in duplicate and non-reverse transcribed controls and no-template 
controls were included in the assays. The thermal profile began with 2’ at 50°C and 10’ at 
95°C followed by 40 cycles of 95 °C for 15 s and 60 °C for 1’. The comparative CT 
method was used (Livak and Schmittgen, 2001) to determine the fold changes in 
gene expression, which were calculated with the threshold method (2-∆∆CT). Relative 
quantification was performed, and the values were normalized to the internal reference 
gene. The cyclophilin gene and β-actin gene were tested as reference genes. Cyclophilin 
was amplified to calculate the relative expression because it has previously been 
demonstrated to be stable under these conditions.  
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Prebiotic activity 
 
Lactobacillus casei ssp casei (Orla-Jensen) Hansen and Lessel (ATCC® 393™) was 
maintained at the Health, Animal Science and Food Safety department of the University 
of Milan (Italy). Stock cultures were maintained in Man Rogosa Sharpe (MRS) with 
acetate and manganese, which act as specific growth factors for lactobacilli. The MRS 
composition is indicated in the Table 2. 
Table 2: Man Rogosa Sharpe (MRS) medium composition 
Ingredients Grams/Litre 
  
Peptone 10.0 
Meat extract 8.0 
Yeast extract 4.0 
D(+)-Glucose 20.0 
Dipotassium hydrogen phosphate 2.0 
Sodium acetate trihydrate 5.0 
Triammonium citrate  2.0 
Magnesium sulfate heptahydrate 0.2 
Manganous sulfate tetrahydrate 0.05 
Final pH 6.2 +/- 0.2 at 25°C  
 
A series of in vitro experiments were conducted to evaluate the influences of whey, casein 
and soya protein retentates on the growth of Lactobacillus Casei. The bacteria were grown 
to the stationary phase in MRS broth and then serially diluted in peptone water to 104-105 
CFU. Protein retentate stock solution (100 µg/µL) was diluted in peptone water until the 
treatment concentrations were achieved. In 96 well-plates, 25 µL of the different 
concentrations (from 0.39 up to 3.12 µg/µL) of each whey, casein and soya retentate were 
mixed with 225 µL of 104-105 CFU lactobacilli culture, and the plate was then incubated 
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at 37°C for 48 h in anaerobic conditions. At the end of the incubation period, the treated 
bacteria were serially diluted 10-fold in peptone water, and 100-µL aliquots of each 
dilution were spread in duplicate onto the surfaces of the MRS agar plates. The MRS agar 
plates were incubated anaerobically at 35°C. After 48 h, the number of viable bacterial 
cells/colonies was counted. The entire experiment was repeated twice, and each treatment 
was performed in triplicate to confirm the results. 
 
Statistical analysis 
 
The data were analyzed as the mean values ± the standard errors of three independent 
experiments using one-way ANOVA. SAS 9.3 software (SAS Institute, Cary, NC, USA) 
was used to identify the significant differences between treatment and control data. The 
differences between means were considered statistically significant at P<0.05 (*). 
Results & discussion 
 
The HT29-MTX-E12 cells were first used in this study in the undifferentiated state to test 
the proliferative roles of in vitro-digested milk and soya proteins and after 21 days of 
culture to study the modulation of mucus-production by protein retentate treatments. 
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MTT assay: Cell viability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Effects of whey protein retentate (A), casein protein retentate (B) and soya 
protein retentate (C) on cell viability after 3 and 24 h. The values that were significantly 
different from the cell viability obtained in the control cells (0 µg/µl) are indicated by * 
(P<0.05)  
A 
B 
C 
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When the lower range of concentrations tested (0.39-1.56 µg/µl) was considered, the soya 
protein retentate appeared to be the most effective (Figure 1) in enhancing HT29-MTX-
E12 cell viability compared with the untreated cells. The whey and casein protein 
retentates in the lower range of the tested concentrations maintained intestinal cell 
viability. In contrast, at the higher concentration range (3.12-50 µg/µl), all of the protein 
retentates reduced the viability of the HT29-MTX-E12 cells in dose-dependent manners. 
Ganjam et al., 1997 demonstrated the ability of β-casomorphin-7, which is a casein 
peptide, to modulate the proliferation and induce apoptosis in rat and human intestinal 
cells. The inhibitory roles that were detected at the specific concentrations of the protein 
retentates may be interesting from the perspective that the HT29-MTX-E12 cells have a 
cancerous origin. Thus, the milk and soya peptides may exhibit anti-proliferative effects 
in colon cancer cells as has been previously reported (Meisel & FitzGerald, 2003). 
The results presented here indicated that all of the protein retentates, at specific 
concentrations, were able to modulate the viability of the HT29-MTX-E12 cells and to 
exert trophic effects on the intestinal epithelia. The citomodulatory effects of the food-
derived peptides require further investigation before the full influence of their 
physiological effects at the intestinal cell level can be determined. Based on the viability 
assay, a range of concentrations (0.78-3.12 µg/µl) for the mucus-production evaluation 
was selected.  
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Assessment of HT29-MTX-E12 morphology and mucus production 
 
 
Figure 2: Representative Images of mucin production by HT29-MTX-E12 cell lines at 
days 7, 14, and 21, 20X objective. Mucin production was visualized by Alcian blue 
staining.  
7 days 14 days 21 days 
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Effects of whey, casein and soya protein retentates on HT29-MTX-E12 mucin production: 
PCR for the MUC5AC gene and cyclophilin 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Total RNA was isolated with Nucleospin RNA II (Macherey-Nagel, Dü ren, 
Germany) from HT29-MTX-E12 cells treated (24 h) with DMEM alone (CTR, LINE 2-3); 
0.78, 1.56, 3.12 µg/µL casein protein retentate (LINEs 4-6), 0.78, 1.56, and 3.12 µg/µL 
whey protein retentate (LINEs 7-9), or 0.78, 1.56, and 3.12 µg/µL soya protein retentate 
(LINEs 10-12). RiboRuler low Range RNA Ladder Thermo Fisher Scientific (LINE1).  
18s 
28s 
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Figure 4: The presence of the control and MUC5AC genes were tested by qualitative 
PCR. (A) Representative gel of cyclophilin cDNAs obtained from the HT29-MTX-E12 
cells exposed to DMEM alone (CTR, LINE 1), 0.78, 1.5, and 3.12 µg/µL casein protein 
retentate (LINEs 2-4), 0.78, 1.56, and 3.12 µg/µL whey protein retentate (LINEs 5-7), or 
0.78, 1.56, and 3.12 µg/µL soya protein retentate (LINEs 8-10. (B) Representative gel of 
the MUC5AC cDNAs obtained from the HT29-MTX-E12 cells exposed to DMEM alone 
(CTR, LINE 1), 0.78, 1.56, and 3.12 µg/µL casein protein retentate (LINEs 2-4), 0.78, 
1.56, and 3.12 µg/µL whey protein retentate (LINEs 5-7), or 0.78, 1.56, and 3.12 µg/µL 
C 
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soya protein retentate (LINEs 8-10). (C) MUC5AC gene expressions in the HT29-MTX-
E12 cells treated with whey, casein and soya retentate determined by quantitative RT-
PCR. The data are expressed as the relative MUC5AC expression levels relative to the 
controls (untreated cells, DMEM). Each point represents the mean of three independent 
experiments that were performed in duplicate. 
The mucus gel layer is part of the intestinal mucosa and acts as a protective barrier against 
pathogenic microorganisms, food toxins and hard dietary constituents; it protects the 
intestinal epithelium from the corrosive activities of gastric juice and bacterial and 
endogenous proteases. The intestinal mucus is composed of 95% water and electrolytes 
(Ca2+, Mg2+, Na+), carbohydrates glycoproteins, peptides and lipids. The viscosity of the 
mucus gel derives from glycoproteins called mucins that are primarily secreted by goblet 
cells in the colon.  
To determine whether the whey, casein and soya retentate affected mucin expression and 
secretion, HT29-MTX-E12 cells were treated for 24 h with each of the compounds. As 
demonstrated in Figure 4, casein protein retentate modulated the expression of MUC5AC 
mRNA at the concentration of 0.78 µg/µl, but the higher concentrations tested were not 
able to significantly affect MUC5AC mRNA after 24 h of treatment. Soya protein 
retentate reduced the expression of MUC5AC mRNA (Figure 4). These results accord 
with those of previous studies that have demonstrated the roles of milk peptides in 
modulation of gastrointestinal mucus production. Martinez-Maqueda et al. (2013) 
reported that casein hydrolysate stimulates HT29-MTX-E12 cells and promotes the 
expression of MUC5AC. The same group demonstrated the mucin-secreting role of whey 
protein hydrolysate in HT29-MTX-E12 cells. However, the whey protein peptide β-
lactorphin increases the synthesis of mucin proteins without eliciting differences in 
MUC5AC gene expression (Martinez-Maqueda 2012). Plaisancie et al. (2013) 
demonstrated increases in mucin secretion and MUC2 and MUC4 gene expression in 
HT29-MTX-E12. β-casomorphin-7 increases MUC5AC mRNA expression and the 
secretion of this mucin, as demonstrated by Zoghbi et al. (2006). 
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Prebiotic activity 
 
The results revealed that, at specific concentrations, whey and casein protein retentate 
were effective in promoting the growth of Lactobacillus casei in vitro, compared with 
soya protein retentate. Casein retentate was the most effective in promoting Lactobacillus 
casei growth compared with whey and soya. Specifically, the 1.56 µg/µL of the casein 
retentate significantly (P<0.05) enhanced bacterial growth, compared with the control (0 
µg/µL) (Figure 5, 6). From a health-promotion perspective, this finding is very important 
due to the growing interest in the promotion of the probiotic bacteria along the 
gastrointestinal tract. Probiotic bacteria play a role in the enhancement of gut health by 
competitively excluding pathogens and by producing positive substances for the gut 
microenvironment. However, the specific mechanism by which casein retentate increased 
Lactobacillus casei proliferation needs to be further identified. This proliferative property 
may be related to the antioxidant peptides contained in the digesta, which can modulate 
oxidative stress in the medium via the creating of a more beneficial environment for the 
growth and proliferation of the bacteria. 
This preliminary finding suggests that milk proteins may have a role in the maintenance 
and/or increase in the numbers of prebiotic bacteria in the human gut, leading to a more 
protective environment. 
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Figure 5: Effects of increasing concentrations (µg/µl) of whey protein retentate, casein 
protein retentate and soya protein retentate on Lactobacillus casei proliferation 
(prebiotic activity) after 48 h of incubation in an anaerobic environment. The results are 
expressed as colony-forming units (CFU/mL), and the values that significantly differed 
from those obtained in the control (0 µg/µl) are indicated by * (P<0.05). 
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Figure 6: Effects of increasing the concentrations of whey protein retentate, casein 
protein retentate and soya protein retentate on Lactobacillus casei proliferation (colony 
formation) after 48 h of incubation in MRS agar in an anaerobic environment. 
Altogether, the analyses of prebiotic bacteria and goblet intestinal cell viability may 
represent a complementary and valuable tool, in addition to the available ex vivo and in 
vivo strategies, for the study of the bioactivities of food components in the gut. Although 
the in vitro results may be questionable compared with those obtained in vivo, the results 
obtained with the prebiotic bacteria and goblet cells in vitro may contribute to clarify and 
better describe the effects observed in vivo, when variance in responses between species 
or sexes are observed. However, the results from in vitro cell-based model studies should 
be considered as such and further studies in animal and human models are needed (Purup 
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& Nielsen, 2012). However, further studies on mRNA and mucin proteins expression will 
be performed to confirm the modulation of mucus production that is induced by milk 
protein digested.  
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CHAPTER II: VITAMIN E ROLE AS HEALTH PROMOTING FOOD 
INGREDIENT AND ITS ABILITY IN CONTROLLING OTA INDUCED TOXIC 
EFFECTS IN VITRO 
 
In the past decades, important advances have been made in understanding the adequate 
vitamin E status in animal and human diet, by an appropriate nutrition. The interest in 
vitamin E originates from its role as antioxidant able to counteract oxidative stress. 
However, only partial results are available regarding the role of vitamin E at cellular and 
molecular level (Abid-Essefi et al., 2003 Baldi et al., 2004; Fusi et al., 2008). The 
regulation of cell proliferation, gene expression, cell death and DNA damage are emerging 
functions of vitamin E, stimulating the current research on vitamin E in the target tissues, 
as the kidney and the mammary gland (Baldi, 2005). 
 
Vitamin E structure and functions 
 
The increased interest and research in micronutrient supplements derives from the 
potential roles of the antioxidant micronutrients (i.e., vitamin C, vitamin E, and the 
carotenoids) in balancing oxidative stress (Rock et al., 1996). Vitamin E is a fat-soluble 
vitamin that is naturally synthesized by plants (seeds and oils) and is widely used as 
functional ingredient in foods, pharmaceuticals, and cosmetic preparations (Chiu & Yang, 
1992). 
The term vitamin E is used to describe a family of eight molecules that have a chromanol 
ring and a phytol side chain as common structural features (Gonnet et al., 2010).  
Vitamin E is present in nature in eight different forms that include four tocopherols (α, β, 
γ, and δ) and four tocotrienols (α, β, γ, and δ). All of these compounds occur in a variety 
of isomers (e.g., eight stereoisomers of α-tocopherol result from the synthesis of this 
compound). Among all forms of vitamin E, α-tocopherol is the most active in biological 
systems. The bioavailabilities of the eight stereoisomers have been investigated in several 
animal species, and it has been concluded that the bioactivity is related to ages, species 
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and assessment criteria (Blatt et al., 2004). The differences in bioavailability are also 
related to the stereoisomer composition (Dersjant-Li and Peisker, 2010). 
Although the other naturally occurring forms of vitamin E (β-, γ-, and δ-tocopherols and 
the tocotrienols) are absorbed, they are not converted to α-tocopherol in humans, and they 
are recognized poorly by the α-tocopherol transfer protein (α-TTP) in the liver. 
The natural form of α–tocopherol is composed of 100% RRR-α-tocopherol and is 
produced by plants, whereas the synthetic form (all-rac-α-tocopherol) consists of a 
mixture of eight stereoisomers in equal amounts. Indeed, when α-tocopherol is chemically 
synthesized, eight possible stereoisomers are produced due to the three stereocenters in 
the molecular structure. Four stereoisomers exhibit 2R configurations (RRR, RRS, RSR, 
and RSS), and four exhibit 2S configurations (SRR, SSR, SRS, and SSS) (Figure 1). All 
of the stereoisomers exhibit antioxidant activities, but only the 2R stereoisomers exhibit 
high biological activities (Traber & Steven, 2011; Vagni et al., 2011). In food and feed, 
vitamin E activity is expressed in International Units (IU). The relative activities of RRR 
and all-rac-tocopherol were been calculated in 1979 by the United States Pharmacopenia 
(USP) as 1 mg for all-rac-α-tocopherol acetate (all-rac-α-tocopheryl acetate, equal to 1 
IU), and all-rac-α-tocopherol has a bioactivity of 1.1 IU. RRR-α-tocopherol has a 
bioactivity of 1.49 IU, and RRR-α-tocopherol acetate has a bioactivity of 1.36 IU (Vagni 
et al., 2011). The institute of Medicine (IOM) redefined the USP conversion factors for 
human due to the instability of the 2S stereoisomers of all-rac-α-tocopherol in human 
plasma and tissues (National Academy of Science, IOM, 2000). However, Jensen et al., 
(2007) and Dersjant-Li & Peisker (2009) suggested that studies aimed at reconsidering the 
bioavailabilities of α-tocopherol isomers should be required to consider livestock animals 
and that appropriate revisions of the conversion factors should be performed. 
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Figure 1: Natural and synthetic tocopherol stereoisomers 
 
Antioxidant activity of α-tocopherol: in vitro evidences 
 
Vitamin E is a potent radical scavenger that prevents the propagation of free radicals in 
cell systems and, particularly, protects polyunsaturated fatty acids (PUFAs) within 
membrane phospholipids and plasma lipoproteins (EFSA, 2015). Polyunsaturated fatty 
acids (PUFAs) of the cell membranes are vulnerable to attack by ROS, and such attacks 
can initiate a chain reaction of lipid peroxidation that damages the membrane of the cell.  
In the cellular environment, ROS-mediated free radicals damage can be reversible or 
irreversible and targets the molecules such as DNA, lipids and proteins. High levels of 
ROS generation are due to their abilities to propagate the oxidative reactions initiated by 
single radical species. A balance of antioxidants is needed to control high levels of ROS 
generation and the consequent oxidative damage and related implications before they 
become irreversible. The physiological antioxidant defense systems of the cell are 
normally able to detoxify reactive intermediates or repair damage caused by ROS 
generation. However, imbalances between ROS production and the physiological 
antioxidant system lead to oxidative stress. 
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α-tocopherol is localized in the cell membrane and is associated with lipoproteins due to 
its lipophilic nature. α-tocopherol performs its antioxidant role by scavenging the peroxyl 
radical and blocking free radical propagation. Reactions between lipid peroxyl radicals 
and α-tocopherol result in α-tocopheroxyl radicals and lipid peroxides. Subsequently, 
ascorbic acid can reduce α-tocopheroxyl radicals back to α-tocopherol by donating 
electrons (Azzi et al., 2000; Nakamura & Omaye, 2009). The ability of α-tocopherol to 
scavenge ROS is greater than those of other tocopherols (Zingg, 2007). 
In contrast to other cellular antioxidants, α-tocopherol activity is nonenzymatic, rapid, and 
appears to depend on the microenvironmental conditions, including its concentration and 
the presence of oxidants compounds from foods and the environment. 
Among the environmental- and food-mediated oxidative stressors, OTA represents a 
cause of ROS generation that may compromise antioxidant defense mechanisms.  
OTA is produced by filamentous mold species belonging to the genera Aspergillus and 
Penicillium. This toxin has aroused public concern due to its wide range of toxicological 
effects and its widespread distribution in feed and food (EFSA, 2006). OTA is considered 
to be a potent nephrotoxic, hepatotoxic and teratogenic substance in different animal 
species and exhibits a long half-life in human blood (Stojković et al., 1984). After small 
intestinal absorption, OTA enters in bloodstream where it strongly binds serum proteins 
and is subsequently distributed to different tissues and organs, including the kidney, which 
is the primary target (Hagelberg et al., 1989; Palli et al., 1999; Pfohl-Leszkowicz and 
Manderville, 2011). However, lower OTA concentrations can be detected in different 
tissues, such as the liver, adipose tissue and muscles. Additionally, detectable amounts of 
OTA have been found in the milk of several species, including humans, rabbits, rats and 
ruminants, which suggests that the mammary glands could be among the potential targets 
of this mycotoxin (Fink-Gremmels, 2008; Sorrenti et al., 2013). At the cellular level, 
several OTA mechanisms of action have been proposed, and metabolic activity, cell 
membrane damage, oxidative stress and DNA damage have been studied. However, the 
mechanisms by which OTA elicits its cytotoxic action vary from tissue to tissue. OTA can 
express its toxicity through the covalent binding of OTA metabolites to DNA or via an 
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indirect mechanism of action (Pfohl-Leszkowicz and Manderville, 2011; Ali et al., 2011). 
Accumulating evidence has demonstrated that, in vitro, OTA expresses its toxicity 
through an indirect mechanism that primarily consists of the overproduction of reactive 
oxidative species (ROS) that cause oxidative stress (Palma et al., 2007; Zheng et al., 
2013). ROS overproduction leads to a wide array of oxidative cell lesions at membrane, 
mitochondria and DNA levels that can induce cell death. Indeed, according to the cell type 
examined and the time of exposure, the oxidative effects of OTA may cause apoptosis, 
necrosis or cancer (Costa et al., 2007). 
ROS production has been correlated with DNA oxidation and with the subsequent 
formation of DNA adducts. One of the major OTA-induced oxidative DNA damage 
products is 8-hydroxy-2′-deoxyguanosine (8-OHdG). 8-OHdG is an abundant base 
modification in mammalian DNA that is associated with oxidative stress (Cheng et al., 
1992) and is commonly used as an in vitro biomarker for assessments of OTA-induced 
oxidative damage (Zheng et al., 2013). 
Increasing evidence suggests that OTA is responsible of the perturbation of cell-cell 
interactions and cell-cell signaling (Mally et al., 2006; González-Mariscal et al., 2005; Mc 
Laughlin et al., 2004; Schramek et al., 1997) 
Tight junctions represent the most apical components of the intercellular junctional 
complex, which also includes adherens junctions, desmosomes and gap junctions. Tight 
junctions are composed of multiple transmembrane, scaffolding and signaling proteins 
between which occludin and Zo1 interact to connect with the actin cytoskeleton (Harhaj 
et al., 2004). 
Several strategies, including some nutrient supplementations, have been proposed to 
reduce OTA toxicity (Denli et al., 2010; Sorrenti et al., 2013).  
Among these strategies, antioxidant molecules, such as vitamin E, vitamin A, lycopene, 
and phenolic compounds, have demonstrated different beneficial effects in combating 
OTA toxicity in vivo and in vitro and thus exhibited key roles in promoting health (Sorrenti 
et al., 2013). The preferential localization of α-tocopherol to the cell membrane enhances 
its functional role as a lipid antioxidant and membrane stabilizer (Wang et al., 1999).  
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Baldi et al. (2004) evaluated the protective effects of α-tocopherol in OTA-induced 
oxidative damage. A panel of five well-characterized human and animal cell lines stressed 
with OTA, SK-N-MC (human neuroblastoma), MDCK (Madin Darby canine kidney), 
AML-12 (mouse liver hepatocytes), LLC-PK1 (pig kidney), and BME-UV1 (bovine 
mammary epithelium) cells have been successfully used to investigate the effects of α-
tocopherol in counteracting ROS production. The counteracting effect of α-tocopherol has 
been demonstrated based on signiﬁcant differences in cell sensitivities to OTA, and BME-
UV1 and MDCK cells are the most sensitive of the tested cell lines. 
However, much remains to be investigated regarding the cellular bioactivities and 
membrane stabilizing roles of vitamin E and specifically α-tocopherol. In light of the 
EFSA recommendations for research (EFSA, 2015), which suggest the performance of 
studies to develop various biomarkers and endpoints as indicators of the α-tocopherol 
health-promoting requirements in vivo, a comprehensive knowledge of the in vitro 
antioxidant mechanisms of α-tocopherol represents an unavoidable focus of research. 
Additionally, few reports in the literature have compared the activities of different 
tocopherol isomers with respect to the in vitro oxidative environment.  
Therefore, the second chapter of this thesis is composed of three studies in which the main 
aim was to evaluate the roles of two different α-tocopherol forms in counteracting the 
oxidative damage induced by oxidative stressors (e.g., hydrogen peroxide and OTA) in 
vitro.  
 First, the in vitro relative bioefficacies of RRR-α-tocopherol (RRR- α-T) and all-
rac-α-tocopherol (all-rac-α-T) in counteracting the cytotoxic effects induced by 
oxidative challenges, specifically hydrogen peroxide (H2O2), were investigated in 
BME-UV1 and MDCK cells. 
 Further, the oxidative damage induced by OTA in vitro was characterized in the 
selected cell models while considering different endpoints.  
 The obtained results, together with the well-established nephrotoxic action of 
OTA, led to the study of the role of all-rac-α-tocopherol in MDCK cells subjected 
to oxidative stress induced by OTA.  
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Study I: Relative bioefficacy of RRR-α-tocopherol (RRR- α-T) versus all-rac-α-
tocopherol (all-rac-α-T) in in vitro cell culture models 
 
Aim of study I 
 
In light of the conversion factors recently revised in human, the main aim of this study 
was to investigate the in vitro relative bioefficacy of RRR-α-tocopherol (RRR- α-T) versus 
all-rac-α-tocopherol (all-rac-α-T) in counteracting the cytotoxic effect induced by 
hydrogen peroxide (H2O2) in Bovine Mammary Epithelial cell line (BME-UV1) and 
Madine Darby Canine Kidney cell line (MDCK).  
In this study two commercial forms of α-tocopherol were considered: 
1) (±) α-tocopherol prepared by organic synthesis (all-rac-α-T); 
2) naturally occurring (±) α-tocopherol (RRR- α-T) delivered entirely from soybeans 
 
Material & methods 
 
Cell lines & culture conditions 
 
BME-UV1 cells were routinely cultivated in 75-cm2 plastic culture flasks in complete 
medium, which is a mixture of 50% DMEM-F12, 30% RPMI-1640 and 20% NCTC-135 
supplemented with 10% Foetal Bovine Serum (FBS), 0.1% lactose, 0.1% lactalbumin 
hydrolysate, 1.2 mM glutathione, 1.0 µg/ml insulin, 5.0 µg/ml transferrin, 1.0 µg/ml 
hydrocortisone, 0.5 µg/ml progesterone, 10.0 µg/ml L-ascorbic acid and 5ml/L pen/strep. 
MDCK cells were routinely cultivated in 75-cm2 plastic culture flasks in complete 
medium, which is a mixture of MEM (EBSS), 10% Foetal Bovine Serum (FBS), 2mM 
Glutamine, 1% Non Essential Amino Acids (NEAA) and 2 ml/L of pen/strep. 
Cells were maintained at 37°C into an incubator in a humidified atmosphere containing 
5% CO2. The cells were incubated until the monolayer was sub-confluent (3 to 5 days). 
Medium were changed every 2 days.  
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After reaching the sub-confluence, cells were trypsinized and seeded (seeding density: 
BME-UV1 2 x 105cells/mL; MDCK 1 x105 cells/mL) into 96-wells tissue culture plates. 
After 24h of incubation at 37°C in an atmosphere of 5% of CO2 a sub-confluent layer of 
cells was reached. 
 
RRR-α-tocopherol (RRR- α-T) and all-rac-α-tocopherol (all-rac-α-T) dose-response 
curve 
 
In the first set of experiments a dose-response curve, with several tocopherol 
concentrations was performed in order to determine the appropriate concentrations for 
further oxidative challenge experiments. In subdued lighting, the two forms of tocopherol 
were dissolved in ethanol to give 10 mM solutions. Further dilution in serum-free culture 
medium produced concentrations, ranging from 100 µM to 1nM. The concentrations of 
RRR- α-T and all-rac- α-T selected for oxidative challenge experiments were 100µM and 
1nM for BME-UV1 and for MDCK cell line. The selection has been made also on the 
base of previous results and on the data obtained in studies conducted by Baldi and 
collaborators (2004). Work solutions were stored in the dark before addition to cultures. 
Cells incubated with only basal medium, specific for each cell model, were used as 
control. The effect of RRR- α-T and all-rac-α-T on both BME-UV1 and MDCK cell lines 
was determined by MTT test. 
MTT assay measures the production of the chromophore formazan from 3-(4, 5-
dimethylthiazol-2-yl)-2, 5 diphenyltetrazoliumbromide. Formazan is produced in viable 
cells by the mitochondrial enzyme succinate dehydrogenase. Three replicates per 
treatment were employed and the experiment was repeated at least twice.  
In particular, the percentage of cells viability induced by protein retentate treatments was 
calculated as follows  
% cell viability = (mean optical density of treated cells/ mean optical density of control 
cells) x 100. 
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Evaluation of RRR-α-tocopherol (RRR- α-T) and all-rac-α-tocopherol (all-rac-α-T) 
activity in counteracting the cytotoxic effect induced by oxidative challenges 
 
Preliminary experiments were performed to determine H2O2 cytotoxicity, the LC50 was 
calculated in both cell lines (MTT test). 
In the second set of experiments a putative difference in the protective effect of the two 
forms of tocopherol against oxidative challenges was evaluated. Cells were trypsinized 
and inoculated into wells of 96-cell tissue culture plates (seeding density: BME-UV1 2 x 
105 cells/ml; MDCK 1 x105 cells/ml). Cells were pre-incubated for 3 h with the selected 
RRR- α-T and all-rac- α-T concentrations and then exposed to increasing H2O2 
concentrations ranging from 250 to 750 µM for BME-UV1 cell line and from 125 to 175 
µM for MDCK cell line for the following 24h. 
The effect of RRR- α-T and all-rac- α-T on both BME-UV1 and MDCK cell lines in 
counteracting H2O2 toxicity was determine with the MTT and LDH tests in order to 
evaluate cell viability and membrane stability, respectively. 
The LDH assay quantitatively measures lactate dehydrogenase (LDH), a stable cytosolic 
enzyme that is released upon cell lysis. In order to examine cell membrane damage 
induced by the different treatments Lactate dehydrogenase enzyme release (LDH) assay 
was performed using a CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega) as 
instructed by the manufacturer. Briefly, after the treatments, supernatants were removed 
and centrifuged for 5 minutes at 1500 × g (4°C). 50 μL of each supernatant was transferred 
to a new 96 well plate. Cellular monolayers were lysed by adding 15 μL of 9% Triton X-
100 solution in water per 100 μL of basal medium (EMEM), followed by an incubation 
for 1 h at 37 °C. Cells debris were removed by centrifugation for 5 min at 1500 × g (4 °C) 
and 50 μL of each cell lysate was transferred to 96 well plate. Then, 50 μL of LDH 
substrate was added to the supernatants and cell lysates. After the incubation for 30 
minutes at room temperature in the dark, the enzymatic assay was stopped by adding 50 
µL of 1 M acetic acid and the plate was read at 490 nm using a Biorad 680 microplate 
reader. 
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The percentage of LDH release was calculated as follows: 
%LDH release= LDH medium/ (LDH medium + LDH cell lysate). 
 
Statistical analysis 
 
At least three replicates at each incubation time were performed and all experiments were 
performed three times. Results are expressed as mean ±SEM. The effect of various 
treatments were evaluated by one-way analysis of variance using the GLM procedure of 
SAS (SAS institute Inc, NC, USA). Values significantly different from controls are 
indicated as P<0.05. 
 
Results & discussion 
 
RRR-α-tocopherol (RRR- α-T) and all-rac-α-tocopherol (all-rac-α-T) dose-response 
curve 
 
After 24 h of incubation a significant (P<0.05) stimulatory effect of all-rac- α-T and RRR- 
α-T (Figure 1) on BME-UV1 cells viability was observed. A higher percentage of cell 
viability in BME-UV1 cells treated with all-rac- α-T and RRR- α-T compared with control 
cells (DMEM), was observed. The proliferative effect induced by RRR- α-T form was 
higher at the lowest concentrations (1 nM and 0.01 µM) than all-rac-α-T.  
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Figure 1: Effect of all-rac- α-T (All) and RRR-α-T (RRR) (concentrations ranging from 
1nM to 100 µM) on BME-UV1 cell viability. Results are from three independent 
experiments with triplicate wells and presented as least square means ± SEM relative to 
cell viability obtained in basal medium (DMEM). 
 
In MDCK cell line, after 24h of treatment with increasing concentrations of all-rac- α-T 
and RRR- α-T (Figure 2) a maintenance of the cell viability was demonstrated. 
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Figure 2: Effect of all-rac- α-T (All) and RRR-α-T (RRR) (concentrations ranging from 
0.01nM to 100 µM) on MDCK cell viability. Results are from three independent 
experiments with triplicate wells and presented as least square means ± SEM relative to 
cell viability obtained in basal medium (MEM). 
 
Evaluation of RRR-α-tocopherol (RRR- α-T) and all-rac-α-tocopherol (all-rac-α-T) 
activity in counteracting the cytotoxic effect induced by H2O2 
 
In order to set up the challenge we have first investigated the half-lethal concentration 
(LC50) of H2O2 in both cell lines. In BME-UV1 cells LC50, after 24h of H2O2 treatments, 
was 375.87 µM, while in MDCK cells, LC50 was 140 µM after 24h of H2O2 exposure.  
Effect on cell viability: MTT test 
In the second set of experiments, the ability of RRR- α-T and all-rac- α-T forms to 
counteract the damage induced by the oxidative stressors as H2O2 was assessed, 
considering the cell viability and the stability of the cell membrane. 
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In BME-UV1cells (Figure 3) pre-treatments with 100 µM of RRR- α-T and 100 µM all-
rac- α-T were able to significantly (P<0.05) counteract the oxidative effect induced by the 
highest H2O2 concentration tested (750 µM). 
 
 
Figure 3: Effect of pre-treatment with all-rac- α-T (All) and RRR- α-T (RRR) against H2O2 
cytotoxicity in BME-UV1. Results are from three independent experiments with triplicate 
wells and presented as least square means ± SEM relative to cell viability obtained in 
basal medium (DMEM). Values significantly different from cell viability obtained in H2O2 
alone are indicated by * (P<0.05). 
In MDCK cells (Figure 4) pre-treatments with 1nM of all-rac-α-T were able to 
significantly (P<0.05) reduce the oxidative effect of H2O2 when it was supplemented at 
125 µM and 150 µM. 
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Figure 4: Effect of pre-treatment with all-rac- α-T (All) and RRR- α-T (RRR) against H2O2 
cytotoxicity in MDCK. Results are from three independent experiments with triplicate 
wells and presented as least square means ± SEM relative to cell viability obtained in 
basal medium (MEM). Values significantly different from cell viability obtained in H2O2 
alone are indicated by * (P<0.05). 
 
Effect on membrane stability: LDH test 
 
The preferential localization of α-tocopherol in the cell membrane enhances its functional 
role as lipid antioxidant. Therefore, the membrane stabilizer ability of both all-rac-α-T 
and RRR-α-T was evaluated by LDH release in BME-UV1 and MDCK cells. After 24 h 
of co-incubation with all-rac-α-T or RRR-α-T and H2O2 solutions, in BME-UV1 cell line 
no differences in LDH release were detected. In MDCK cells, the pre-incubation with all-
rac-α-T determined a significant (P<0.05) reduction of the membrane damage, induced 
by 175 µM of H2O2. 
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In conclusion, RRR-α-T and all-rac-α-T demonstrated to have antioxidant activity in 
vitro. The dose-response curve experiments showed that RRR-α-T and all-rac-α-T 
tocopherols were able to maintain (MDCK cells) and increase (BME-UV1 cells) the cell 
viability. In this study the oxidative cellular stress was simulated by H2O2 treatment. It 
has been observed that adequate concentrations of RRR-α-T and all-rac-α-T could reduce 
the oxidative damages induced by H2O2 in both BME-UV1 and MDCK cells as 
demonstrated by cell viability and membrane stability results. However, further 
investigations will help in describing their specific mechanism of action in vitro.  
RRR-α-T form has been demonstrated to have higher biological activity compared with 
all-rac-α-T form in vivo (Weiss et al., 2009) and it could be due to the different tissue 
uptake of the tocopherol forms and to the different stereoisomers composition. It has been 
established that after consumption of all-rac-α-T, 2R-α-tocopherols are well retained in 
circulation; however, 2S-α-tocopherols are actively metabolized and eliminated in humans 
(Traber et al., 1998). Further work is required toward translation of the in vitro findings 
to improve the in vivo impact of RRR-α-T and all-rac-α-T intake, and their health-
promoting effect in animals and humans.  
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Study II: Cytotoxicity, apoptosis, DNA damage and methylation in mammary and kidney 
epithelial cell lines exposed to OTA  
 
Aim of study II 
 
In the present study the cytotoxicity of OTA was first investigated by the evaluation of 
metabolic activity, membrane stability and apoptotic cell rate in BME-UV1 and MDCK 
cell lines. Further, the effect of the addition of OTA has been evaluated at DNA level by 
the determination of the DNA integrity, by the quantification of DNA adduct formation 
(8-OHdG) and by the assessment of the global DNA methylation status (5-mC) in order 
to improve the available data regarding OTA mode of action in vitro. 
 
Material & methods 
 
Chemicals 
 
OTA and all other chemicals were purchased by Sigma-Aldrich (St. Louis MO, USA), 
unless otherwise indicated. 
 
Cell culture & treatments 
 
BME-UV1 and MDCK cell were maintained in culture as previously describe in the study 
I. Cell lines were maintained at 37°C in a humidified 5% CO2 incubator until sub-
confluence. Medium was replenished every second day for both cell lines and cells were 
passaged for exposure to treatment media while in the logarithmic growth phase. OTA 
was dissolved in methanol (100%) to obtain a stock solution of 10,000 μg/mL. The 
treatment concentrations of OTA were composed of serum free basal medium (DMEM 
for BME-UV1 and EMEM for MDCK cells) contained OTA at several concentrations 
(from 0.15 μg/mL up to 10 μg/mL). Preliminary experiments showed that the 
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concentration of methanol employed in the serum free OTA dilutions had no effect on cell 
metabolic activity. Portion (150 μl) of cell suspension (2.5 x 105 cell/mL for BME-UV1 
and 1 x 105 cell/mL for MDCK) were dispensed into 96 well-plates (NuncClon Surface, 
Nunc, Denmark). Under these conditions, a sub-confluent monolayer was observed after 
24 hours of incubation at 37°C in an atmosphere of 5% CO2. At sub-confluence, complete 
medium was removed from each well and BME-UV1 and MDCK cells were exposed to 
treatment concentrations of OTA (150 μL/well) for an incubation time of 24 hours. 
 
Cell viability: MTT test 
 
Cell viability was determined after incubation with OTA by measuring the production of 
the chromophore formazan from 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium 
bromide. Formazan is produced in viable cells by the mitochondrial enzyme succinate 
dehydrogenase. 
After 24 hours of OTA treatment, medium was removed and 150 μL MTT stock solution 
(5 mg/ mL) in Phosphate Buffer Saline (PBS, Euroclone) were added to each well and the 
plate was incubated for 3 h at 37°C in a humidified chamber. After incubation time MTT 
solution was removed to stop the reaction and 150 μl of dimethyl sulfoxide was added to 
dissolve the formazan. The optical density of the dimethyl sulfoxide solution at 570 nm 
was determined on a Biorad 680 microplate reader (Biorad, Veenendaal, The 
Netherlands). In particular, the percentage of cells viability after OTA treatments was 
calculated as follows  
% cell viability = (mean optical density of treated cells/ mean optical density of control 
cells) x 100. 
From MTT assay results, the Half Lethal Concentration 50 (LC50) of OTA was calculated 
for each cell line. 
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Membrane stability: LDH test 
 
BME-UV1 and MDCK cell lines were treated with selected concentrations of OTA (0.3, 
0.6 and 1.25 µg/mL) chosen on the basis of LC50. In order to examine cell membrane 
damage induced by OTA treatments Lactate dehydrogenase enzyme release (LDH) assay 
was performed using a CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega) as 
instructed by the manufacturer. Briefly, after 24 hours of OTA treatment, supernatants 
were removed and centrifuged for 5 minutes at 1500 × g (4°C). 50 μL of each supernatant 
was transferred to a new 96 well plate.  
Cellular monolayers were lysed by adding 15 μL of 9% Triton X-100 solution in water 
per 100 μL of basal medium (EMEM), followed by an incubation for 1 h at 37 °C. Cells 
debris were removed by centrifugation for 5 min at 1500 × g (4 °C) and 50 μL of each cell 
lysate was transferred to 96 well plate. Then, 50 μL of LDH substrate was added to the 
supernatants and cell lysates. After the incubation for 30 minutes at room temperature in 
the dark, the enzymatic assay was stopped by adding 50 µL of 1 M acetic acid and the 
plate was read at 490 nm using a Biorad 680 microplate reader. The percentage of LDH 
release was calculated as the amount of LDH in the supernatant over total LDH from both 
supernatant and cell lysate. 
 
Apoptosis: Tunel (TdT-mediated dUTP nick end labeling) test 
 
BME-UV1 and MDCK cells were seeded at a density of 0.3 ×106 and 0.2 ×106 cells/mL, 
respectively, in a two-well chamber slides (Nunc Lab-Tek, Nunc, Denmark) and 
maintained for 24 hours. Afterward, the medium was removed and the cell monolayers 
washed twice with PBS. Based on results obtained from previous assays, the 
concentrations of 0.8 μg/mL and 1 μg/mL of OTA were selected and added to BME-UV1 
and MDCK cells respectively for the following 24 hours. 
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At the end of the incubation, the medium was removed and the cells fixed with refrigerated 
methanol for 10 min at -20°C. The Tunel assay was performed using the DeadEnd 
Colorimetric Apoptosis Detection kit (Promega, Madison, WI, USA). The monolayers 
were washed twice with PBS and permeabilized by immersing the slides in 0.2% Triton 
X-100 solution in PBS for 5 min at room temperature. After washing with PBS, cells were 
incubated with biotinylated nucleotide mixture together with terminal deoxynucleotidyl 
transferase enzyme. Horseradish peroxidase–labeled streptavidin (streptavidin HRP) was 
then added to bind to these biotinylated nucleotides, which are detected using the 
peroxidase substrate hydrogen peroxide and the stable chromogen diaminobenzidine 
(DAB). Afterward, to distinguish and calculate the apoptotic and non apoptotic cells, 
haematoxylin staining was performed. Images (20X) were captured under an Olympus 
BX51 microscope. For each experiment, ~500 cells were counted in randomly selected 
fields, and the percent of Tunel-positive cells were calculated. 
 
DNA damage: agarose gel electrophoresis and 8OH-dG adduct formation 
 
BME-UV1 and MDCK cells were cultured in 25 cm² flasks (Sarstedt, Germany) at the 
seeding density of 1x106cells/mL and left untouched for 24 hours at 37°C and 5% of CO2. 
Cells were treated with the treatment medium containing the selected concentrations of 
OTA (0.3-1.25µg/mL) and the subsequent day cells were collected for purification and 
quantification of the DNA.  
DNA from BME-UV1 and MDCK cells was extracted using the Wizard® genomic DNA 
purification kit (Promega Corporation, Madison, WI, USA) according to manufacturer’s 
instructions. The concentration and the quality (260/280) of the total DNA was 
determined by UV spectrophotometry at 260nm and by agarose gel electrophoresis 
followed by Image Lab™ software analysis (BioRad).  
Specifically, loading buffer was added to 5µg DNA for each treatment and to 5µg of DNA 
ladder (Molecular Weight Marker II, Roche) and the samples were analysed by 
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electrophoresis on a 1% agarose gel (1.30 hour at 65V/200mA) with 1X Tris/Boric 
acid/EDTA (TBE) buffer (BioRad). DNA was subsequently used for the further analysis 
investigating DNA damage induced by OTA treatments. 
To assess DNA damage induced by OTA treatment, HT 8-oxo-dG ELISA kit II 
(Trevigen®) was employed. After DNA collection and quantification, a concentration of 
500 µg/mL of BME-UV1 and MDCK cell DNA was fragmented in single nucleotides and 
processed according to the manufacturer’s protocol. Results are expressed as [8-OHdG] 
(nM) / DNA (µg/mL). 
 
Global DNA methylation: 5-methyl-Cytosine (5-mC) 
 
The same DNA samples were employed for the analysis of 5-mC in BME-UV1 and 
MDCK cell lines. 
In particular, in order to investigate if OTA treatment and the DNA damage could be 
linked to change in the global DNA methylation, MethylFlash Methylated DNA 5-mC 
quantification (Epigentek) was performed as indicated by the manufacturer. The 
percentage of 5-mC was calculated in 100ng DNA extracted BME-UV1 and MDCK cells 
treated with OTA using the second-order regression equation of the standard curve that 
was constructed with negative control and positive controls in the same experiment. 
Results are expressed as 5-mC percentage over the total DNA. 
 
Statistical analysis 
 
Results are expressed as mean value ± standard error of three independent experiments in 
triplicate wells. 
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Statistical differences between control and treated cells for all experiments were evaluated 
by one way analysis of variance (ANOVA) using the General Linear Model procedure of 
SAS 9.4. The level of significance at P <0.05 was considered statistically significant.  
 
Results & Discussion 
 
Graphical representation of results 
 
Figure 1: Graphical summary of the study II results  
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Cell Viability: MTT test 
 
Cytotoxicity of OTA was first assessed by the determination of cell viability in BME-
UV1 and MDCK cells. 
In particular, the incubation with increasing concentrations (ranging from 0 up to 10 
μg/mL) of OTA for 24 hours determined a dose dependent inhibition of cell viability1 in 
both cell lines (Figure 2A and B). LC50 was calculated in both BME-UV1 and MDCK 
cells after 24 hours of OTA incubation and reported in Table 1.  
 
Figure 2: Effect of increasing concentrations of OTA added to the culture medium for 24 
hours on cell viability (MTT test) in BME-UV1 cells (A) and MDCK cells (B). Results are 
from three independent experiments with triplicate wells and presented as least square 
means ± SEM relative to cell viability value obtained in basal medium (0 µg/mL OTA). 
Table 1. LC50 values of OTA in BME-UV1 and MDCK cell lines as determined by MTT 
test. 
 LC50 (µg/mL) 
BME-UV1 0.8 
MDCK 1 
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Considering the LC50 values, the range of OTA concentrations for the further experiments 
was determined in 0.3 -1.25μg/mL for both BME-UV1 and MDCK cells. 
 
Membrane stability: LDH release assay 
 
The cell membrane damage induced by OTA on BME-UV1 and MDCK cells was 
investigated by the release of LDH, a biomarker of membrane integrity. As showed in 
Figure 3A and 3B, 24 hours incubation with OTA induced a dose dependent LDH release 
in both cell lines, indicating that OTA caused cell membrane damage. OTA significantly 
(P<0.05) increased LDH release in BME-UV1 cells at all the concentrations tested, 
compared with control cells (0 μg/mL OTA). In particular, a percentage of 46% of LDH 
release has been observed in BME-UV1 cells treated with 1.25 μg/mL of OTA. In MDCK 
cells, 1.25 μg/mL of OTA induced 35% (P<0.05) LDH release, compared with control 
cells (0 μg/mL of OTA). 
 
Figure 3: Effect of increasing concentrations of OTA added to the culture medium for 24 
hours on membrane stability (LDH release) in BME-UV1 cells (A) and MDCK cells (B). 
Results are from three independent experiments with triplicate wells and presented as 
least square means ± SEM relative to membrane stability in basal medium (0 µg/mL OTA). 
Values significantly different from membrane stability obtained in basal medium are 
indicated by * (P<0.05). 
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The MTT assay was performed to measure the cell viability after OTA treatment, the 
quantification of the LDH release was used as a biomarker of the integrity of the cell 
membrane. The above-mentioned assays together may provide a picture of the 
cytotoxicity effect of OTA in BME-UV1 and MDCK cells. 
The first finding of this study confirmed the cytotoxicity of OTA in BME-UV1 and 
MDCK cells, as previously observed (Baldi et al., 2004). According to LC50, both cell 
lines cells showed a higher sensitivity to OTA compared with other cell models. 
Hepatocellular (Hep3B) cells exhibited a LC50 of 104µM after 24 hours of OTA treatment 
(Anninou et al., 2014). In OTA treated-PK15 cells the LC50 obtained by MTT and Trypan 
Blue assays were 14 And 20 µM, respectively (Klarić et al., 2012). The sensitivity of 
BME-UV1 cells is significant considering that OTA and its metabolites were detected in 
milk of several species (Sorrenti et al., 2013), even if their carry over in ruminant milk is 
limited, due to the rumen microflora hydrolysis. However, rumen detoxification capacity 
is saturable and can vary with changes in the diet, the duration of OTA exposure, and the 
health and production status of the animal (Cheli et al., 2015; Fink-Gremmels, 2008), 
leading to a more consistent OTA transfer to milk in ruminants. 
 
Apoptotic cell rate: Tunel (TdT-mediated dUTP nick end labeling) assay 
 
The number of apoptotic cell nuclei induced by OTA treatment on BME-UV1 and MDCK 
cells was investigated by Tunel assay. Representative photos of BME-UV1 and MDCK 
cells morphology incubated with complete medium alone (control cells, 0 µg/mL of OTA) 
for 24 hours are showed in Figure 4A and C, respectively.  
In the absence of OTA, the uniformity of monolayers, the typical cell-cell interactions in 
cultures were evident in both cell lines tested, with only a small amount of apoptotic nuclei 
detected. The average percentage of apoptotic nuclei calculated in the selected fields for 
BME-UV1 control cells was of 1.37± 0.88 (Figure 4A), while for MDCK control cells 
was 2.2±0.88 (Figure 4C). 
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In BME-UV1 cells co-incubated with 0.8 µg/mL of OTA for 24 hours, the average 
percentage of apoptotic nuclei was 10± 0.86 (P<0.05). In addition the uniformity of the 
monolayers was greatly compromised and floated cellular debris have been detected in all 
the observed fields (Figure 4B).  
In MDCK cells co-incubated with 1 µg/mL of OTA for 24 hours, the average percentage 
of apoptotic nuclei was 24.86 ± 0.88 (P<0.05), as demonstrated by the high presence of 
dark brown nuclei in the Figure 4D.  
 
Figure 4: Representative photos of TUNEL-stained BME-UV1 and MDCK cells. The 
TUNEL-positive nuclei, indicating apoptotic cells, are stained in dark brown, while the 
vital nuclei are stained violet (haematoxylin). (A) BME-UV1 cells in culture for 24 h (0 
µg/mL OTA); (B) BME-UV1 cells incubated with 0.8 µg/mL OTA for 24 h; (C) MDCK 
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cells in culture for 24 h (0 µg/mL OTA); (D) MDCK cells incubated with 1 µg/mL OTA 
for 24 h. (Bars 100 µm) 
 
In the present study, the Tunel assay, widely used for detecting apoptotic cells at earlier 
stages, demonstrated that the cellular monolayers observed were compromised and the 
cellular debris were present, underlining the OTA-induced cytotoxicity in both BME-UV1 
and MDCK cells. Tunel positive apoptotic nuclei were observed in MDCK cells and this 
finding is consistent with the kidney as the main target of OTA and in line with previous 
findings (Gekle et al., 2000). After OTA incubation, an increased number of apoptotic 
cells has been described in different kidney in vitro models (Schwerdt et al., 1999; Kamp 
et al., 2005), and in cells from different sources (Cui et al., 2010). In this study, a lower 
but consistent number of apoptotic cells was also detected in BME-UV1 cells incubated 
with 0.8µg/mL OTA. However, given the amount of detached cells and cellular debris 
floated in the observed fields we can speculate that a different mechanism of death 
intervened in OTA-treated BME-UV1 cells, also considering the high level of membrane 
damage previously described by LDH release assay in this cell line. 
Moreover, since the cell death is a multi-stage procedure, quantifying and characterize the 
apoptotic process need several techniques and remains to be elucidated in BME-UV1 cell 
lines. 
 
DNA damage: agarose gel electrophoresis and 8OH-dG adduct formation 
 
The DNA was extracted from BME-UV1 and MDCK cells incubated with selected 
concentrations of OTA and a qualitative analysis was performed by agarose gel 
electrophoresis. OTA incubation caused a dose-dependent DNA degradation in BME-
UV1 cells, as illustrated by the appearance of DNA ladders in Figure 5A. No specific 
DNA degradation was detected in MDCK cells treated with OTA. 
101 
 
Further, the effect of OTA on the formation of DNA adduct was investigated in the DNA 
of BME-UV1 and MDCK cells. The formation of 8-OHdG was significantly increased 
(P<0.05) in BME-UV1 cells treated with specific OTA concentrations, compared with 
control cells (Figure 5B). In particular, a 24 hours exposition of 1.25μg/mL OTA led to a 
concentration of 9.03nM of 8-OHdG adduct formation in BME-UV1, whereas in the 
BME-UV1 control cells (0 μg/mL OTA) the concentration of 8-OHdG was 2.23 nM. No 
difference was detected in MDCK cells treated with OTA compare with control, 
suggesting a different pathway of OTA toxicity in this cell line. 
 
Figure 5: (A) Effect of increasing concentrations of OTA evaluated on the integrity of 
DNA extracted from BME-UV1 and MDCK cells and loaded on agarose gel 
electrophoresis. Line 1A:DNA Ladder; Line 2A DMEM (0 μg/mL OTA); Line 3: 0.3 μg/mL 
OTA; Line 4: 0.6 μg/mL OTA; Line 5: 1.2 μg/mL OTA; Line 1B: MEM (0 μg/mL OTA); 
Line 2B: 0.3 μg/mL OTA; Line 3B: 0.6 μg/mL OTA; Line 4B 1.25 μg/mL OTA; Line 
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5B:DNA Ladder. (B)Effect of increasing concentrations of OTA on 8-OHdG adduct 
formation in BME-UV1 cells and MDCK cells. Results are from three independent 
experiments with triplicate wells and presented as least square means ± SEM relative to 
8-OHdG adduct formation in basal medium (0 µg/mL OTA). Values significantly different 
from 8-OHdG adduct formation obtained in basal medium are indicated by * (P<0.05). 
 
The capability of OTA and its metabolites to bind DNA is still conflicting and OTA-DNA 
damaging potential was mainly related to free radical overproduction and oxidative stress. 
Previous studies demonstrated the ability of OTA to induce DNA damage in vitro, such 
as by the chromosomal aberration and the formation of DNA strand breaks, DNA adducts 
and DNA-DNA cross links (Mally & Dekant, 2005; Yang et al., 2015; Rutigliano et al., 
2015). OTA-induced adduct formation has been investigated in different cell lines. Zheng 
et al. demonstrated the toxic effect of 25µM of OTA in HepG2 cells with a significant 
increase in the formation of 8-OHdG and an induction of global DNA hypo-methylation. 
Further, DNA degradation and 8.8ng/mL 8-OHdG adduct formation was found in kidney 
LLC-PK1 cells after 60µM of OTA treatment (Costa et al., 2008). OTA caused the 
formation of 8-OHdG also in HPBMCs cells, as demonstrated by Liu et al. (2012). 
However, biological data associated to the activity of OTA on the mammary gland tissue 
are rather limited, especially those regarding the induction of DNA damage. The results 
here obtained demonstrated the genotoxic effect induced by OTA in vitro with a 
significant DNA degradation and 8-OHdG adduct formation in the DNA of BME-UV1 
cells after 24 hours of treatment. Considering the in vitro condition, we can speculate that 
the 8-OHdG formation occurred independently of metabolic activation. The investigation 
of the mechanism of adduct formation, by the covalent binding of OTA metabolites to 
DNA or by an indirect mechanism (ROS-mediated DNA damage) in BME-UV1 cells is 
complex and requires further qualifiers and different endpoint to measure as HPLC 
techniques and 32P-postlabelling assays (Obrecht-Pflumio & Dirheimer, 2000). 
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However, a different scenario turned up when MDCK cells were treated with OTA, with 
no DNA degradation detected by the agarose gel-electrophoresis and no significant 8-
OHdG adduct formation occurred. This may be owed to a different cell response to the 
mycotoxin activity, as also suggested by the different LDH release results and number of 
apoptotic cell detected with Tunel assay. In addition, although 8-OHdG is one of the most 
studied oxidative biomarker and widely considered a simple and a valid method to 
estimate the cellular oxidative damage related to the genotoxic potential of OTA (Zheng 
et al., 2013; Kasai et al., 1997; Faucet et al., 2004), different forms of DNA damage are 
known to be produced in vitro. Therefore, it becomes important to make effort in the 
investigation of other cell biomarkers in BME-UV1 and MDCK cells to describe and 
characterize OTA-induced damages at DNA level. 
 
Global DNA methylation: 5-methyl-Cytosine (5-mC) 
 
Methylation of cytosine in the DNA of BME-UV1 and MDCK cells was investigated in 
order to determine whether the cytotoxic action of OTA and the subsequent DNA damage 
induction could also affect the pattern of global DNA methylation in these cell lines. In 
both BME-UV1 and MDCK control cells (0 μg/ml OTA) the average percentage of 5-mC 
was below 6%. No detectable changes in the global DNA methylation pattern have been 
observed after OTA treatment in BME-UV1 and MDCK cells (Figure 6).   
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Figure 6: Effect of increasing concentrations of OTA on DNA global methylation in BME-
UV1 cells (A) and MDCK cells (B). The level of global DNA methylation is indicated by 
the percentage of 5-mC in the total cytosine. Results are from three independent 
experiments with triplicate wells and presented as least square means ± SEM relative to 
membrane stability in basal medium (0). 
 
The methylation of the 5th position of cytosine to form 5-mehtyl Cytosine is one of the 
most important epigenetic biomarker in mammalian cell genome, and it is commonly 
associated with DNA integrity. Specifically, if the DNA adduct occurs in a methylated 
portion of the DNA it could alter the cytosine methylation profile at this site. Adduct 
formation by OTA may impair the global methylation of the DNA as suggested for other 
mycotoxins (Kouadio et al., 2007). Zheng et al. (2013) demonstrated a link between OTA 
treatment and the decrease of 5-mC percentage, leading to a global DNA hypo-
methylation in hepatic cells. 
However, in the present study the global DNA methylation appears not to be affected in 
BME-UV1 and MDCK cells treated with OTA. The 8-OHdG adduct formation observed 
in BME-UV1 incubated with OTA was not associated with global DNA methylation 
alteration. This finding suggests that the in vitro relationship between OTA incubation, 
adduct formation and DNA methylation is not resolved yet. Other epigenetic markers, 
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higher OTA concentrations and different in vitro models need to be used in order to have 
a complete understand of OTA mode of action at the DNA level.  
Overall, the cytotoxicity potential of OTA impaired BME-UV1 and MDCK cell viability, 
cell membrane integrity, DNA integrity and increased the number of apoptotic cells. The 
major difference in the OTA-induced toxicity was a more consistent formation of DNA 
adduct in BME-UV1 cells, compared with MDCK cell line. However, the high apoptotic 
cell number detected in MDCK cells is consistent with the kidney as the primary target of 
OTA in vivo. These findings could help in ameliorate the characterization of OTA mode 
of action in vitro, suggesting that a different mechanism of toxicity may occur in these 
cell lines and merits a deeper characterization. Given the high OTA cytotoxicity in MDCK 
cells together with the high number of apoptotic cells detected, we can speculate that a 
predominant cytotoxic mechanism of OTA rather than a genotoxic mechanism of action 
occurs, with marked effects on cell metabolic activity, membrane and tight junction’s 
integrity.  
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Study III: α-tocopherol role in counteracting OTA toxic activity in MDCK cells: effects 
on cell viability and tight junctions 
 
Aim of study III 
 
Kidney represents one of the main target organs of OTA toxicity. Increasing evidence 
suggested that OTA is responsible of the perturbation of cell-cell interactions as well as 
cell-cell signaling. At kidney level, tight junctions varies along the nephron. The level of 
complexity of the tight junction increases moving forward the distal tubule. MDCK cells 
represent an estimable model of the distal tubule/collecting duct (Feldman et al., 2005) 
and for the OTA toxicity studies. Therefore, the aim of this study was to evaluate the OTA 
effects on cell viability, apoptotic rate and occludin and Zo1 localization and the role of 
α-tocopherol in counteracting its effects in MDCK cells. 
Material & methods  
 
Chemicals 
 
OTA, all-racemic α-tocopherol and other chemicals were purchased from Sigma-Aldrich 
(St. Louis MO, USA), unless otherwise specified. OTA was dissolved in methanol (100%) 
to obtain a stock solution of 10,000 μg/mL. The treatment concentrations of OTA were 
composed of basal medium (EMEM, serum free) contained OTA at several concentrations 
(from 0.15 μg/mL up to 5 μg/mL). Preliminary experiments showed that the concentration 
of methanol employed in the serum free OTA dilutions had no effect on cell metabolic 
activity 
In subdued lighting, α-tocopherol was dissolved in ethanol to give 10 mM solutions. 
Further dilutions with basal EMEM medium produced micromolar (10 µM) and 
nanomolar (1 nM) concentrations. These diluted stock solutions were stored in the dark 
before addition to cultures accommodated in a cabinet without lighting. 
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Cell culture 
 
Madin Darby canine kidney (MDCK) cell line was purchased and maintained as 
previously indicated in the study II and III. At confluence, cells were detached from the 
flasks by trypsinisation and re-suspended in culture medium to a concentration of 1 x 105 
cell/mL. Portions of cell suspension were dispensed in the most suitable supports for the 
following experiments. Cells used in this study were between passage number 22 and 25. 
 
Determination of cell viability and LDH release in the presence of OTA and α-tocopherol 
 
In dose response experiments, MDCK cells were exposed to increasing concentrations of 
OTA (0-5 µg/mL). Cell culture medium, in fact, was replaced with red phenol and serum 
free media in which serial concentration of OTA was diluted. After 24 h of incubation, 
cell viability was detected by measuring the production of the tetrazolium compound [3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine ethosulfate; 
PES) (Promega, Madison, WI, USA). CellTiter 96® AQueous solution were added to each 
well and the plates were incubated for 3 h at 37°C in a humidified chamber. To measure 
the amount of soluble formazan produced by viable cells the absorbance at 490 nm on a 
Biorad 680 microplate reader (Biorad, Veenendaal, The Netherlands) was recorded. Cells 
incubated with EMEM alone, representing 100% viability, were included as negative 
controls in all experiments. 
The half Lethal Concentration (LC50) was calculated considering the percentage of 
cytotoxicity (1- mean optical density in the presence of OTA/mean optical density of 
EMEM alone). 
In another set of experiments, MDCK were cultured in the presence of OTA doses around 
LC50 determined as previously described, in the presence or absence of α-tocopherol (1 
nM or 10 µM). Cells were first pre-incubated for 3 h with α-tocopherol and then exposed 
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to increasing concentrations of OTA (0-1.2 µg/mL) for the following 24 h. Cells were also 
exposed to antioxidant alone or ethanol (the α-tocopherol solvent) alone to evaluate any 
non-specific effects. Cell viability was evaluated by the CellTiter 96® AQueous assay, as 
previously described.  
To determine the LDH release, the MDCK cells were exposed to OTA solutions 
(concentration range: 0-1.2 µg/mL) in the presence or absence of α-tocopherol (1 nM or 
10 µM). Cells were treated as mentioned above. At the end of the incubation period the 
media were removed and cells washed with PBS twice. LDH release was detected by 
CytoTox 96® Non Radio-active Cytotoxicity Assay (Promega, Madison, WI, USA), as 
described by manufacturer. Briefly, after treatments supernatants were removed and 
centrifuged for 5 min at 1500 × g at 4 °C. 50 μL of each supernatant was transferred to a 
96 well plate. Cells were lysed by adding 15 μL of 9% Triton X-100 solution in water per 
100 μL of culture medium, followed by incubation for 1 h at 37 °C. Cells debris were 
removed by centrifugation for 5 min at 1500 × g at 4 °C and 50 μL of each sample was 
transferred to 96 well plate. Then, 50 μL of LDH substrate was added to the supernatants 
and cell lysates. After incubation for 30 min at room temperature in the dark, the 
enzymatic assay was stopped by adding 50 µL of 1 M acetic acid. The optical density at 
490 nm was determined on a microplate reader. The percentage of LDH release was 
calculated as the amount of LDH in the supernatant over total LDH from both supernatant 
and cell lysate. 
 
Detection of apoptotic cells induced by OTA alone and after the treatment with α-
tocopherol by TUNEL (TdT-mediated dUTP nick end labeling) assay 
 
MDCK cells were seeded at a density of 2 × 105 cells/mL in chamber slides (Nunc Lab-
Tek, Nunc, Denmark). Cells were cultured in complete medium for 24 h. Afterward, the 
media were removed and the MDCK monolayers washed twice with PBS. Based on 
results obtained from previous assays, the cells were exposed to OTA solutions (0.6 
µg/mL) in the presence or absence of α-tocopherol (1 nM or 10 µM, 3 h pre-treatment) 
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for the following 24 h. At the end of the incubation, the media were removed and the cells 
fixed with ice cold methanol for 10 min at -20°C. The monolayers were washed twice 
with PBS and permeabilized by immersing the slides in 0.2% Triton X-100 solution in 
PBS for 5 min at room temperature. The TUNEL assay was performed using the DeadEnd 
Colorimetric Apoptosis Detection kit (Promega, Madison, WI, USA). After washing with 
PBS, cells were incubated with biotinylated nucleotide mixture together with terminal 
deoxynucleotidyl transferase enzyme. Horseradish peroxidase–labeled streptavidin 
(streptavidin HRP) was then added to bind to these biotinylated nucleotides, which are 
detected using the peroxidase substrate hydrogen peroxide and the stable chromogen 
diaminobenzidine (DAB). Afterward, to visualize and estimate the apoptotic and normal 
cells, haematoxylin staining was performed. Images (20X) were captured under an 
Olympus BX51 microscope. For each experiment, ~500 cells were counted in randomly 
selected fields, and the percent of TUNEL-positive cells was calculated. 
 
Evaluation of the effect of OTA and α-tocopherol pretreatment on occludin and Zo1 
localization 
 
To determine localization of occludin and Zo1, MDCK cells were seeded, cultured and 
treated as described above. At the end of the treatment with α-tocopherol solutions (1 nM 
and 10 µM) combined with OTA (0.6 µg/mL) or OTA solution alone, cells were washed 
in PBS, fixed and permeabilised with Triton. Cells were subsequently, incubated with 
polyclonal rabbit anti occludin (1: 400 dilution in PBS, Invitrogen, US) or anti Zo1 (1: 
400 dilution in PBS, Invitrogen, US) antibodies overnight at 4°C. The cellular monolayers 
were washed in PBS and then secondary antibody DyLight®594 Anti-rabbit IgG (9 μg/ml 
of 10 mM HEPES, 0.15 M NaCl, pH 7.5, 0.08% sodium azide, Vector Laboratories Inc., 
UK) and DyLight®488 Anti-rabbit IgG (9 μg/ml of 10 mM HEPES, 0.15 M NaCl, pH 
7.5, 0.08% sodium azide, Vector Laboratories Inc., UK) was applied for 90 minutes at 
room temperature, respectively. Finally, the monolayers were embedded in Vecta- shield 
Mounting Medium (Vector Laboratories Inc.) and observed using a Confocal Laser 
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Scanning Microscope (FluoView FV300, Olympus, Italy). The immune-reactive 
structures were excited using Argon/Helio-Neon-Green lasers with the excitation and 
barrier filters set for the used fluorochromes. Images showing the superimposition of the 
fluorescence were obtained by sequentially acquiring an image slice from each laser 
excitation or channel. To quantify occludin and Zo1 - immunoreactivities in cell 
monolayers, pixel intensities were determined using the histogram/area functions of the 
FluoView software, which assigned gray levels (GL) within a 0–256 gray scale. Data were 
presented as mean fluorescence intensities. 
Double immunofluorescence tests were conducted to evidence possible co-localizations. 
Briefly, after permeabilitation, the cellular monolayers were incubated with polyclonal 
rabbit anti-occludin (1: 400 dilution in PBS, Invitrogen, US) antibodies overnight at 4°C. 
The cells were washed in PBS and then incubated for 90 minutes at room temperature 
with secondary antibody DyLight®594 Anti-rabbit IgG (Vector Laboratories Inc., UK). 
The cells were then washed in TBS and incubated with rabbit IgG for 2 h (Vector 
Laboratories Inc.) to inhibit the binding of the anti-Zo1 antibody to the goat anti-rabbit 
IgG used in the first sequence. For the second step, the cells were treated with anti-Zo1 
antibody, washed in PBS and incubated for 90 minutes at room temperature with 
DyLight®488 Anti-rabbit IgG (Vector Laboratories Inc., UK). Finally, the monolayers 
were embedded in Vecta - shield Mounting Medium (Vector Laboratories Inc.) and 
observed using a Confocal Laser Scanning Microscope (FluoView FV300, Olympus, 
Italy). The specificity of the immunofluorence reactions has been verified by incubating 
cellular monolayers with PBS instead of the second step antibody procedure. The results 
of these controls were negative (i.e. staining was abolished).  
For quantification of occludin and Zo1 peaks of immunofluorescence, the laser power and 
photomultiplier tube voltage were constant so that fluorescence intensities of various 
cellalar monolayers could be compared. Images were digitized under constant gain and 
laser offset, with no postcapture modifications. Before quantification, the images were 
digitally zoomed three times. Pixel intensities were determined using the histogram/area 
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function of the FLUOVIEW software, which assigned the gray levels (GL) within a 0–
256 Gy scale. Data were presented as mean fluorescence intensity. 
 
Statistical analysis 
 
The data are expressed as means and standard errors (SE). At least three replicates at each 
incubation time were performed, and all the experiments were performed twice. The data 
obtained were analyzed by one way ANOVA (GLM) (SAS); Duncan’s post hoc multiple 
range test was used with P ≤ 0.05 considered statistically significant. 
 
Results & discussion 
 
Determination of cell viability and LDH release in the presence of OTA and α-tocopherol 
 
After 24 h of incubation in the presence of OTA, MDCK showed a LC50 of 0.94 µg/ml. 
The effect of 3 h pre-incubation with µ-tocopherol on OTA cytotoxicity is shown in 
Figure 1. α-tocopherol at 1 nM significantly (P < 0.05) reduced OTA cytotoxicity by 20%, 
only when the mycotoxin was present at 0.3 µg/mL. In presence of higher OTA 
concentrations used, no reduction of OTA cytotoxicity was detected.  
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Figure 1: Effect of pre-treatment with α-tocopherol 3 h against OTA induced cytotoxicity 
in MDCK cells at 24 h. Results are from three independent experiments with triplicate 
wells and presented as least square means ± SEM relative to cell viability obtained in 
basal medium (DMEM). Values significantly different from cell viability obtained in OTA 
alone are indicated by * (P<0.05). 
Moreover, these data have been confirmed by the results obtained in the LDH assay. In 
fact, the presence of 1 nM α-tocopherol was able to significantly (P < 0.05) reduce the 
LDH release in MDCK cells, when OTA was present at 0.3 and 0.6 µg/mL (Figure 2).  
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Figure 2: Effect of pre-treatment with α-tocopherol 3 h against OTA induced LDH release 
in MDCK cells at 24 h. Results are from three independent experiments with triplicate 
wells and presented as least square means ± SEM relative to LDH release obtained in 
basal medium (MEM). Values significantly different from LDH release obtained in OTA 
alone are indicated by * (P<0.05). 
 
Detection of DNA damage induced by OTA alone and after the treatment with α-
tocopherol by TUNEL (TdT-mediated dUTP nick end labeling) assay 
 
Figure 3 shows representative photos of the morphology and the nuclear stain of MDCK 
cells maintained in culture media and incubated with OTA with and without a 3 h pre-
incubation with α-tocopherol (1 nM and 10 µM) for 24 h, respectively. In particular, 
MDCK cells maintained in culture media for 24 h form a uniform cellular monolayer, 
characterized by the typical cell-cell interaction, in which the percentage of apoptotic cells 
was 1.37 ± 0.89 (Figure 3a). In the presence of OTA (0.6 µg/mL), the monolayers were 
disrupted and the percentage of TUNEL-positive cells was 11.01 ± 0.89, as demonstrated 
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by the presence of dark brown nuclei in the Figure 3b. The pre-incubation with α-
tocopherol significantly (P < 0.05) reduced the percentage of apoptotic nuclei in MDCK 
cells induced by the presence of OTA. In fact, the 1 nM α-tocopherol pre-incubation was 
able to decrease the number of apoptotic cells, as showed by the reduction of the 
percentage of TUNEL-positive cells to 2.67 ± 0.89 (Figure 3c). MDCK cell pre-
incubation with 10 µM α-tocopherol induced a slight decrease of the percentage of 
apoptotic nuclei to 7.43 ± 0.89 (Figure 3d). 
 
Figure 3: Apoptosis induced by OTA in MDCK cells. TUNEL-positive cells showed dark 
brown nuclei staining, while the vital cell nuclei presented violet (haematoxylin) staining. 
Representative photographs of selected fields are shown. (a) MDCK cells maintained in 
culture medium for 24 h. (b) MDCK cells incubated for 24h with 0.6 µg/mL OTA. (c) 
MDCK cells pre-incubated with 1 nM α-tocopherol and treated with 0.6 µg/mL OTA for 
the following 24 h. (d) MDCK cells pre-incubated with 10 µM α-tocopherol and treated 
with 0.6 µg/mL OTA for the following 24 h. Bars = 100 µm. 
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Evaluation of the effect of OTA and α-tocopherol pretreatment on occludin and Zo1 
 
In the observed cellular monolayers, immunofluorescence staining revealed that both 
occludin and Zo1 were present in the thin peripheral cytoplasmic rim of the MDCK cells 
and partially co-localised (Figure 4a). When OTA treated cells have been observed at 
confocal microscopy, reduction in the intensity of occludin and Zo1 have been detected 
(Figure 4b). Immunofluorescence peaks confirmed that occludin and Zo1 presence in 
MDCK monolayers maintained with culture media (control) were significantly (P < 0.05) 
higher than those detected in the monolayer treated with OTA. The 3 h pre-incubated cells 
with 1 nM α-tocopherol showed peaks of occludin and Zo1 significantly (P < 0.05) higher 
than those revealed in OTA (0.6 µg/mL) treated cells. The pre-incubation with 10 µM α-
tocopherol determined only a numerical increase of occludin and Zo1 peaks respect to 
those present in OTA treated cells (Table 1). 
Table 1. Comparison between mean fluorescence intensity peaks of the cellar monolayers 
exposed to control medium, OTA (0.6 µg/mL), α-tocopherol (1 nM and 10 µM) and OTA 
(0.6 µg/mL) for 24 h. 
 
 Control 
OTA 
(0.6 µg/mL) 
10 µM α-tocopherol 
and OTA 
1 nM α-tocopherol and 
OTA 
Occludin 151.42 ± 12.72a 76.94 ± 12.72b 104.18 ± 12.72b, c 139.19 ± 12.72a, c 
Zo1 218.22 ± 15.34a 117.94 ± 15.34b 120.85± 15.34b 171.54 ± 15.34c 
a,b,c Means within a row with different superscripts differ (P < 0.05) 
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Figure 4. Immunofluorescence analysis of occludin and Zo1 in MDCK cells. In cells 
maintained in culture medium (a), the presence of occluding (red dots) and Zo1 (green 
dots) and their co-localition (yellow dots) are evident. In the cells incubated with OTA 
(0.6 µg/mL) for 24 h (b), the signals for occludin, Zo1 and their co-localization are 
reduced compared with the cell pre-incubated with 1 nM α-tocopherol (c). Bars = 20 µm. 
At kidney level, it is well know that OTA at µM concentrations could affect several 
cellular processes, such as direct and unspecific inhibition of macromolecules (DNA, 
protein) synthesis, reduced cell growth and decreased cell viability (Gekle et al., 2005). 
Oxidative stress represents one of the mechanism by which this compound is able to exert 
its toxicity. As described in the review of Sorrenti et al.2013, growing evidence of the role 
of several antioxidants in the modulation of OTA toxicity support their protective function 
in vitro models. In particular, the α-tocopherol at nM concentrations has been able to 
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counteract the OTA toxicity in primary cells (Fusi et al.,2010) and established cell lines 
(Baldi et al.2004). 
The release of cytosolic LDH represents a valuable marker of cellular membrane integrity 
and could be used to evaluate the mechanism of action by which OTA could exert its 
action and the role of α-tocopherol in counteracting its toxicity. The amount of LDH 
release increased in association with increasing concentration of OTA (Figure 2), in 
accordance with previous studies conducted using MDCK cells (Gekle et al., 2000) and 
other cell models (Petrik et al., 2005). 
Overall, our results indicate that the pre-incubation with α-tocopherol could preserve the 
cell viability, due to its position and movements in the cellular membrane, and its activity 
in cytosolic reduction reactions that recycles tocopheroxyl radicals, thus preventing lipid 
peroxidation (Traber & Atkinson, 2007). 
As demonstrated by several studies (Gekle et al., 2005; Petrik et al., 2005; Gekle et al., 
2000), OTA was able to induce apoptosis in MDCK cells, confirming that nM 
concentration led to renal damage, but the mechanisms by which it has been manifested 
are multiple and complex.  
In this framework, α-tocopherol could find a key role. In fact, it could suppress lipid 
peroxidation and cell death induced by OTA and other oxidative stressors in various cell 
types, stabilizing the cellular membrane and breaking the chain propagation, taking place 
at this level. One possible explanation of the more protective action exerted by the lower 
concentration of α-tocopherol (1 nM) could be due to its intracellular concentration and 
not to its concentration added to medium, as reported by Niki (2014). Moreover, the 
function of α-tocopherol could be not explained by only its chain breaking activity (Zingg, 
2007; Azzi, 2007), but it could monitor the oxidative environment and could act as sensor, 
transferring the information to the cell, as affirmed by Azzi (2007). 
As reported by Blasig et al.(2011) occludin is sensitive to oxidative stress, appearing as 
an early and specific target for reactive species. Due to the close structural and functional 
118 
 
interactions between occludin and the other proteins of the tight junctions, in particular 
Zo1, this sensitivity influenced the process involved in cell-cell interaction. Because lipid 
peroxidation represents one of the mechanisms of action of OTA, the integrity of cellular 
monolayers may be affected resulting in the disruption of connection, as evidenced by the 
reduction in the intensity of immunofluorescence staining.  
In this study, the immunofluorescence analyses (Figure 4) revealed changes in the pattern 
of occludin and Zo1 in the presence of OTA. The oxidative stress could influence the 
interaction between occludin and Zo1 (Rao, 2008). This relationship is very important for 
the maintenance of epithelial tight junctions. The disruption of the occludin-Zo1 complex 
in the MDCK monolayers treated with OTA has been confirmed by the lower intensity of 
the fluorescence in the co-localization (Figure 4b) of these proteins. Moreover, the 
presence of OTA was able to alter cell adhesion and gap junction in MDCK cells. In fact, 
as demonstrated by Mally et al. (2006) the presence of OTA at µM concentration (> 
25µM) has been able to influence the intercellular communication and change the pattern 
in b-cadherin and e-cadherin labelling, supporting the role of OTA in altering cell 
adhesion and cell-cell signalling, that may contribute to explain its toxicity. 
Oxidants, indeed, reduce occludin specific membrane localization and influence the 
regulatory activity in cell-cell interaction, which could be counteract by the presence of 
antioxidants. Considering the data obtained with the immunofluorescence staining, we 
could speculate that the presence of α-tocopherol has been able to counteract OTA effects 
on occludin and Zo1 location. These results are in accordance with those obtained by Lee 
et al.(2006). In fact, primary brain micro-vessel endothelial cells, isolated from rats, 
exposed to oxidative stimuli (hydrogen peroxide) after the 24 h pre-incubation with α-
tocopherol have been able to maintain the occludin continuous pattern at cell-cell 
boundaries. The pre-treatment with α-tocopherol blocked the loss of occludin presence in 
the tight junctions. 
Overall, these results confirmed that OTA is able to induce dose-related damages in 
MDCK cells and the protective role of α-tocopherol in counteracting its toxicity. In 
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particular, LDH release, cell viability as well as apoptotic events induced by OTA have 
been counteracted by the presence of nM concentration of α-tocopherol. Moreover, α-
tocopherol may play an important role to reduce the negative impact of the oxidative stress 
at cell-cell interaction level. In fact, OTA demonstrated to be able to disrupt cell-cell 
interaction in the monolayers, involving occludin and Zo1. α-tocopherol was able to 
influence the functional interactions between these proteins of the tight junctions, 
supporting its basic properties in the cellular membranes and in cellular metabolism.  
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CHAPTER III: CELL-MICRONUTRIENT INTERACTION STUDIES 
 
Study I: Role of choline and methionine in Bovine Mammary Epithelial cell line 
exposed to hydrogen peroxide 
 
Choline and methionine are considered methyl group sources and are nutritionally 
interrelated. Choline is considered to be a vitamin-like compound that is essential for 
mammals when the supply in methionine and folates is not adequate (Zeisel, 2000). This 
consideration led to the concept of choline as vitamin-like compound despite it does not 
satisfy the standard definition of vitamin (McDowell, 1989). Functions of choline in the 
organism can be divided into two areas: choline per se, and choline as a source of methyl 
groups (Pinotti et al., 2008). Choline per se is a constituent of all cell membranes in the 
form of phosphatidylcholine, lysophospatidylcholine, choline plasmalogen or 
sphingomyelin and it plays a crucial role in lipid metabolism. Choline is also an important 
source of labile methyl groups for the biosynthesis of other methylated compounds. Based 
on this second function choline and methionine are interchangeable, as sources of methyl 
groups. However, as choline and methyl-group metabolism are closely interrelated, it has 
been difficult to separate the effects of choline deficiency from methyl-groups deficiency. 
In this context, ruminants have represented an interesting model due to some specific 
features. In adult ruminants, choline (Baldi and Pinotti, 2006; Pinotti et al., 2008; baldi et 
al., 2011) and methionine (National research Council, 2001; Baldi et al., 2008; Jenkins & 
McGuire, 2006) are degraded in the rumen, and can be limiting nutrients for milk 
production. This is particularly true at the onset of lactation, when the mammary gland 
represents an important site of utilisation of both choline and methionine. Moreover, at 
this stage, mammary gland is exposed to significant stressors, such as free radicals, 
metabolic stress, oxidative and toxic compounds (Baldi, 2005), that associated with 
differentiation of secretory parenchyma and intense mammary gland growth (Sharma et 
al., 2011), make the availability of limiting nutrient even more crucial. 
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Aim of study I 
 
Starting with these assumptions, we determined the contribution of choline and 
methionine on BME-UV1 cells viability upon hydrogen peroxide-induced stress. We 
determine the contribution of choline and methionine on BME-UV1 cells viability upon 
hydrogen peroxide-induced stress. 
 
Material & methods 
 
Cell line and cell culture 
 
The BME-UV1 cell line is maintained in the Laboratory of Cell Culture-Department 
VESPA (University of Milan, Italy). The origin of the BME-UV1 established bovine 
mammary epithelial cell line has been described previously (Zavizion et al., 1996). Cells 
are routinely cultivated in plastic flasks (Corning Glass, Corning, NY, USA) in complete 
medium, which is a mixture of 50% DMEM-F12, 30% RPMI-1640 and 20% NCTC-135 
supplemented with 10% foetal bovine serum (FBS) (BioWhittaker, Cambrex, Belgium), 
0.1% lactose, 0.1% lactalbumin hydrolysate, 1.2 mM glutathione, 1 µg/ml insulin, 5 µg/ml 
transferrin, 1 µg/ml hydrocortisone, 0.5 µg/ml progesterone, 10 µg/ml L-ascorbic acid and 
antibiotics (100 IU/ml penicillin and 100 µg/ml streptomycin). The cells are maintained 
at 37°C in a humidified 5% CO2 incubator until sub-confluence. All medium supplements 
are from Sigma-Aldrich. The cells used in the present work were at the passage numbers 
between 34-44. 
 
Determination of the half-lethal concentration (MTT assay) induced by hydrogen 
peroxide 
 
In order to calculate the half-lethal concentration (LC50), that correspond to the 
concentration of H2O2 which is lethal to 50% of the cells after 24, 48 and 72 h of 
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exposure, a dose-response curve was set up. BME-UV1 cells were dispensed into wells of 
96-well tissue culture plates (2.5x105 cells/ml, in 150 µl of complete medium). After 24 h 
of incubation at 37°C in an atmosphere of 5% CO2, medium was removed and cell 
monolayer was exposed to increasing concentrations of H2O2 (0-500 µM) for the 
following 24, 48 and 72 h. 
The effects of H2O2 treatments on cells viability were determined using MTT. MTT test 
is a colorimetric assay based on the production of the chromophore formazan from 3-(4, 
5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazoliumbromide. Formazan is produced in viable 
cells by the mitochondrial enzyme succinate dehydrogenase. The standard protocol with 
minor modifications, as described by Baldi et al.(2004), was used. Briefly, at the end of 
the incubation, the media were removed and 150 μL MTT stock solution (5 mg/ml) in 
PBS was added to each well, and the plates were incubated for 3 h at 37 °C in a humidified 
chamber. Afterward, 150 μL dimethyl sulfoxide was added to each well to dissolve 
formazan. Absorbance at 540 nm was determined on a Biorad 680 microplate reader (Bio-
rad, Veenendaal, The Netherlands). Cells incubated with culture medium alone, 
representing 100% viability, were included as negative controls in all experiments. The 
percentage cytotoxicity was calculated as follows: Percentage cytotoxicity = (1 – mean 
optical density in presence of hydrogen peroxide /mean optical density of negative 
control) × 100.  
 
Determination of the effect of choline and methionine against hydrogen peroxide-induced 
toxicity 
 
The identification of the most suitable combinations of choline and methionine for further 
experiments with H2O2, was established by a dose-response curve (MTT test). 
BME-UV1 cells were dispensed into wells of 96-well tissue culture plates as described 
above. The cell monolayers were exposed for 24 h to serial concentrations of choline, 
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ranging from 125 to 1000µM according to Chao et al.(1988), and methionine, ranging 
from 178 to 1430µM. 
Two combination of choline and methionine, Low Choline/Methionine dosage (LCM) and 
High Choline/Methionine dosage (HCM), were chosen in order to keep the ratio between 
them constant and equilibrate; the proportion between choline and methionine has been 
established on molar basis (Sharma & Erdman, 1988). Insulin (1 µg/ml) has been included 
in all experiments in order to support their uptake (Rilemma, 2004). 
To the purpose to evaluate the ability of choline and methionine combined in 
counteracting H2O2 cytotoxicity, two ranges of H2O2 were identified according to LC50 
previously calculated. The first range, defined low H2O2 concentrations (from 15.62 µM 
to 62.5 µM) and the second range, defined high H2O2 concentrations (from 83.2 µM to 
333 µM). 
BME-UV1 cells have been first pre-incubated with LCM and HCM. Subsequently, cells 
have been exposed to low and high ranges of H2O2 for 24 h, 48 h and 72 h. 
Cells exposed to H2O2 alone have represented the control. Effect of choline and 
methionine combined in counteracting H2O2 cytotoxicity on BME-UV1 viability was 
evaluated by MTT test, whose procedure has previously described.  
 
Statistical analysis 
 
At least three replicates at each incubation time were performed and all experiments were 
performed at least twice. Results are expressed as mean and SD. The effect of various 
treatments was evaluated by one-way analysis of variance using the GLM procedure of 
SAS (SAS institute Inc, NC, USA). Values significantly different from controls are 
indicated as P<0.05. 
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Results & discussion 
 
Determination of the half-lethal concentration (LC50) induced by hydrogen peroxide 
 
The effect of H2O2 on BME-UV1 cell viability was evaluated by a dose-response curve 
(MTT test). As shown in Figure 1 up to 125 µM of H2O2, at all incubation time, cell 
viability was maintained over 50%, while higher H2O2 concentrations have produced a 
strong reduction of BME-UV1 viability, indicating a dose-dependent sensitivity of the cell 
line tested. Based on these data, we have calculated the LC50 at all incubation time, 
corresponding to 376.5 µM, 249.9 µM and 244.9 µM after 24h, 48h and 72h, respectively 
(Figure 1). BME-UV1 cell line has shown a dose and time-dependent sensitivity. 
 
Figure 1: evaluation of cell viability (% of control) over time of BME-UV1 cells exposed 
to increasing concentrations of hydrogen peroxide. Cell viability has been evaluated by 
MTT test 
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Determination of the effect of choline and methionine against hydrogen peroxide -induced 
toxicity 
 
The most effective combinations of choline and methionine in term of maintenance of cell 
viability after 24 hours were: 500 µM and 715 µM for choline and methionine and 1000 
µM and 1430 µM for choline and methionine (Figure 2), even if no significative effects 
have been observed. These two selected amounts of choline and methionine were named 
Low Choline/Methionine dosage (LCM) (500/715 µM) and High Choline/Methionine 
dosage (HCM) (1000/1430 µM). 
 
Figure 2: Evaluation of cell viability (% of control) of BME-UV1 cells exposed to 
increasing concentrations of choline and methionine for 24 hours. Cell viability has been 
evaluated by MTT test 
BME-UV1 cell line was treated with combinations of LCM and HCM and two H2O2 levels 
for the following 24, 48 and 72 h. The experiment was set up in two different steps.  
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In the first set of experiments, we have tested LCM and HCM effects in a weak condition 
of stress represented by low H2O2 concentrations (ranging from 15.62 to 62.5μM). We 
found that choline and methionine significantly (P< 0.05) enhanced cell viability on 
average by 21% and 25.8% after 48 and 72h, respectively, whereas their effect at 24h was 
limited (Figure 3). The effects were independent of the choline/methionine concentrations 
used. 
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Figure 3: Evaluation of the effect of Low Choline/Methionine dosage and High 
Choline/Methionine dosage against low concentrations of hydrogen peroxide (ranging 
from 15.62 to 62.5 µM). The role of Low Choline/Methionine dosage and High 
Choline/Methionine dosage has been evaluated by MTT test. (*P<0.05) 
In the second set of experiments, we have tested LCM and HCM effects in a condition of 
stress around LC50, represented by high H2O2 concentrations (ranging from 83.2 to 333 
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µM). In this range of H2O2 tested, choline and methionine significantly (P< 0.05) 
enhanced cell viability on average by 15% and 17% after 48 and 72h, respectively. No 
effects were observed at 24h (Figure 4), indicating a time dependent activity of LCM and 
HCM. The effects, again as in the previous experiments, were independent of the 
choline/methionine concentrations used. 
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Figure 4: Evaluation of the effect of Low Choline/Methionine dosage and High 
Choline/Methionine dosage against low concentrations of hydrogen peroxide (ranging 
from 83.5 to 333 µM). The role of Low Choline/Methionine dosage and High 
Choline/Methionine dosage has been evaluated by MTT test. (*P<0.05) 
Irrespective of the methionine and choline concentrations used, after 48 and 72h of 
incubation, cell proliferation was enhanced by choline and methionine presence in the 
medium, indicating a possible modulating effect exert by the two nutrients against H2O2. 
On the contrary, after 24h of incubation, choline and methionine did not influence the 
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viability of cells exposed to H2O2. The observed positive effects on cell viability were 
higher at the lowest range of H2O2 concentration tested, compared to the highest 
concentrations. Therefore, in the present study it has been observed that choline and 
methionine could play a crucial role in counteracting oxidative damage induced by H2O2 
in bovine mammary epithelial cells, even though the real mechanism is not clear.  
Oxidative stress occurs when the presence of oxidizing agents, free radicals and reactive 
oxygen species (ROS), exceeds the antioxidant capabilities of the organism. This lack of 
balance between oxidants and antioxidants leads to tissue injuries and to a wide range of 
degenerative diseases. Therefore, it is important to assess the damaging effects of 
oxidative stress on in vitro models and to understand protective mechanisms by which the 
cells respond to stress. Miranda et al. (2011) reported that the effect of H2O2 is different 
in relation to the cell type tested. In fact, some cell types respond to H2O2 with an increase 
in cell proliferation (Sigaud et al., 2005), while other cell types, including bovine 
mammary cells (Miranda et al., 2011), respond to H2O2 treatment by decreasing viability 
rate as supported by data herein presented. 
In mammalian cells, oxidative degradation of membrane lipids can result in loss of 
membrane integrity, defective membrane transport mechanisms, and increased 
permeability. It has demonstrated that high concentrations of H2O2, cause cell membrane 
damage to Caco-2 cells with an increase in lipid peroxidation and a decrease of cell 
viability (Wijeratne et al., 2005). 
Choline and methionine have been identified as required nutrients and play various 
biological functions on cells, including regulation of growth and proliferation (Guo et al., 
2004; Pinotti, 2012). Our results showed that, under a condition of stress, choline and 
methionine have an important role in enhancing viability of BME-UV1 and, if 
supplemented in the culture medium in adequate concentrations, they have a possible role 
in counteracting oxidative stress induced by H2O2. In this respect, previous in vivo studies 
have indicated a potential relation between methyl-group and oxidative status. In 
particular, Sachan et al. (2005) have reported that choline and other methyl group sources 
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supplementation have reduced oxidative stress, and have promoted conservation of retinol 
and α-tocopherol in humans. In the same way Pinotti et al. (2003) and Baldi and Pinotti 
(2006) have reported a smaller depletion in vitamin E concentrations in choline 
supplemented dairy cows than in controls, suggesting a possible effect of choline on 
antioxidant status. However in these studies the real mechanisms by which choline has 
produced these interactions with antioxidant status have been not fully elucidated, and in 
most of the cases methionine has been directly involved. Thus based on present results it 
can be speculate that, in a condition of adequate bioavailability of methionine, the use of 
choline per se can be enhanced, which may affect both cell membrane stability and in turn 
cell response to stressor, such as H2O2. 
The results presented here suggest that choline and methionine could play a role in 
counteracting oxidative damage induced by H2O2 in bovine mammary epithelial cells. The 
cytotoxicity, induced by H2O2 addition, could be reduced by supplementation of these two 
limiting and essential nutrients, i.e. choline and methionine. This effect seems to be time 
and dose-dependent. In particular choline/methionine treatment is effective in a weak 
condition of oxidative stress, and at 48 and 72 h of exposure. However, present results are 
referred to viability only, and therefore the real mechanism of choline and methionine on 
oxidative stress in a bovine mammary epithelial cell deserves further investigations.  
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Study II: Effect of Zn Oxide and Zn Chloride on Human and Swine Intestinal Epithelial 
Cell Lines. 
 
Zn is an abundant trace element in the body recognized as essential micronutrient. At 
intestinal level, Zn is involved in the modulation of immune system, affecting both non-
specific and acquired immunity (Fraker et al., 2000; Frieke, 2000), in mucosal resistance 
to infection, in the restoration of mucosal barrier integrity and the promotion of antibody 
production against intestinal pathogens (Sargeant et al., 2011). The absorption of Zn 
occurs primarily in the small intestine and is influenced by different dietary factors such 
as the presence of Zn antagonists (e.g. calcium, phytate, fibers). Low molecular weight 
binding ligands such as citrate, picolinate and amino acids enhance its absorption 
(Lönnerdal, 2000). Zn is supplemented in human multivitamin formulations and in animal 
feedstuff in either inorganic or organic forms. In pig livestock, Zn has been included as 
nutritional additive at concentration lower than 150ppm as indicated in the Reg. CE 
1831/2003. Whereas, pharmacological concentrations of Zn >1000ppm are commonly 
used as alternative to in-feed antibiotics (Poulsen, 1995). Generally, inorganic Zn salts 
(e.g. Zn oxide) are the most commonly forms supplemented in animal diets. It has been 
previously demonstrated that in swine livestock the supplementation of 150ppm of Zn 
Oxide (ZnO) improves gut health (Rosselli et al 2005). Also, ZnO at pharmacological 
concentrations reduces the incidence of diarrohea in the weaned piglets (Owusu-Asiedu 
et al., 2003). New approaches are necessary to optimize Zn supplementation in feedstuffs 
in order to improve animal health and to control Zn release in the environment. Moreover, 
further investigations into the mechanism by which Zn supplementation improves 
intestinal swine condition may shed light on the role of Zn in human gut level. Studies 
conducted in vitro reported that ZnO inhibits bacterial growth, plays a pivotal role in 
maintaining epithelial barrier integrity and function, may improve mucosal repair and 
paracellular permeability (Roselli et al, 2003). Nevertheless, despite the wide use of Zn 
oxide in in vivo trials, few studies were focused on its effect at cellular level (Sargeant et 
al., 2010; Sargeant et al., 2011). The importance of intestinal cell models of human and 
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pig origins in in vitro platforms for preclinical research is well recognised (Langerholc et 
al., 2011). In this context, in vitro studies can provide evidences regarding the mechanism 
of action of specific dietary compounds at cellular level, as well as discover any cytotoxic 
effects of these molecules. Cell culture models have been often used to evaluate the 
cellular mechanisms of several compounds (Baldi et al, 2004; Rebucci et al, 2007). In 
addition, in vitro animal and human cell models represent a suitable alternative to in vivo 
animal experiments (Cencič & Langerholc, 2010) for the determination of Zn supplements 
effects. 
 
Aim of the study II 
 
The aim of the present study was to assess the effect of two widely used additives in 
feedstuff, on the intestinal epithelium. In particular, the effect of ZnO and ZnCl2 was 
investigated in human (INT-407) and porcine (IPI-2I) cell line models. 
 
Materials and Methods 
 
Cell line and cell culture conditions 
 
The Human embryonic intestinal cell line (INT-407), a non-transformed epithelial cell 
line, originally derived from ileum of a 2-month-old human embryo, was obtained from 
the American Type Culture Collection. INT-407 were routinely cultivated into 75 cm2 
tissue culture flasks in RPMI-1640 medium supplemented with 200mM glutamine, 1% 
non-essential amino acids (NEAA) and 10% Fetal Bovine Serum (FBS). Cells used in this 
work were between passages 36-40. 
The IPI-2I cell line, derived from the ileum of an adult boar and immortalized by 
transfection with an SV40 plasmid (pSV3) (Kaeffer et al., 1993), was obtained from 
American Type Culture Collection. IPI-2I were routinely cultivated into 75cm2 tissue 
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culture in DMEM-F12 supplemented with 4mM glutamine, 0.024UI/ml insulin and 10% 
Fetal Bovine Serum (FBS). Cells used in this work were between passages 5-12. 
Cells were cultured in an atmosphere of 5% CO2 at 37 °C until sub-confluence. Cell 
monolayers were washed with phosphate buffered saline (PBS) and trypsinized with 
0.25% trypsin-EDTA. After 48 hours, cells were detached and re-suspended in culture 
medium to a concentration of 2.5 x 105 cells/ml. Portions (200 μl) of cell suspension were 
dispensed into sixty wells of a ninety-six-well tissue culture plates. 
 
Zn oxide and Zn chloride solutions 
 
A stock solution of 400mM ZnO (Zn content 80.34%) was prepared in 5% of acetic acid. 
Starting from this stock, ZnO treatment solutions (50, 200, 1000 and 4000 μM) were 
dissolved in serum-free medium. 
A stock solution of ZnCl2 (Zn content 47.97%) was prepared as described in Merck Index 
instructions (1989). In detail, 1 g of ZnCl2 was dissolved in 0.25 ml of 2% HCl. Starting 
from this stock, ZnCl2 treatment solutions (50, 200, 1000 and 4000 μM) were dissolved 
in serum-free medium. 
IPI-2I and INT-407 were exposed to treatment solutions in concentration mentioned above 
(200μl) of ZnO and ZnCl2 for the following 3 and 24h. In particular, for each cell lines we 
tested four concentrations of Zn sources in triplicate (3 wells per treatment) at two 
incubation times (3 and 24h). Moreover, at least two independent experiments were 
performed. The concentrations of ZnO and ZnCl2 were selected on the basis of preliminary 
assays (data not shown) whereas the times of exposure were selected on the basis of the 
intestinal transit time in according to Roselli et al. (2003). 
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Evaluation of the effect of different Zn sources on cell viability: MTT test 
 
The effect of Zn sources on IPI-21 and INT-407 cell lines was evaluated by MTT test 
using an incubation period of 3 and 24 hours under serum-free conditions. In particular, 
after removing the treatment solutions, 150μl MTT stock solution (5mg/ml) in PBS was 
added to each well and the plates were incubated for 1.5 h in a humidified chamber. The 
reaction was accomplished by removing the incubation solution and adding 150μl 
dimethyl sulfoxide to dissolve the formazan. The optical density of dimethyl sulfoxide 
(540 nm) was determined on a Biorad 680 microplate reader. Cells incubated with culture 
medium alone representing 100% viability, were included as negative controls in all 
experiments. This assay measured the production of the chromophore formazan from (4,5 
– dimethylthiazol – 2 - yl) - 2,5 -diphenyltetrazoliumbromide (MTT) (Sigma-Aldrich). 
Formazan was produced in viable cells by the mitochondrial enzyme succinate 
dehydrogenase. 
 
Statistical analysis 
 
At least three replicates (3 wells per treatments) at each incubation time were performed 
and two independent experiment were conducted. The data are presented as means and 
standard error (SE) and analyzed by one-way ANOVA (SAS, 2010). Duncan’s post-hoc 
multiple range test was used, with P < 0.05 considered statistically significant. Different 
concentrations of the two Zn sources were tested using a model including the systematic 
effects of the source of Zn (n = 2), concentrations of Zn (four levels). The effect of the 
assay (n = 2) was included as a blocking factor. 
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Results & discussion 
 
INT-407 cells have been exposed to a wide range of ZnO and ZnCl2 concentrations in 
order to establish the cell viability in response to Zn treatments (figure 1). In particular, 
INT-407 cell line treated for 3h with 50μM of ZnO increased cell viability up to 120% of 
the control. The same tendency in term of enhancement of cell viability was observed after 
3 and 24h of exposure to 50 μM of ZnCl2. Higher concentrations of ZnO and ZnCl2 have 
affected cell viability in a dose- dependent way. A significative (P < 0.05) reduction of 
cell viability was observed. 
As shown in Figure 2, IPI-2I have shown a different susceptibility to ZnO and ZnCl2 
treatment. In particular after 3h of incubation, ZnO did not significantly inhibited IPI-2I 
cell viability, which remained about 80% at 50, 200 and 1000μM. Whereas, a significative 
(P < 0.05) reduction in IPI-21 cell viability was observed at the highest Zn oxide 
concentration tested (4000 μM). A significative reduction (P < 0.05) was observed at all 
concentrations of ZnO tested after 24h of incubation. A similar dose and time dependent 
effect was also observed when IPI-21 cells were treated with increasing concentrations of 
ZnCl2 for 3 and 24h. 
Overall, a dose-response effect was observed after ZnO and ZnCl2 treatments in both the 
intestinal cell lines considered suggesting that in vitro cell models are suitable for studying 
the effect of Zn additives on cell viability. In particular, it was observed that after 3 hours 
of incubation, which correspond to the transit time for several nutrients, cell viability was 
maintained by the lowest ZnO and ZnCl2 presence in the medium. 
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Figure 1. Effect of increasing concentrations of ZnO and ZnCl2 on cell viability of INT-
407 after 3h and 24h of treatment measured by MTT test. The graph shows the percentages 
of cell viability over control. Values significantly different from proliferation obtained 
with 0 μM Zn sources (control medium 100% viability) are indicated: a, P < 0.05 
 
Figure 2. Effect of increasing concentrations of ZnO and ZnCl2 on cell viability of IPI-2I 
after 3h and 24h of treatment measured by MTT test. Values significantly different from 
proliferation obtained with 0μM Zn sources (control medium 100% viability) are 
indicated: a, P < 0.05 
MTT assay is a viability assay that measures the metabolic activity the cells. MTT assay 
used in this study represent a simple and useful method to preliminary qualify the effect 
of a large number of compounds (Zn, tocopherol, probiotics) at cellular level (Baldi et al., 
2004; Rebucci et al., 2007). Faller et al. (2002) reported that this assay showed a better 
correlation with in vivo assay than other bioassays. Cell-based model represents simplify 
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biological system and may be used in the evaluation of nutritional additives effects. In this 
study, two intestinal epithelial cell lines from different species have been considered. This 
is essential in order to better characterize the response of dietary compounds on a specific 
epithelium. Despite the wide use of Zn as animal feed supplement, little studies have 
focused on its effect in vitro. The intestinal cell lines INT-407 and IPI-2I showed to be 
suitable models of the intestine and represent a simple tool to investigate the role of Zn 
supplements. 
INT-407 showed to be the most sensible model to Zn supplements considered in this 
study, whereas IPI-2I showed to be the most resistant. Viability of IPI-2I cells is reduced 
at ZnO and ZnCl2 concentrations >1000uM, whereas Sargeant et al. (2010) found a 
reduction of IPEC-J2 cell viability at concentrations >100μM of ZnO. However, the 
lowest concentrations of both ZnO and ZnCl2 considered in this study have maintained 
the viability of INT-407 and IPI-2I underlining the beneficial role of Zn on human and 
swine intestine. In particular, it was observed that after 3 hours of incubation, which 
correspond to the transit time for several nutrients, cell viability was enhanced by the 
lowest ZnO and ZnCl2 concentrations tested, indicating that these compounds may have 
a beneficial role for human and swine intestinal epithelium. Overall, these results 
contribute to determine the role of Zn in human and swine intestinal epithelium. In 
general, this study confirm that the use of in vitro cell-based models for screening the 
biological activity of single compounds at specific concentrations and in a strictly 
controlled environment could offer novel insight in the field of human and animal 
nutrition, making in vitro models an essential tool in biological studies. However, cell-
based models may not reflect the in vivo condition of the intestinal cells in their natural 
state in the intact organism, where bioavailability, metabolism, binding and transport 
proteins may influence the biological effect of Zn sources. Therefore, further in vivo 
experiments are necessary in order to extend the results obtained in vitro, to clarify the 
contribution of Zn supplements in gut health, and to improve Zn supplementation in 
animal feed and in human formulations.  
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ADD-ON PROJECT -Health-promoting role of intact milk proteins: in vivo human 
intervention study 
 
Introduction 
 
Diet, obesity and ageing population increase the risk of chronic disease. Animal products 
are a staple source of nutrients in the human modern western diet. High blood pressure – 
a modifiable risk factor of CVD – is responsible for 13% of all deaths in the world annually 
and hence hypertension is one of the five leading global risks for mortality (Givens, 2010; 
Givens et al., 2014). In this context, milk and dairy products are reported to possess a wide 
range of biological properties (Huth et al., 2006; Wada & Lönnerdal, 2014) and are 
therefore potential neutraceutical (health-promoting food) ingredients. Several target of 
such health-promoting food components are proposed as cardiovascular health, bone 
health, weight management, immune defense, digestive health. Further, milk peptides 
have previously demonstrated to contribute in the reduction of the CVDs and colorectal 
cancer (Cho et al., 2004; Aune et al., 2012; Fekete et al., 2013). Evidence from human 
intervention studies suggests that both whey and casein may be effective in lowering blood 
pressure. However limited data are available on the impact of intact milk proteins on 
vascular function. Pal & Ellis (2011) and Pal et al. (2010a; 2010b) performed one of the 
few studies investigating the differential effect of whey and casein on vascular function 
and reported that mainly whey protein appeared to improve vascular reactivity. However, 
to date, no adequately powered randomised control intervention studies have been 
performed (Givens et al., 2010; Fekete et al., 2013). Therefore, the study aims to 
investigate the acute and chronic effect of milk proteins on heart disease risk markers as 
blood pressure and vascular function. In particular, this study has been designed to test 
the hypothesis that the incorporation of whey protein in the habitual diet for 8 weeks will 
result in an increase in vascular reactivity and a reduction in blood pressure, plasma lipids 
and markers of insulin resistance compared with casein and maltodextrin (as non-protein 
control). 
140 
 
Material & methods 
 
Study protocol 
 
People with primary, prehypertension and stage 1 hypertension (i.e. blood pressure within 
range 120/80 to 159/99) were recruited (9). Twenty-one males and twenty-one females 
were recruited from the Reading area by emails to University staff and from local 
companies such as Prudential, local council etc, posters, use of Hugh Sinclair Unit of 
Human Nutrition and Sensory Dimensions participant databases, leaflets in local papers, 
and internet advertisements. Subjects were selected if they meet the study criteria. All 
participants gave their informed consent before taking part in the study. 
Inclusion criteria: 
 A signed consent form 
 Blood pressure: 120/90-159/99 
 Age: 30-65 years 
 BMI 20-35 kg/m2 
 Glucose <7 mmol/l (Not diagnosed with diabetes) 
 Chol <8 mmol/l 
 TAG <4 mmol/l 
 Normal liver and kidney function 
 Haemoglobin (>130 g/l) 
Exclusion criteria: 
 Milk allergy, lactose allergy, collagen allergy 
 Cardiovascular, renal, gastrointestinal, respiratory, endocrine, liver disease or 
cancer 
 Surgery in the previous 6 months 
 Secondary hypertension 
 Excess alcohol consumption (drinking >28 unit/wk man; >21 unit/wk women) 
 Smoker 
 Vegan 
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 Taking nutritional supplementation (e.g. fish oil, proteins) 
 Anaemia 
 Coeliac disease 
 
Potentially suitable participants were identified and asked to attend a screening session 
during which a fasting blood sample was taken and their height, weight (Tanita Europe 
BV, Middlesex, UK) and waist circumference were measured. One blood sample has been 
sent to the Royal Berkshire Hospital’s Department of Clinical Biochemistry (Reading, 
UK) for full blood count analysis and the second was used to analyse fasting blood lipids 
(total cholesterol, HDL-cholesterol and TAG) and glucose, as well as liver and kidney 
function enzymes (glomerular filtration rate, alkaline phosphatase, alkaline transferase, 
-glutamyl transferease, serum creatinine, total bilirubin and uric acid) using the Ilab 600 
(Instrumentation Laboratories Ltd., Warrington, UK). After 20-30 mins rest, blood 
pressure (BP) was measured 4-6 times for up to an hour (10-15 mins intervals) by an 
electronic sphygmomanometer in order to gain typical values and minimise ‘white coat 
effect’. 
 
Chronic study days 
 
In the chronic study subjects was randomised to one of three feeding groups (G1: 
whey/maltodextrin/casein, G2: casein/whey/maltodextrin, G3: 
maltodextrin/casein/whey). The intervention products was 56g (containing 50 g protein) 
whey protein isolate (WPI90, commercially available, provided by Volac Int. Ltd.), 
calcium caseinate (commercially available, provided by Garret Ingredients Thornbury) 
and maltodextrin (commercially available, Myprotein). The study started with a two-week 
run-in period where no intervention was provided to any of the volunteers, but they 
consumed their habitual diet and collected dietary information. During this period subjects 
attended the Hugh Sinclair Unit of Human Nutrition for a ‘familiarisation visit’ in order 
to have their blood pressure measured and the elasticity of vessels determined by 3 non-
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invasive techniques: Flow Mediated Dilatation (FMD), Pulse Wave Analysis (PWA) and 
Digital Volume Pulse (DVP). The aim of the two-week run-in period was to familiarise 
subjects with the techniques to minimise the impact of stress on the subsequent (baseline) 
assessments. 
After the two-week run-in period participants were randomly assigned to one of the three 
feeding groups (G1: whey/cmaltodextrin/casein, G2: casein/whey/maltodextrin, G3: 
maltodextrin/casein/whey). At visit 1 (baseline) subjects were advised on how to take the 
protein powders. The participants were advised to replace a drink or snack from their 
habitual diet with the study protein to ensure the diets are isocaloric. This is necessary in 
order to avoid any changes in body weight. Participants were asked to consume the 
intervention products for a period of 8 weeks. Intervention periods were separated by a 
four-week wash-out period when participants did not consume any powders. 
 
Graph 1: Chronic study design 
 
All powders are commercially available. The sachets of the studypowders were identical 
and provided in individual doses of 28g in powder form, 2 sachets were consumed a day. 
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At the end of each treatment, participants were asked whether they experienced any 
change in their health (side-effect) and how they tolerated the powders. 
During intervention, subjects were asked to attend the Hugh Sinclair Unit of Human 
Nutrition for six intervention visits (on the first and the last days of each intervention 
period) over a period of 32 weeks. During these visits, fasting spot urine and fasting blood 
samples were taken and vascular reactivity was measured. Furthermore, subjects have 
worn 24-hour ambulatory blood pressure monitors on these days. 
 
Acute study days 
 
The acute study has been designed to test the hypothesis that ingestion of breakfast 
(croissant, butter, and short breads, with a milk shake which contains 28g protein powder) 
and lunch (Philadelphia cheese sandwich, with butter and a drink containing 28 g protein 
powder) containing whey protein (mixed into water with vanilla flavouring) result in a 
postprandial increase in vascular reactivity and a reduction in blood pressure, plasma 
lipids and markers of insulin resistance compared with the equivalent dose of casein and 
maltodextrin. 
Subjects (n=24) for the acute study were the participants who were already involved in 
the chronic study. Subjects will be required to attend longer sessions at the Hugh Sinclair 
Unit of Human Nutrition on three of the chronic study visits days (the first day of each 
intervention). 
Vascular measurements (see details below) were conducted after subjects have rested for 
30 minutes. The non-invasive vascular reactivity measurements were conducted in the 
following order: FMD and PWA at baseline (at -30 mins, fasted) and at regular intervals 
(120, 300, 450 mins) following protein drink consumption (28 g protein). 
After a cannula was inserted into the ante-cubital vein, blood samples has been taken at 
30 min (fasted) before breakfast and 0, 30, 60, 90, 150, 210, 270, 330, 360, 390, 420, 480 
min after breakfast at 0 min (Graph 2). Lunch was given at 330 min. Subjects were asked 
to finish their meals within 10-20 minutes. 
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Graph 2: Acute study design 
 
Physical examination 
 
Waist circumference, height, weight and blood pressure were measured at the screening 
visit, and repeated on each of the visits performed. 
 
Blood and urine samples 
 
A 50 ml fasting blood sample were taken during each of the six chronic study visits to the 
nutrition unit. From the fasting blood samples, glucose, insulin, nitric oxide (NO), fasting 
lipids (total, LDL, HDL cholesterol, triacylglycerol and non−esterified fatty acids), 
inflammatory biomarkers (CRP, TNF−α and IL6), ACE activity, AcSDKP-activity were 
measured. Postprandial blood samples (taken during three acute study visits; total 173 ml) 
were tested for glucose, insulin, TAG, NEFA, CRP, TNF-α, IL6, and nitric oxide, ACE 
activity, AcSDKP-activity.  
A fasting spot urine sample has been collected prior to the chronic intervention visits on 
each treatment arm (week 0 and 8; 6 times in total) to the nutrition unit. From the urine 
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collection, urinary microalbuminurea (marker of microvascular disease), creatinine and 
calcium excretion were measured. 
 
Vascular measurments: Flow Mediated Dilatation (FMD) 
 
Vascular function was assessed non-invasively using FMD, a technique which assesses 
the vasodilatory response of a vessel to elevations in blood flow-associated shear stress. 
Occlusion of the forearm is created by inflating a sphygmomanometric cuff (as used for 
measuring blood pressure) on the arm. After maintaining an inflation pressure of 200 mm 
Hg for 5 minutes, the pressure is released quickly to induce a brief high flow state and 
vasodilatation of the brachial artery. The brachial artery is imaged using ultrasound both 
before the application of the cuff (baseline) and for 5 minutes after release of the pressure 
cuff. Endothelium-dependent vasodilation is assessed by measuring the change in brachial 
artery diameter compared to baseline, and is defined as % FMD. This measurement 
reflects changes in elasticity of larger blood vessels. 
 
Vascular measurments: Pulse Wave Analysis (PWA)/ Pulse Wave Velocity (PWV) 
 
Aortic compliance was assessed from carotid to femoral pulse wave velocity (PWVc-f) 
using a non-invasive Sphygmocor system and the augmentation index is calculated from 
measurements of the carotid to radial wave form. PWVc-f is computed from the time delay 
between the upstroke of the arterial pressure wave at the carotid and femoral arteries and 
the anatomical carotid to femoral distance. On each occasion subjects are rested in the 
supine for 15 min and blood pressure is recorded using an automated sphygmomanometer 
(Omron 70CP). PWVc-f is measured using the SphygmoCor VW apparatus with 
Sphygmocor analysis software (SphygmoCor version 7.01 AtCor Medical Pty, Australia). 
A total of six measurements are made with the criteria that the coefficient of variation is 
less than 5% for three of the six 
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measurements for the results to be acceptable. Augmentation index is derived from 
measurements of the carotid to radial pulse wave form using the Sphymocor analysis 
software in the pulse wave analysis mode. 
 
Ambulatory blood pressure (ABP) 
 
Ambulatory blood pressure were measured over a 24h period at baseline (week 0) and 
week 8 of each intervention period using the ScanMed Oscillometric ABP device 
(www.scanmed.co.uk). This device has been validated independently according to the 
British Hypertension Society (BHS, www.bhsoc.org) Protocol (A/A grade). 
 
Results 
 
The obtained results will be submitted to a scientific journal after the complete data 
analysis and compared with the results of the in vitro investigation of the effects of 
proteins digested, reported in the chapter I of this thesis.  
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GENERAL CONCLUSIONS 
 
This thesis focused on the study of milk proteins, antioxidant and other micronutrients 
that are likely to have significant influences as health-promoting molecules and to improve 
the nutritional quality of human and animal diets. Overall, predictive efficacy of the 
health-promoting components was determined by the use of in vitro models in all of the 
studies performed. Cell-based bioassays were found to be valuable screening tools for the 
evaluation of the cell-nutrient interaction effects. 
Milk proteins are considered important sources of bioactive peptides with high 
nutritional and functional properties. The health-promoting effects of intact whey and 
casein proteins were evaluated after in vitro SGD. Permeate (absorbed fraction) and 
retentate (intestinal fraction) were obtained and used to study their health-effects in vitro. 
Soya protein was include as non-animal protein in all the experiments performed. 
Following SGD, the milk proteins exhibited antioxidant activity, ACE-inhibitory activity 
and tropho-functional properties at the intestinal cell level. The whey protein permeate 
exhibited higher ACE-inhibitory activity compared with the casein and soya protein 
permeate. SGD increased the ACE-inhibitory activity of whey protein and the antioxidant 
activity of all the protein tested. At specific concentrations, casein, whey and soya proteins 
were able to modulate intestinal cell viability and the production of intestinal mucus. 
Moreover, the proliferation of Lactobacillus casei was increased by specific 
concentrations of whey and casein proteins. Modulations of mucus production and 
probiotic bacteria growth were observed, and casein was the primary protein that was able 
to stimulate MUC5AC gene expression and promote Lactobacillus casei growth. 
Lactobacillus casei was chosen because it is physiologically present in the human gut. 
Additionally, previous studies have demonstrated the roles of milk peptides in the 
promotion of Lactobacillus casei growth (Pecorini et al., 2005). Altogether, the analyses 
of prebiotic bacteria growth and goblet cell proliferation may represent a complementary 
approach to the study of the bioactivities and functions of food proteins in the gut. 
Additionally, the comparison of the two major intact milk proteins performed in this thesis 
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could provide valuable information regarding which is efficacious in improving health. 
However, robust and well-designed in vivo studies will be required to confirm the potential 
beneficial influences of milk-derived proteins and peptides on human health. The interest 
in studying the functionality and health-benefiting potentials of milk bioactives in 
nutritional sciences is mainly related to medical research but also represents enormous 
benefits for health and food companies and for the animal production sector, in accordance 
with the increasing interest in the production of novel functional foods to improve the 
quality of food and feed. The results of this thesis support the presently available 
knowledge, which indicates that ACE-inhibitory peptides, caseino-phosphopeptides and 
intestinal health-promoting peptides from milk should be used for the formulation of 
healthy foodstuffs. The obtained results will stimulate both in vitro future studies aimed 
at the complete determination of the influences of milk proteins on the different target 
organs and their specific modes of action and in vivo studies with high predictive power, 
regarding human health. The in vivo human intervention study conducted at Reading 
University is currently addressing this topic and will help to define the roles of the intact 
milk proteins used in this thesis, in different human health parameters. 
Vitamin E supplementation is a common practice in animal nutrition due to its 
health-promoting effects as an antioxidant. Vitamin E seems to be involved in immune 
system improvements and the promotion of animal health and production (Vagni et al., 
2011). Hung et al. (2004 & 2005) demonstrated an inverse relationship between 
antioxidant vitamin intake and CVD in humans. Vitamin E is considered to be one of the 
most important components of the cellular antioxidant system. In this thesis, the 
antioxidant roles of specific concentrations of α-tocopherol were demonstrated in vitro 
based on the ability to reduce oxidative damage induced by food toxicants, such as OTA. 
α-tocopherol was found to play an important role in reducing oxidative stress at the 
cellular level, in different cell models. Food toxicants, such as OTA are able to disrupt 
cell monolayers and damage DNA, which leads to cell death, as demonstrated in this 
thesis. Food toxicants reduce occludin membrane localization and influence cell-cell 
interactions, and these effects can be counteracted by the presence of antioxidants. In this 
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thesis, it was demonstrated that α-tocopherol supplementation may counteract short-term 
OTA toxicity at different cellular levels, which supports the defensive role of α-tocopherol 
in the cell membrane. Furthermore, the obtained results demonstrated that α-tocopherol is 
able to influence the functional interactions between tight junction proteins, which 
supports its protective roles in the cell membrane and cellular metabolism. The 
immunofluorescence analyses performed in this thesis revealed changes in the patterns of 
occludin and Zo1 in the presence of OTA. Pre-treatment with α-tocopherol blocked the 
loss of occludin protein in the tight junctions of kidney cells. 
During my Ph.D., I have also investigated the in vitro roles of different 
micronutrients, specifically choline/methionine and different Zn formulations. Due to 
their physiological health-promoting effects, they are commonly used in animal nutrition 
and are parts of normal diets. Previous in vivo animal studies have indicated a potential 
relation between methyl groups and oxidative status and a direct effect of choline on 
antioxidant status. Choline and methionine have been identified as required nutrients and 
exhibit various biological functions in cells that include the regulation of growth and 
proliferation. The results of this thesis confirmed that choline and methionine have 
important roles in enhancing cell viability and counteracting oxidative stress in conditions 
of oxidative stress. Despite the wide use of Zn as animal feed supplement, few studies 
have focused on its effect in vitro. In vitro studies may be useful for improving Zn 
supplementation in animal feed and in human formulations. The intestinal cell lines INT-
407 and IPI-2I were found to suitable models of the intestine and represent simple tools 
for investigations of the role of Zn supplements. Specific concentrations of both ZnO and 
ZnCl2 are considered to be capable of maintaining the viability of intestinal cells, which 
underlines the beneficial role of Zn in on the human and swine intestinal epithelia. 
Overall, these results contribute to the definition of the role of dietary health-
promoting compounds in human and animal target tissues. The use of in vitro cell-based 
models to screen the biological activities of single compounds at specific concentrations 
and in strictly controlled environments could offer novel insights in the field of human 
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and animal nutrition; thus, in vitro models are an essential tool. However, cell-based 
models may not exactly reflect the in vivo conditions of the cells in their natural state in 
the intact organism in which bioavailability, metabolism and binding and transport 
proteins may influence the biological effects of dietary components. Therefore, further in 
vivo experiments are necessary to extend the in vitro results and to clarify the contributions 
of health-promoting components in animal feed and in human formulations. 
The improved knowledge regarding milk protein bioactives, antioxidants and 
micronutrients represents a crucial point for future systematic efforts to improve food and 
feed quality. Finally, the dietary bioactive components with health -benefits supported by 
sufficient scientific substantiation have the potential to be increasingly important 
components of healthy lifestyles and to benefit the public and the food industry. 
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